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cavities following 1, 2 and 4 hours of incubation. Cells as time progresses cells are shown to be 
reverting from a spherical to a dendritic morphology typical of cultured neuroblasts giving 
preliminary indications that captured cells remain viable. 
Page 129: Figure 3.8. Confocal images of cells at x400 magnification treated with DiOC6 (green) and 
DRAQ-7 (red) dyes illuminated with a 488 nm Argon laser to show the progression of lysis by 
osmotic imbalance as an onset of DRAQ-7 localisation within nuclei.  
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Page 132: Figure 3.9. FeSEM image of microcavity surface at 20000x magnification using 
accelerating voltage of 20 kV and working distance of 3.4 mm, showing PtNP immobilised to the 
inner surface of a gold microcavity. 
Page 133: Figure 3.10. i/t curves for peroxide detection of immobilised PtNP in 10 mM H2SO4 at a 
potential of -250 mV vs Ag/AgCl for microcavity arrays ranging from 106 – 100 cells and  no cell 
control. At 600 seconds the program is paused and an injection of H2O2 is made to 200mM, when the 
program is resumed a sharp current increase is observed. At 2400 seconds the program is stopped and 
the final current is recorded. 
Page 134: Figure 3.11. Final currents from PtNP detection runs vs total number of cells applied to 
microcavity arrays. Currents generation was carried out by the injection of H2O2, to a final 
concentration of  200 mM under an applied potential of -250 mV vs Ag/AgCl. 1800 seconds after the 
peroxide injection the final current is measured. 
Page 136: Figure 3.12. Currents evolved from amperometric i/t curves carried out on microcavity 
arrays in 10mM H2SO4  with 200mM H2O2 at an applied potential of -100mV vs. Ag/AgCl over a 
range of miR-132 concentrations from 1ȝM to 1aM showing no linear correlation to miRNA 
concentration. Error bars were generated from repeated independent electrodes where n = 3. 
Page 137: Figure 3.13. Example of i/t curve for peroxide detection of immobilised PtNP in 10 mM 
H2SO4 at a potential of -100mV vs Ag/AgCl. At 600 seconds the program is paused and an injection 
of H2O2 is made to 200mM, when the program is resumed a sharp current increase is observed. At 
2400 seconds the program is stopped and the final current is recorded. 
Page 138: Figure 3.14. Cyclic voltammograms in 0.5mM FcMeOH vs. Ag/AgCl at a scan rate of 100 
mV/s  of a bare microcavity array (black), the microcavity array following modification with an 
alkanethiol monolayer (blue) and the microcavity array following amperometric i/t curve carried out 
in 10mM H2SO4 with 200mM peroxide under an applied potential of -100mV vs. Ag/AgCl (Red).  
Page 140: Figure 3.15. Currents evolved as a result of amperometric i/t curves carried out using gold 
microcavity arrays as working electrodes in 10mM H2SO4 with varying concentrations of H2O2 at -
250 mV vs. Ag/AgCl.Error bars (not visible for 2 mM and 200μM) were generated from repeated 
independent elecrtrodes where n = 3. 
Page 141: Figure 3.16. Voltammograms of microcavity arrays carried out in 2mM FeMeOH with 10 
mM H2SO4 as supporting electrolyte from 0 to 600 mV vs. Ag/AgCl at a scan rate of 100 mV/s before 
and following amperometric i/t curves carried out in varying concentrations of H2O2 to investigate 
stripping of functional materials from the surface of the electrode.  
Page 143: Figure 3.17. Values for current per cm2 recorded for miRNA assay carried out on 
microcavity arrays (Blue) compared with those recorded for planar gold electrodes (Red). Error bars 
were generated from repeated independent electrodes where n = 3 
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Page 145: Figure. 3.18. Secondary emission FeSEM image of 1ȝm cavity at 120000x magnification 
under an accelerating voltage of 20 kV with visibly apparent nanoscale imperfections on the inner 
surface of the microcavity. 
Page 148: Figure 3.19. Cyclic voltammograms of 3µm microcavity arrays carried out in 10 mM 
H2SO2 vs Ag/AgCl at a scan rate of 100 mV/s before and following attempts to temperature anneal 
the nanoscale roughness of cavities. Through integration of the gold oxide reduction peak the 
microscopic surface area of the microcavity arrays were measured and shown to have decreased. This 
observation would suggest that nanoscopic imperfections in the surface of the microcavity array that 
are considered to be the cause of background peroxide reduction have been annealed together due to 
the phenomenon of melting point depression. Note: tick marks on the y-axis are given in 100 μA 
increments. 
Page 159: Figure.4.1. Schematic representation of electrode fabrication and miR-132 detection 
strategy. A planar ITO electrode (A) is functionalised with a self-assembled monolayer of 16-
phosphonohexadecanoic (B). Metal nanoparticles are then electrodeposited through the monolayer (C) 
and then a self-assembled monolayer of thiolated capture oligonucleotide is formed on the surface of 
the metal nanoparticles (D). The electrodes are then incubated in a solution of miRNA target and a 
portion of the target, miR-132, hybridises to the capture strand on the nanoparticles (E). An 
oligonucleotide-luminophore probe is then allowed to hybridise to the free end of the miRNA target 
(F) and this probe is then detected through electrochemiluminescence. 
Page 165: Figure. 4.2. Cyclic voltammogram of a 3 mm diameter glassy carbon electrode between 
800 and -200 mV Vs. Ag/AgCl carried out in 2mM FcMeOH and 100mM phosphate buffer as 
supporting electrolyte at a scan rate of 100 mV/s. 
Page 167: Figure 4.3. Solution redox voltammetry shown for 20ȝM RuPICNH2 in 100mM phosphate 
buffer. Voltammetry was carried out using a 3 mm diameter glassy carbon electrode and a potential 
window of 600 – 1500 mV vs. Ag/AgCl at scan rates between 20 and 7.5 V s-1. The single electron 
oxidation/ reduction process of RuPICNH2 is observed at approximately 1100 mV vs. Ag/AgCl. 
Page 168: Figure.. 4.4. Plot of log ʋ vs. Log Ipc for RuPICNH2 aqueous voltammetry data. 
Voltammetry was carried out using a 3 mm diameter glassy carbon electrode and a potential window 
of 600 – 1500 mV vs. Ag/AgCl at scan rates between 20 and 7.5 V s-1 vs. Ag/AgCl. 
Page 169: Figure. 4.5. Differential pulse voltammetry data for 25µM RuPICNH2 and 25µM RuBpy3 
in 10mM PBS with a 3 mm diameter glassy carbon working electrode and platinum counter electrode, 
carried out vs. Ag/AgCl. Oxidation of both compounds is observed at approximately 1100 mV. 
Page 171: Figure 4.6. ECL output of solution of 2ȝM Ru(bpy)2PIC-NH2 in 10mM PBS with 10mM 
TPA as co-reactant Vs. Ag/AgCl at a scan rate of 100 mV/s. The onset potential of ECL signal is 
observed to be between 700 and 800 mV and the oxidation of Ruthenium compounds is observed at 
approximately 1100 mV. 
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Page 173: Figure 4.7. Reaction Scheme for the Conjugation of thiolated probe oligonucleotide strand 
to RuPICNH2 luminophore via CBTF crosslinker. First step of the reaction is carried out in DMSO at 
room temp. for a minimum of 10 minutes followed by addition to an biomimetic aqueous solution of 
oligonucleotide and reacted for a minimum of 60 minutes. Reproduced from Kolodych, S., Koniev, 
O., Baatarkhuu, Z., Bonnefoy, J.Y., Debaene, F., Cianferani, S., Van Dorsselaer, A., and Wagner, A., 
CBTF: New Amine-to-Thiol Coupling Reagent for Preparation of Antibody Conjugates with 
Increased Plasma Stability. Bioconjugate Chemistry, 2015. 26(2): p. 197-200 
Page 175: Figure 4.8. ECL data for miR-132 detection assay carried out on planar gold electrodes in 
10mM DPBS and 50mM TPA as co reactant. ECL signal was generated by cyclic voltammetry 
between 200 and 1800 mV vs. Ag/AgCl at a scan rate of 100 mV/s. 
Page 179: Figure 4.9 Cyclic voltammograms of ITO electrode throughout the fabrication of metal 
nanoparticles on the electrode surface. 2 mM FcMeOH in 100 mM PB was used to determine the 
electrochemical surface area of a bare ITO electrode (Blue), electrode following the formation of a 
C16 monolayer on the surface (Red) and following the electrodeposition of nanoparticles to the surface 
(green). Voltammetry was carried out vs. Ag/AgCl at a scan rate of 100 mV/s. 
Page 181: Figure 4.10. Cyclic voltammetry and FeSEM images of nanoparticles formed at varying 
concentrations of HAuCl4 with varying deposition times. Cyclic voltammetry of ITO AuNP substrates 
was carried out in 10 mM H2SO4 Vs. Ag/AgCl at a scan rate of 100 mV/s, and integration of the gold 
oxide formation peak at approximately 800 mV was used to determine the overall surface area of gold 
electrodeposited to the electrode surface. FeSEM SE imaging was carried out under an accelerating 
potential of 2.0 kV.  
Page 182: Figure 4.11. Amperometric i/t curves generated during electrodeposition of nanoparticles to 
the surface of ITO electrodes. Note, the initial 20 ms nucleation overpotential had been omitted in 
order to show detail. Values for charge passed during deposition of AgNP, AuNP and PtNP were 188, 
331 and 72.3 mC respectively. 
Page 184: Figure. 4. 12. Cyclic voltammogram of PtNP electrodeposited to ITO electrode between 
1500 and -300 mV Vs. Ag/AgCl at a scan rate of 100 mV/s..  carried out in 10mM H2SO4 as 
supporting electrolyte. At approximately 200 mV the peak associated with Pt reduction is observed 
indicating the formation of PtNP on the surface of the electrode. Further evidence of PtNP formation 
is observed as the onset of current at approximately -350 mV  due to the evolution of hydrogen gas by 
water hydrolysis at the Pt surface. Through integration of the platinum reduction peak at 
approximately 200mV the surface area of Pt deposited to the surface of the electrode may be 
determined. 
Page 185: Figure 4.13. Cyclic voltammogram of AgNP electrodeposited to ITO electrode between 
1000 and -200 mV Vs. Ag/AgCl at a scan rate of 100 mV/s..  carried out in 10mM H2SO4 as 
supporting electrolyte. Oxidative and reductive peak maxima associated with AgNP occur at approx. 
550 and 200 mV vs. Ag/AgCl respectively. 
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Page 187: Figure. 4.14. FeSEM images of (A)AuNP, (B)AgNP and  (C)PtNP electrodeposited to ITO 
electrodes. Imaging shows that AuNP and AgNP samples exhibit good size and  spatial distribution 
on the electrode surface, while PtNP electrodeposited to the surface show markedly poorer spatial 
distribution on the electrode surface and a broader distribution of nanoparticle diameter. 
Page 188: Figure. 4.15. Size distribution data for AuNP, AgNP and PtNP respectively. AuNP and 
AgNP deposition yields particles with an average size of 45nm and 71nm respectively, however the 
electrodeposition of PtNP shows poor control over size. 
Page 189: Figure. 4.16. Overlaid absorption spectra of AuNP electrodeposited to an ITO electrode 
with that of commercial nanoparticles in solution of varying sizes. Absorbencies of both solution and 
surface bound nanoparticles were determined in deionised water using a 5x7 mm windowed cuvette 
and a pathlength of 1 cm. 
Page 191: Figure. 4.17. Absorption plots of both commercial 40nm AuNP in solution and AuNP 
electrodeposited to the surface of an ITO electrode normalised to the number of nanoparticles in each 
sample. 
Page 192: Figure 4. 18. Overlaid surface plasmon absorption spectra of AuNP AgNP and PtNP 
deposited to the surface of ITO electrodes. The Ȝmax for AuNP, AgNP and PtNP were 562 nm, 428 nm 
and 520 nm respectively. 
Page 195: Figure. 4.19. Raman spectra of nanoparticle-ITO electrodes with C16 monolayers on the 
surface conjugated to RuPICNH2. Samples were excited with a 514 nm laser at 100% intensity using a 
50x objective with a 300 µm for 10 accumulations and an acquisition time of 10.  For both AuNP and 
AgNP, a peak can be seen at ~1600 cm-1, believed to be a combination of peaks associated with C=C 
stretch modes of the bipyridyl groups, however this cannot be resolved. 
Page 197: Figure. 4.20. Raman spectra of nanoparticle-ITO electrodes with RuPICNH2 immobilised 
to the surface through hybridised miRNA. Samples were excited with a 514 nm laser at 100% 
intensity using a 50x objective with a 300 µm for 10 accumulations and an acquisition time of 10.  
Both AuNP and AgNP electrodes exhibit strong raman signals associated with the bipyridyl groups of 
RuPICNH2. 
Page 199: Figure. 4.21. Confocal microscopy images of ITO-NP electrodes used in raman study. 
Images on the left are PT, Au and Ag monolayer-luminophore conjugated surfaces respectively, 
exhibiting a high degree of background luminescence due to conjugation of luminophore to the entire 
electrode surface. Images on the right are of miRNA bound luminophore exhibiting better 
nanoparticle definition. 
Page 201: Figure. 4.22. Overlaid ECL outputs of planar ITO (Blue) and AuNP ITO (Red) in the 
absence of RuPICNH2, and planar ITO (Green) and AuNP-ITO (Purple) in the presence of 500 nM 
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RuPICNH2. All ECL was carried out in 100mM phosphate buffer with 50mM TPA as co-reactant vs. 
Ag/AgCl at a scan rate of 100 mV/s. 
Page 202: Figure. 4.23. ECL intensities of Planar and AuNP ITO electrodes plotted as a function of 
[miR-132] incubated with the electrode surface. All ECL measurements were carried out in 100mM 






Electrochemical Cellular and Nucleic Acid Based Biomarker 




The rapid, specific, and sensitive detection of biomarkers for disease state and 
progression has become an expansive field in research due to advances in both the 
understanding of biomarkers and diagnostic detection strategies. The detection of 
both cellular and molecular biomarkers through electrochemical means provides a 
rapid and sensitive strategy for the detection of specific markers of disease, in this 
case neuroblastoma. Chapter 1 of this thesis reviews the current literature reports on 
both cellular and molecular biomarkers for neuroblastoma disease progression as 
well as detection methods, both electrochemical and otherwise, that may be applied 
to the detection of neuroblastoma. 
In Chapter 2 the detection of cellular biomarkers of neuroblastoma via 
electrochemical analysis is discussed, chiefly focusing on the immobilisation of 
neuroblastoma cells to an electrode surface and the subsequent detection of 
immobilised cells through electrochemical impedance spectroscopy and 
amperometric detection of electrocatalytic platinum nanoparticles. Following on 
from this, Chapter 3 focuses on the detection of a molecular biomarker of 
neuroblastoma disease progression, miR-132. This detection strategy relies on the 
partial hybridisation of the miRNA target, miR-132, to a self-assembled monolayer 
of nucleic acid strands on the surface of an electrode. Electrocatalytic platinum 
nanoparticles uniformly decorated with probe oligonucleotides are then hybridised to 
the free end of the miRNA target and detected amperometrically through the 
electrocatalytic reduction of H2O2 at the nanoparticle surface. 
The focus of this work then shifts in Chapter 4 to the formation of a detection 
strategy based on electrochemiluminescence, whereby a luminophore, Ruthenium II 
(bis-2,2-bipyridyl)-2(4-aminophenyl) imidazo[4,5-f][1,10] phenanthroline is 
immobilised to the surface of a nanoparticle decorated electrode surface and is 
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detected by ECL. This body of work explores possible avenues for the enhancement 
of the electrochemiluminescent signal generated by immobilised luminophore by 
plasmonic enhancement of luminescent signal through nanotexturing of electrode 
surfaces. Chapter 4 then details work carried out to translate this work to a working 
assay for the detection of miRNA using multiple combinations of nanoparticle 
(Au/Ag/Pt) and luminophore. By carefully selecting the electrode surface and 
luminophore an overall enhancement of signal is observed for immobilised probes 
and a calibration plot for the concentration of miR-132 applied to the electrode 


















1. Literature Review. 
 
1.1. miRNA and Neuroblastoma. 
 
1.1.1. Neuroblastoma Overview. 
 
Neuroblastoma is the most common form of extracranial solid tumour found in 
children and arises from embryonal malignancies within the sympathetic nervous 
system. Neuroblastoma in children over the age of eighteen months often requires 
aggressive multimodal treatment and is associated with a mortality rate of 50 – 
60%[1]. However, in cases where patients are children below the age of eighteen 
months most cases can be cured with moderately intensive treatment and in some 
cases spontaneous regression can occur whereby no treatment is required[2]. This 
gives rise to a degree of clinical uncertainty as to whether a malignancy should be 
approached aggressively in order to affect the highest certainty  of disease 
eradication or use milder treatments to spare the patient the potentially life changing 
effects of more aggressive treatment. Therefore, it would be favourable to have a 
fast, highly specific and highly sensitive method of detecting and profiling tumour 
cells that is minimally invasive. Reliance on age profiling for the identification of 
aggressive malignancies is not specific and the challenge currently is to develop an 
analytical approach to define malignancies so that therapeutic approaches may be 
tailored to patients on an individual basis. Between the 1980s and mid 2000s the 
standard model for screening of preclinical Neuroblastoma was the detection of 
catecholamine metabolites in urine[3].  However, this approach offers little 
information about the intrinsic properties of the metastasis and studies showed that 
this led to the unnecessary treatment in many cases of patients that would have had a 
similar outcome if their condition had not have been detected[3, 4]. This led to the 
cessation of a public health initiative in Japan in 2004 that had been screening infants 
for neuroblastoma since 1984[5].  
Extensive research[6-11] has been carried out to date to identify biomarkers for 
different disease states of neuroblastoma, including genomic and proteomic 
approaches. Several studies carried out show that epigenetic regulation of cellular 
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processes plays an important role in neuroblastoma pathophysiology[6, 9, 11, 12] 
and for this reason it is an attractive approach for the identification and profiling of 
tumour cells. Qualitative identification of malignancies through specific epigenetic 
biomarker detection allows for the profiling of disease pathophysiology.  This may 
provide insights into the disease state and the cellular processes within the 
malignancy, allowing clinical samples from patients to be profiled on the basis of the 
diseases exact state of progression. Thus, the patient’s treatment can be tailored to 
their exact disease state, avoiding the possibility of excessive or inadequate 
treatment. 
Patients in the later stages of disease progression and, therefore at a greater risk, have 
been shown to develop circulating tumour cells (CTC), the incidence of which has 
been linked to poorer prognoses in patients[13, 14]. Immobilisation and detection of 
CTC provides a minimally invasive route for the detection of disease as it 
circumvents the requirement for biopsy tissue sampling. Profiling of CTC can then 
be carried out to determine the exact pathophysiology of the malignancy and also 




1.1.2. Epigenetic Regulation and miRNA. 
 
The field of epigenetics refers to the variety of physiological traits of a cell that are 
not due to a change in the sequence of its DNA, but rather the post transcriptional 
regulation of cellular processes, for example the regulation of messenger RNA 
translation by smaller genetic elements known as micro RNA (miRNA). miRNA are 
short non coding strands of RNA, usually around 22 nucleotides (nt) in length.  They 
were discovered in the early nineties by Lee et al in C. elegans, when they found that 
the gene lin-4 that was previously implicated in the timing of larval egg development 
did not encode for a protein but instead produced two short strands of RNA 61nt and 
22nt in length, of which the former was thought to be a precursor to the latter[15]. 
These short RNA strands were found to be complementary to sites in the 3’ 
untranslated region (UTR) of the lin-14 gene that had previously been implicated in 
the down regulation of lin-14 expression by Wightman et al. in 1991[16]. Further 
studies by Wightman et al. in 1993 showed that the transcriptional products of the 
lin-4 gene led to reduced levels of the LIN-14 protein without a significant reduction 
in messenger RNA (mRNA). This led to the proposal of a regulatory pathway in 
which the silencing of the lin-14 gene occurs by the base pairing of short lin-4 RNAs 
to the 3’UTR of the lin-14 gene transcript that interrupts protein production at the 
translation step[17]. 
Since then the biogenesis and mechanism of repression by miRNA has been 
elucidated and well documented in the literature. The vast majority of miRNA 
encoding genes are structurally similar to those of normal protein encoding genes 
and primary miRNA transcripts (pri-miRNA) are produced by RNA polymerase II, 
though some may be transcribed by RNA polymerase III. These transcripts in many 
cases require splicing along with capping and polyadenylation. Within the nucleus, 
the microprocessor complex, containing the class 2 ribonuclease III enzyme Drosha 
along with the RNA binding protein DGCR8, carry out the cleavage of Pri-miRNA 
into stem loop structures of precursor-miRNA. From the nucleus the pre-miRNA are 
transported to the cytoplasm by RAN-GTP dependent exportin 5 where they are fully 
processed to miRNA. This final processing step is carried out by the Ribonuclease 
III enzyme Dicer, which cleaves the stem loop from the pre-miRNA to leave a 
double stranded miRNA fragment. The strand that is to be used in miRNA 
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signalling, commonly referred to as the guide strand is then capable of associating 
with the protein argonaute while the remaining strand is discarded. The protein 
argonaute is associated with a much larger polypeptide known as the RNA Induced 
Silencing Complex (RISC) which carries out the silencing of mRNA to post-
transcriptionally regulate gene expression within the cell. The complete RISC is 
directed to the mRNA via the miRNA associated with it and the miRNA hybridises 
to the mRNA with imperfect complementarity. Importantly, this ability of miRNA to 
hybridise with their targets in an imperfect manner means that a single miRNA can 
be implicated in the regulation of many mRNA. Once hybridised the mRNA cannot 







Figure 1.1. Depicted here is the archetypical pathway for miRNA. While many deviations from this 
linear pathway of expression exist this is by far the most common route for the expression of miRNA 
and its subsequent cellular regulation action. Reproduced from Winter, J., et al., Many roads to 




1.1.3. miRNA and Oncogenesis. 
 
Despite the discoveries made by Wightman & Lee in 1993 the field of miRNA 
epigenetics did not begin to gain widespread popularity until 2001 when the full 
extent of the involvement of miRNA in cellular regulation and disease 
pathophysiology began to develop[19-21]. Since then a great deal of interest has 
been taken in the regulatory roles of miRNA within the cell. Currently, there is a vast 
amount of literature detailing the involvement of miRNA in apoptosis and 
proliferation, and to this end there is a great deal of interest in the relationship 
between miRNA and cancer. Many studies have shown that the miRNA expression 
profile of a cancer cell can differ not only from that of a healthy cell, but can also 
give details about the disease state of certain tumours, including Neuroblastoma[6, 
22]. The c-MYC oncogene, for example, which has been shown to be a distinctive 
feature of malignant Neuroblastoma along with n-myc another oncogene[23], plays a 
part in a whole host of reprogramming effects of the cell when aberrantly expressed, 
has also been shown to have a profound effect on the expression profiles of miRNA 
that have been implicated in the downstream regulation of genes involved in the cell 
cycle, apoptosis, angiogenesis and metastasis. 
The c-MYC oncogenes ability to promote tumorigenesis by miRNA regulation is 
two-fold. Not only does it decrease the expression of miRNA involved in tumour 
suppression and apoptosis, but it also increases the expression of miRNA involved in 
cell proliferation and avoiding apoptosis. For example, c-MYC expression directly 
promotes the expression of the miR-17-92 miRNA gene cluster that has many roles 
in the development of cancer. In this cluster, miR-17 and miR-20a help to control the 
expression of the E2F1-3 genes that control the procession of the cell cycle from G1 
to S phase. Overexpression of E2F1-3 can induce G1 cell cycle arrest and therefore 
expression of the E2Fs requires strict control. The inhibitory effects of these two 
miRNA, coupled with the promoting effects of MYC on the E2F1-3 locus has been 
hypothesised to fine tune the timing of activating EF2s and promote the procession 
of the cell cycle from G1 to S phase to avoid cell cycle arrest[24]. miR-17 along with 
related miRNA in its cluster also can inhibit the expression of the cyclin dependant 
kinase p21 which is essential for the cell cycle arrest checkpoints between G1-S and 
G2-M phases. Therefore, increased concentrations of these miRNA can ensure the 
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bypassing of DNA damage checkpoints in the cell cycle and therefore promote 
proliferation[25]. In contrast, many miRNA are also down regulated during aberrant 
expression of c-MYC that would otherwise inhibit proliferation, for example the 
miR-34a that controls the production of cyclin dependant kinases (CDK4, CDK6) 
essential for the formation of the protein kinase complex that facilitates the 
progression of the cell cycle[26, 27]. Therefore, the combined effects of both up and 
down regulation of miRNA expression has a powerful combined effect on the 
proliferation of the cell. 
 
 
Figure 1.2. Myc mediated oncogenesis. c-Myc along with n-Myc are often found to be involved in the 
development of neuroblastoma. Here it can be seen that Myc mediated miRNA expression is a 
precipitating factor in the dysregulation of many processes that promote oncogenesis such as cell 
cycle upregulation and inhibition of apoptosis. Reproduced from Bui, T.V. and J.T. Mendell, Myc: 




c-MYC expression can also have a profound effect on avoiding apoptotic cell death 
by inhibiting miRNA directly involved in apoptosis. MYC directly represses the 
expression of the miR-15a/16-1 cluster that is involved in the silencing of the genes 
responsible for the formation of  the BCL-2 protein that is important for inhibiting 
apoptosis[29]. Without these miRNA to repress BCL-2 formation the cell cannot 
transduce apoptosis signals. MYC also represses  miR-34a, a direct target of p53 and 
contributor to p53 dependant apoptosis[27]. Ectopic expression of the miR-17-92 
gene cluster has been shown to inhibit apoptosis without having a profound effect on 
proliferation in mouse models engineered with enhanced c-MYC expression. 
Furthermore, within this cluster it has been demonstrated that the miR-19 family can 
increase the signalling of phosphoinositide – 3 kinase (PI3K) by the repression of the 
PI3K antagonist PTEN[30]. PTEN dephosphorylates phosphatidylinositol-3,4,5-
Kinase (PIP3), the target of PI3K. PIP3 regulates the activation of AKT downstream 
which in turn activates pathways important in cell growth and survival[31].  
This underscores the extensive manner in which changes in miRNA expression by 
only a single oncogene can have a profound effect on a cell and it’s differentiation to 
a tumour precursor. Therefore, if we can understand the targets of miRNA regulation 
and the processes their targets mediate, then we can use a cell’s expression profile of, 
for example miR-17-92 or miR-34a, to make inferences about the cells disease state 
or likelihood to contribute to metastasis. This is a prime example of why the direct 
detection of intracellular miRNA concentrations is gaining interest. Increasing 
research is being directed into the identification and exploitation of miRNA as 







1.2. Methods for miRNA detection: Current and Emerging. 
 
1.2.1. Hairpins and Molecular Beacons 
 
Since the discovery of miRNA, many different methods have been developed for 
their detection [32-39]. These methods may be characterised by the phase in which 
they are carried out, i.e. solid or solution. In general, solid phase detection methods 
rely on a hybridisation event between a complimentary strand of RNA covalently 
bound to a solid support and the target miRNA, this hybridisation event can then be 
detected and by changing the identity of the label used for each target and several 
different capture strands may be attached to a single surface giving rise to highly 
multiplexed assays. However, the drawback is that it is not suitable for the study of 
miRNA in vivo. Conversely, solution phase experiments rely on the hybridisation of 
a probe strand on RNA in solution with a target, which allows for the detection of 
miRNA in vivo, and in cases where a fluorescent probe is used to produce a signal 
upon hybridisation of the target and probe.  Solution based methods can be used to 
observe intracellular localisation of miRNA. 
As illustrated in Figure 1.3, an example of a solution based method similar to this is 
the employment of a RNA hairpin loop molecular beacon that has a fluorescent dye 
and a quencher on either ends.  In the loop form, the dye and quencher are in close 
proximity and emission is quenched. Hybridisation with a target miRNA strand 
causes the dye and quencher to separate turning on emission. Typically, hairpin 
loops of this nature are single strands of RNA or DNA that have a region of 
antisense complementarity to a target miRNA flanked by short regions or self-
complementarity 4-7nt in length at the 3’ and 5’ ends, resulting in the formation of a 
loop structure in the absence of the miRNA target. The 3’ and 5’ termini are 
covalently modified with a dye and a suitable quencher so that in the absence of the 
miRNA target the dye and quencher are in close proximity to one another and no 
fluorescence is observed. However, upon hybridisation with the target miRNA, the 
hairpin loop undergoes a conformational change, separating the 3’ and 5’ termini, 
with their bound dye and quencher molecules allowing fluorescence to be observed. 
This offers a highly specific, transfectable method for detecting miRNA targets 
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within live cells and can be exploited to determine the relative concentration of 
miRNA between intracellular locations, which may be employed to make inferences 
about their function. However, as a quantification tool, this method performs poorly 
compared to other methods available due to discrepancies in the amount of beacon 
successfully transfected within the cell. This method can be used to carry out in vitro 
quantification[33], but by far the more standard approach for in vitro quantification 
of ribonucleic acids is to use reverse transcriptase PCR (RT - PCR). 
 
 
Figure 1.3. Stem loop detection method employed by Baker et al. Hybridisation of a mature miRNA 
to the stem loop structure of the probe separates the dye and quencher molecules in space as the 
termini of the probe are separated. This results in the loss of FRET between the two and the 
fluorescent dye may then be imaged. Therefore, the concentration of miRNA target may be measured 
as a function of fluorescent intensity  Reproduced from Baker, M.B., G. Bao, and C.D. Searles, In 
vitro quantification of specific microRNA using molecular beacons. Nucleic Acids Research, 2012. 




1.2.2. Amplification by PCR.  
 
Initially used for the detection of mRNA, RT - PCR dramatically increased the 
sensitivity at which mRNA could be studied compared to existing techniques[40]. 
RT - PCR is used in the detection of RNA targets by first converting the RNA 
sequence to complementary DNA (cDNA) using the enzyme reverse transcriptase 
and then amplifying the cDNA by PCR. As the concentration of PCR products is 
doubled for each subsequent cycle (assuming 100% PCR efficiency) the number of 
cycles required to amplify the cDNA to the detection threshold is inversely 
proportional to the initial concentration of cDNA and therefore the initial 
concentration of miRNA. Quantitative analysis can be carried out by using a Taqman 
probe that produces a fluorescent signal with each subsequent amplification step. 
Taqman probes are short single stranded DNA sequences modified at either end with 
a fluorescent probe and complementary quencher molecule that suppresses 
fluorescence. During quantitative PCR the probe hybridises to the DNA to be 
amplified and is the hydrolysed by the 3’-5’ exonuclease of Taq polymerase as it 
synthesises the nascent strand. As the Taqman probe is hydrolysed the quencher and 
fluorophore are separated and the concentration of free fluorophore can be measured. 
Since their initial development, these methods of mRNA detection have allowed 
cases of minimal disease, either early on or residual following treatment, including 
Neuroblastoma, to be detected[41-43]. 
One of the most clinically defining characteristics of neuroblastoma is the increased 
levels of catecholamine output and as such, nucleic acid based detection methods for 
the identification of Neuroblastoma are aimed at identifying increased levels of 
mRNA coding for Tyrosine hydroxylase , the enzyme responsible for catalysing the 
initial step of catecholamine synthesis. This method has been shown to be a robust 
and effective diagnostic tool in the detection of minimal residual disease associated 
with relapse and poor prognosis[22]. This method of quantifying mRNA has also 
been applied to miRNA. However, the small size of miRNA can pose problems. 
PCR usually requires a sequence to be at least double the length of the forward and 
reverse primers, which are usually ~20nt in length to convey good specificity. 
miRNA themselves are ~22nt in length and therefore are too short to amplify by 
traditional means. This problem can be overcome by using a stem loop structure to 
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produce a strand long enough to be amplified that contains the miRNA sequence. 
Hybridising a stem loop RT primer to the 3’ end of the miRNA and initiating reverse 
transcription produces a strand of cDNA complementary to the miRNA on the 3’ end 
of the stem loop structure. The stem loop itself features a universal primer sequence 
for the reverse primer to hybridise to and the forward primer is a DNA analogue of 
the miRNA. Quantification of the PCR products can be carried out in a similar 
fashion to the method described above. This provides a simple and relatively 
economical method for the detection and quantification of miRNA. This method has 
been shown to have improved specificity over linear primers due to base stacking 
and the spatial minimisation of the stem loop structure.[41] RT-qPCR is considered 
to be low to medium throughput, meaning that determining the expression profile of  
many miRNA in a cell for example could prove to be quite labour intensive, however 
recent work has been carried out to increase the number of miRNA that can be 
analysed in a single process[37]. Despite this being a useful tool for the analysis of 
several miRNA concentrations within a reasonably short time frame, it is limited to 






Despite the progress on PCR, for truly high throughput analysis of miRNA 
expression a microarray may be required. Micro arrays rely on the hybridisation of a 
solution phase target nucleic acid to a solid phase capture strand covalently bound to 
a substrate. Once hybridised the target can usually be visualised using a fluorescent 
probe. Each spot or feature on a microarray consists of picomoles of identical 
capture strands of DNA that will specifically hybridise to a target of interest and due 
to advances in microfabrication tens of thousands of DNA strands may be featured 
on a single chip allowing for the detection of thousands of different miRNA from a 
single sample. In the case of miRNA detection, the total RNA content of a sample is 
reverse transcribed and labelled with a fluorescent reporter molecule or a 
label/antigen to bind a fluorescent reporter following hybridisation and washing. 
Further enrichment of short RNA fragments may be carried out by fractionation prior 
to hybridisation to remove cDNA fragments too large to be miRNA and the resulting 
enriched sample is applied to the microarray. Following hybridisation, the array is 
washed and a fluorescent reporter molecule is applied. The microarray is then placed 
in a scanner which measures the relative fluorescent intensity of each feature on the 
array, allowing for both qualitative and quantitative analysis of miRNA expression. 
In a protocol published by Liu et al, the cDNA is labelled with two biotin molecules 
during reverse transcription and following hybridisation Alexa 647 conjugated 
Streptavidin is allowed to bind to the biotin. Each Streptavidin conjugate has four 
Alexa 647 moieties and each biotin on the cDNA can bind one Streptavidin leading 
to an 8 fold signal amplification of hybridisation signal[38]. Due to the capability of 
microarrays to carry out the analysis of thousands of miRNA concentrations from a 
single sample at once, they have become popular features of miRNA profiling 
studies, as a broad spectrum of a cells epigenetic regulatory processes can be studied 
in a single instance with relative ease, although for studies that do not require such 





1.2.4. Quantitation Methods: Quenching. 
 
While these methods previously mentioned require the hybridisation of a miRNA 
target to produce a detectable signal, methods also exist where hybridisation blocks 
the transmission of a signal and the observed signal is inversely proportional to the 
concentration of miRNA. As illustrated in Figure 1.4., Cissell et al have developed 
both solid phase and solution phase assays based on the competitive inhibition of 
signalling probe by the target miRNA. In the solid phase assay, a biotinylated DNA 
complementary to both the target miRNA and a probe modified DNA is immobilised 
onto a neutravidin coated well plate. The probe DNA strand is labelled with a Renilla 
luciferase(Rluc) probe and both it and the miRNA are added to the well. Both 
compete to hybridise to the complementary immobilised capture surface of DNA 
within the well. Following hybridisation, coelenterazine is added to the well which 
binds to the Rluc probes and undergoes oxidative decarboxylation, resulting in 
emission of light. A decrease in the amount of light measured from the well results 
from hybridisation of unlabelled miRNA targets hybridising, thus producing a signal 
that is inversely proportional to the concentration of target miRNA initially 
introduced into the well, and allows the in vitro detection of concentrations of 
miRNA as low as 5pM[44]. In a similar solution based technique, a target miRNA 
once again is in competition with a DNA strand for hybridisation to a 
complementary probe. Here, the competing DNA strand is again modified with Rluc, 
but now the system is based on the bioluminescence resonance energy transfer 
(BRET) between the Rluc and a quantum dot (QD) bound to a complementary 
solution based probe. In the absence of miRNA the Rluc-DNA strand and the QD 
probe strand hybridise in solution and upon the introduction of coelenterazine as a 
substrate for the Rluc, a BRET signal is observed. However, in the presence of the 
target miRNA, hybridisation between the Rluc strand and the QD probe is 
competitively inhibited by the target miRNA and a decrease in signal is observed. 
This method has been shown to be sensitive at concentrations as low as 10nM in 
time frames as short as 30 minutes, resulting in a highly sensitive, rapid and specific 
assay that has potential applications for in vivo detection of miRNA[45]. 
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Figure 1.4. Schematic representation of the bioluminescence based miRNA assay developed by 
Cissell et al. Capture probes on the surface of the neutravidin plate are hybridised with either a 
luciferase conjugated synthetic miR-21 or an unmodified miR-21 analyte. Both miR-21 strands are 
complementary to the capture probe on the surface and both compete for hybridisation. Against a 
control, a decrease in luminescence can be observed that is proportional to the concentration of miR-
21 analyte. Reproduced from Cissell, K.A., et al., Bioluminescence-based detection of MicroRNA, 
miR21 in breast cancer cells. Analytical Chemistry, 2008. 80(7): p. 2319-2325. [44]. 
 
 
While the vast majority of miRNA detection techniques rely on the hybridisation of 
the target to a complementary strand on DNA/RNA, there are techniques that require 
no hybridisation step and still achieve single base difference discrimination. In a 
technique developed by Driskell et al, miRNA targets are allowed to adsorb non-
specifically onto silver nanorods on a glass slide. Once adsorbed, surface enhanced 
Raman scattering is used to detect the adsorbed miRNA. This method has been 
shown to be capable of discriminating between single nucleotide change in the 
miRNA sequence and poses as a potentially powerful miRNA identification tool. 
This process is carried out without the need for hybridisation steps and the miRNA 
are detected without the need for labelling, however there are drawbacks to this 
method. This method is suited for use with pure samples of miRNA and reproducible 
spectra cannot be obtained from complex samples containing several different 
miRNA sequences, making it useful only as an additional step after a miRNA 
separation technique. Spectra must also be taken before and after each individual 
assay to identify their representative raman shift which will lead to labour intensive 
analysis[46].   
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1.3. Electrochemically based assays for the detection of miRNA. 
 
1.3.1. Electrochemical detection of miRNA: Overview. 
 
Electrochemical detection of miRNA is gaining increasing popularity due to the 
inherent benefits associated with electrochemical analysis[47]. The vast majority of 
electrochemically based assays for the detection of miRNA provide rapid, highly 
selective and ultra-sensitive solutions for the detection of genetic biomarkers. 
Extensive research has been carried out on a number of different electrochemical 
techniques that have the potential to be employed in point of care diagnostic systems 
due to their ease of manufacture, cost effective analysis and the potential for 
miniaturisation. The majority of these devices also provide a platform for the direct 
analysis of miRNA samples, circumventing the need for prior amplification 
treatment. Such devices may rely on a number of different electrochemical analytical 
techniques for the transduction and measurement of a signal for the detection of a 
particular genetic biomarker including potentiometry[48], amperometry[34, 39, 49-
51], and impedance spectroscopy[32, 36, 52]. Electrochemical detection of miRNA 
in solution by potentiometry represents a quick simple and cost effective method of 
detecting miRNA at sub-nanomolar concentrations. Potentiometric methods involve 
measuring the potential of a solution between two electrodes in order to determine 
the concentration of an analyte within the solution and has been used for the 
detection of miRNA following amplification by RT-PCR by Goda et al in 2012.  By 
using a mixed self-assembly monolayer of sulphobetaine-3-undecanethiol and thiol 
terminated DNA capture probe strands, target miRNA strands were hybridised to an 
electrode and this hybridisation conferred a change in the surface potential of the 
electrode due to the intrinsic negative charge of the oligonucleotide backbone. This 
change in surface potential through the hybridisation of miRNA targets could be 
monitored in real time and the limit of detection achieved was 20pM for exosomal 
miRNA. [48]. However, the LOD of this assay is at the upper end of the typical 
concentration ranges of circulating miRNA of 200aM – 20pM[53].  Therefore, this 
approach relies on the amplification of miRNA extracts through PCR, adding to the 
cost and labour of analysis. 
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1.3.2. Electrochemical Impedance Spectroscopy Based Detection of miRNA. 
 
For more effective detection of miRNA in solution, a method in which the miRNA is 
confined to an interface may provide greater sensitivity. Electrochemical impedance 
spectroscopy has been used in many studies of the interaction of biomolecules 
throughout the literature and offers a fast, highly sensitive method for the detection 
of interfacial reactions, such as the hybridisation of a target miRNA to an 
immobilised probe at the surface of an electrode[47]. Impedance is a measure of the 
opposition to the flow of an electrical current within a circuit and, similarly to 
resistance, it is measured in Ohms. However, resistance is a concept that may only be 
applied to one component of a circuit, the ideal resistor, which must meet certain 
criteria that make resistance impractical for application in real world settings. For 
example, for resistance to be applicable to an AC circuit, the current must be in 
phase with the AC voltage, the resistance must be frequency independent and the 
resistance must follow Ohm’s law at all currents and potentials. Often this is not the 
case and circuits will demonstrate far more complex behaviour that is only explained 
by impedance. Electrochemical Impedance Spectroscopy allows for the study of the 
impact a material bound to the surface of an electrode can have on polar, ionic and 
dielectric relaxation processes within both the electrolyte and at the electrode 
surface. For these reasons it has been used in the study of many biological and 
bioanalytical systems and has been shown, among other uses, as a powerful tool in 
the field of miRNA detection[32, 36, 52]. For example, in work reported by Peng et 
al Electrochemical Impedance Spectroscopy (EIS) was utilised as a technique for 
detection of miRNA[36]. An electrode modified with a mixed monolayer of nucleic 
acid capture oligonucleotides and 4-mercaptoaniline was used to capture miRNA 
strands covalently modified with 3nm RuO2 nanoparticles. Following the 
hybridisation of the miRNA-RuO2 conjugates to the electrode, the electrode was 
immersed in a solution of 3’3-dimethoxybenzidine and H2O2 for 60 minutes. The 
RuO2 nanoparticles bound to the array via the hybridised miRNA catalysed the 
formation of a polydimethoxybenzidine (PDB) layer on the surface of the electrode 
in the immediate vicinity of the nanoparticle catalyst. As PDB is capable of forming 
an insulating layer on the surface of an electrode, as well having a low porosity 
leading to a blocked surface of the electrode, transfer of charge from the electrode to 
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redox species in solution is inhibited, therefore a change in the charge transfer 
resistance (Rct) can be measured accurately. This, coupled with the cumulative effect 
of polymerisation and the first order Michaelis-Menten kinetics of PDB formation 
(relative to the DNAzyme concentration) made PDB the ideal material for 
impedance based detection. Thus, in this scheme the quantity of nanoparticles (and 
thus the number of miRNA hybridised) to the array is linearly proportional to the 
amount of PDB deposited on the surface of the electrode. The development of this 
polymer formation on the surface of the electrode confers a change in the 
electrochemical admittance of the electrodes interface and therefore a linear change 
in the AC impedance of a circuit containing the electrode can be observed in 
response to PDB deposition. This approach greatly increases the sensitivity of an 
impedance based detection assay over that of label free detection as the deposition of 
PDB on the surface of the electrode amplifies the impedimetric effect of miRNA 
hybridisation due to the non-conductive properties of PDB. This allowed the 
development of an electrochemical assay with a demonstrated lower limit of 
detection of 3fM miRNA[36]. In a similar study, Gao et al used an Indium Tin Oxide 
(ITO) electrode modified with a self-assembled monolayer of charge neutral 
morpholino capture probes for the label free detection of miRNA by impedance 
spectroscopy. The charge neutral nature of the morphilino oligonucleotides not only 
increases the affinity of the array for miRNA targets but also retards the non-specific 
deposition of dimethoxybenzidine molecules. Following hybridisation of the miRNA 
target the electrode is immersed in a mix of dimethoxybenzidine, H2O2 and 
Horseradish Peroxidase.  PDB is then synthesised at the electrode interface where the 
negatively charged miRNA is hybridised and the deposition of PDB is measured as a 
change in the systems impedance. The advantages of this method over the previously 
mentioned case are the label free nature of this technique as well as a slightly 
increased limit of detection of 2fM [32]. This technique of hybridisation mediated 
PDB deposition has also been adapted by Shen et al for the ultrasensitive detection 
of miRNA targets using impedance spectroscopy. In their work, Shen et al used a 
gold electrode hybridised modified with a self-assembly monolayer of capture 
oligonucleotide strands. Following the hybridisation of the target miRNA to the 
capture oligonucleotides, the array is treated with endonuclease I removing the 
unhybridised capture strands. A DNA enzyme conjugate, G quadruplex hemin, was 
then applied to the electrode and hybridised to the lower free portion of the capture-
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target hybrid complex, subsequently bringing the enzyme to the surface of the 
electrode. The electrode was then incubated in dimethoxybenzidine and H2O2 and 
the formation of PDB was once again detected by impedance spectroscopy, with a 
limit of detection of 2fM [52]. 
 
 
Figure 1.5. Schematic representation of an impedimetric miRNA biosensor developed by Shen et al. 
Unhybridised strands of capture probe on the surface of the electrode are removed by exonuclease I 
and hybridised strands remain, allowing the DNA conjugated enzyme to hybridise to the base of the 
probe and catalyse the formation of PDB, changing the impedance characteristics of the electrode 
surface. This change in impedance can be related to the concentration of miRNA target applied to the 
electrode. Reproduced from Shen, W., et al., A label-free microRNA biosensor based on DNAzyme-
catalysed and microRNA-guided formation of a thin insulating polymer film. Biosensors & 




1.3.3. Field Effect Transistor Based Detection of miRNA. 
 
Field effect transistor based biosensors (Bio-FET) have significant promise due to 
their high sensitivity as well as their ability to deliver real time results without the 
need for direct chemical modification of the miRNA target[54-56]. Bio-FETs can be 
thought of as a three electrode system consisting of a source, drain and gate, that 
undergo a change in their source to drain channel conductance due to a change in the 
electrical environment of the semiconductor material of the channel[54]. In the case 
of a Bio-FET used to detect miRNA, the semiconductor is modified with a capture 
strand of nucleic acid that will recognise and hybridise the target miRNA to the 
surface of the semiconductor. The use of Bio-FETs to detect miRNA is at an 
advantage over that of other biomolecular detection schemes involving biomarkers 
derived from peptides due to the highly charged nature of RNA. Upon hybridisation 
of the negatively charged miRNA strand, the charge density of the semiconductor 
material is altered which in turn modulates the conductance of the source to drain 
channel which can be observed as a change in source to drain potential. Therefore, 
the electrical input of the charged nucleic acid species may be thought of as a gate. 
Due to the ability of transistors to be manufactured on the nanoscale, the 
semiconductor gate channel can become sensitive to minute changes in its 
environment, for example hybridisation of a target miRNA to a capture nucleic acid 
on the surface of the gate channel. The small size of the transistor (and therefore the 
gate channel) amplifies the charge of single nuclei acids hybridising to the surface, 
which can be used to create devices that have extremely low detection limits, thus 
making these detection schemes incredibly sensitive. Zhang et al reported the use of 
a silicon nanowire FET (SiNW-FET) based system for the detection of miRNA that 
comprised of one dimensional SiNW modified with charge neutral peptide nucleic 
acid (PNA). The PNA has the advantage of having a higher affinity for the target due 
to a lack of electrostatic repulsion between ribophophate RNA backbones. The 
charge neutral PNA also confers a minimal change to the charge density of the 
semiconductor of the Bio-FET. Following the hybridisation of the target to the 
capture probe a significant change in the conductance of the source to drain channel 
could be seen and this allowed for the development of a miRNA detection system 
with a limit of detection of 1fM[54]. Improving upon this design, Ramnani et al in 
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2013 utilised the CIRV p19 protein as a capture probe for the quantification of 
miRNA with a detection limit of 1aM, however the CIRV p19 has a poorer ability to 
differentiate between miRNA targets compared to that of a complementary strand of 
nucleic acid and should be used purely for quantification of miRNA 
concentration(Figure 1.6.)[55]. Work carried out by Lu et al in 2014 described the 
use of a complementary metal oxide semiconductor compatible SiNW-FET that 
allowed for the development of an assay that was capable of detection as low as 600 
copies of a single miRNA, ~1zM. In conjunction with an anisotropic wet etching, 
this allowed for the cost effective manufacture of the nanoscale semiconductor 
channels that allow for the ultrasensitive, highly selective detection of miRNA[56]. 
However, the initial costs of fabrication of patterned, pre-etched materials, as well as 
the intricacies of the initial design process may prove to be only cost effective if 
carried out on the scale of mass production and research centres may benefit far 
greater from the use of simpler substrates that allow for the atto to femto molar 
detection of miRNA targets without the need for advanced fabrication techniques 





Figure 1.6. Schematic representation of the BioFET system developed by Ramnani et al for the 
detection of miRNA. Silicon nanowires are used as a semiconductor between the source and drain 
channels of this field effect transistor. The silicon nanowires are covalently modified with CIRV 19, a 
nucleic acid binding protein with a high affinity for the binding of RNA duplexes. Upon hybridisation 
of the target miRNA with a probe the duplex becomes bound to the CIRV 19 and this event confers a 
change in the surface chemistry of the semiconducting channel, effectively acting as a gate and 
changing the capacitance of the silicon nanowires. This change in capacitance can be used to measure 
the concentration of miRNA bound to the BioFET. Reproduced from Ramnani, P., et al., Electronic 






1.3.4. Amperometrically Based Detection of miRNA. 
 
Amperometrically based systems for the electrochemical detection of miRNA are 
among the most regularly reported in the literature and are highlighted in this review 
due to their relevance to the work detailed in the later chapters of this report. 
Amperometry is the detection of an analyte by measuring the current of a system at a 
constant applied voltage. As a general scheme, an amperometric device will require 
the immobilisation of the target nucleic acid to the surface of an electrode, often 
through hybridisation of the target miRNA to a self-assembled monolayer of 
complementary nucleic acids. This hybridisation event can then be detected through 
a number of means, for example the electrocatalytic activity of a covalently attached 
moiety on the target stand. This allows for the direct correlation of the arrays 
electrocatalytic activity to the number of hybridised miRNA targets. Work published 
by Gao and Yu in 2007 details the use of an electrocatalytic Ruthenium moiety, 
[Ru(1,10-phenanthroline-5,6-dione)2Cl2], that has the ability to bond with adenine 
and guanine under mild conditions for the amperometric detection of miRNA by the 
electrocatalytic oxidation of hydrazine. Following hybridisation of the target 
miRNA-Ruthenium complex a potential of 100mV was applied to the electrode and 
the electrooxidation current was measured in the presence of 5mM hydrazine.  The 
miRNA detection assay had a detection limit of 200fM[49]. Gao and Yu also 
developed a similar amperometrically based assay for the detection of miRNA by 
using the osmium complex [Os(4,4’-dimethyl-2,2’-bipyridine)2(Isoniazid)Cl]+ 
covalently linked to the 3’ end of a miRNA strand for the detection of immobilised 
target miRNA strands by the electrocatalysis of acetic acid by the osmium moiety. 
The electro-oxidation  of the hybridised electrode was measured in the presence of 
10mM acetic acid under an applied potential of 150mV vs Ag/AgCl, allowing for the 
detection of miRNA target concentrations as low as 800fM[50]. These 
methodologies, while effective at sub-picomolar concentrations, require direct 
modification of the target miRNA and are therefore less favourable for use in the 
detection of clinical miRNA samples than assays that only require the hybridisation 
of the target to a capture nucleic acid and avoid the requirement for the covalent 
modification of the target. To eliminate the requirement for direct modification or the 
target, assays may be developed where the electrocatalytic reporter probe in the 
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assay is bound to a free portion of either the immobilised capture strand on the 
electrode surface or a free portion of the target miRNA strand following its 
hybridisation to the capture strand. An example of this was work carried out by Gao 
in 2012, where an electrode was modified with an oligonucleotide stem loop, where 
the distal portion is complementary to the target miRNA. This allowed the miRNA 
target to open the stem loop into a linear strand conformation upon hybridisation, 
leaving the distal portion of the hybridisation complex free as a single strand. The 
single stranded region was now available for hybridisation with a second nucleic 
acid strand, the probe, which was covalently modified with glucose oxidase, bringing 
the glucose oxidase to the surface. Hybridised probes were then detected by the 
electrooxidation current of 60mM glucose under an applied potential of 300mV[34].  
 
 
Figure 1.7. Amperometrically based system developed by Gao in 2012 for the detection of miRNA. 
The miRNA target is complementary to the distal region of the hairpin loop and upon hybridisation 
the loop changes conformation to a linear strand with a single stranded proximal region. This allows a 
glucose oxidase conjugate nucleic acid strand to hybridise and under an applied potential the 
oxidation of glucose can be detected by an increase in current. This increase in current is proportional 
to the number of miRNA target strand hybridised to the array. Reproduced from Gao, Z.Q., A highly 
sensitive electrochemical assay for microRNA expression profiling. Analyst, 2012. 137(7): p. 1674-




In another scheme by Pöhlmann and Sprinzl, (Figure 1.8.) an electrode was modified 
with a mixed SAM of thiolated anchoring oligonucleotide and octanethiol. An 
oligonucleotide was hybridised to the anchoring oligonucleotide on the electrode, 
featuring two adjacent sites for target strand hybridisation and probe strand 
hybridisation. A probe oligonucleotide covalently modified with a reporter enzyme, 
Esterase 2, was then subsequently hybridised to the oligonucleotide. Between the 
anchoring site and probe site, a target miRNA oligonucleotide was then hybridised, 
creating a continuous base stacking effect and bringing the reporter enzyme into 
close proximity with the electrode surface.  This allows an electrochemical current to 
be generated in two steps, firstly by the enzymatic hydrolysis of the substrate p-
aminophenyl butyrate to p-aminophenol and secondly, by the redox recycling of 
quinoneimine to p-aminophenol. This scheme led to an assay that could carry out the 
detection of miRNA targets to a lower detection limit of 2aM[51]. As the latter 
approaches mentioned above lack the requirement for the direct modification of the 
miRNA target, they facilitate the direct analysis of clinical miRNA samples and 






Figure 1.8. Schematic representation of an amperometric miRNA detection strategy based on a gap 
hybridisation assay developed by Pöhlmann and Sprinzl. A four component RNA hybridisation 
complex, including a fully hybridised miRNA target, is stabilised by the base stacking energy created 
by adjacent nucleotides and brings the Esterase 2 enzyme within close proximity to the electrode 
surface. Esterase 2 can then catalyse the hydrolysis of p-aminophenyl butyrate to the electroactive 
probe p-aminophenol. The high turnover rate of Esterase 2 and the redox recycling of quinonimine to 
p-aminophenyl gives a two-fold amplification to signal generated and this electrochemical signal is 
proportional to the amount of miRNA hybridised to the electrode. Reproduced from Pöhlmann, C. and 
M. Sprinzl, Electrochemical Detection of MicroRNAs via Gap Hybridization Assay. Analytical 
Chemistry, 2010. 82(11): p. 4434-4440 [51]. 
 
 
Similar approaches to these studies have been carried out using conjugated 
catalytically active nanoparticles instead of enzyme conjugates[57-59]. The methods 
described above circumvent the requirement to directly modify the miRNA target 
and therefore allow the direct amperometric detection of miRNA from cells or serum 
and therefore exhibit great potential to be used as user friendly point of care systems. 
The use of metal nanoparticles for the electrocatalytic detection of nucleic acid 
biomarkers has gathered a great deal of interest due to their general ease of 
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modification, their intrinsic electrocatalytic activity and above all their excellent 
surface area to volume ratio. Several examples can be found throughout the literature 
on the use of metal nanoparticles in the amperometric detection of DNA[57-59] that 
give excellent selectivity and display ultrasensitive limits of detection.  This work 
has helped drive the amperometric detection of miRNA using metal nanoparticles as 
nanocatalysts to generate measurable electrochemical currents as a direct result of 
miRNA hybridisation. In work reported by Gao et al. in 2006, miRNA targets were 
hybridised to a capture oligonucleotide on the surface of an electrode and covalently 
modified with an OsO2 nanoparticle on the 3’ end of the target miRNA, bringing the 
nanoparticle in contact with the electrode surface. Bound OsO2 nanoparticles were 
then capable of generating an amperometric signal by the electrocatalytic oxidation 
of 30mM hydrazine under an applied potential of 100mV. This provided a means of 
detecting miRNA in a concentration as low as 80fM[39]. A similar detection 
strategy, currently unreported in the literature, has been developed by Spain et al 
involving the modification of electrocatalytic platinum nanoparticles that are capable 
of generating a measurable current in the presence of H2O2. In this work, a self-
assembled monolayer of capture oligonucleotides was generated on the surface of an 
electrode that were complementary to a 10nt portion of a target miRNA. The 
electrode was incubated with the miRNA and following hybridisation, the electrode 
was placed in a solution of platinum nanoparticles decorated with a probe oligo 
nucleotide that was complementary to the remainder of the target miRNA. This led 
to the immobilisation of platinum nanoparticles on the electrode through target-probe 
hybridisation that were capable of producing a large current through the 




Figure 1.9. Schematic representation of an amperometrically based miRNA detection strategy 
developed by Gao and Yang. Hybridisation of the target miRNA to the capture probes on the surface 
of the electrode is followed by the covalent linking of the 3’ end of the target to an OsO2 nanoparticle. 
The OsO2 nanoparticle then catalyses the reduction of hydrazine under a constant applied potential 
which is detected as an increase in current. Reproduced from Gao, Z.Q. and Z.C. Yang, Detection of 




1.4. Amperometric Nucleic Acid Biosensors: Underlying Mechanics. 
 
1.4.1. Oligonucleotide Self-Assembled Monolayers. 
 
The vast majority of electrochemical biosensors mentioned in this review require the 
formation of a uniform or mixed surface of capture oligonucleotides for the 
immobilisation of miRNA targets prior to their detection. Self-assembled 
monolayers (SAM) have been of great interest in the fields of inorganic chemistry 
and biosensor fabrication due to their ability to control the chemical and physical 
structure of a surface. Typically, SAM are formed by the adsorption of alkanethiols 
on a surface and exhibit highly ordered closely packed layers over relatively long 
ranged distances. One of the most fundamentally functional uses of SAM is the 
ability to tailor the surface chemistry of a sample for a specific application. For 
example, a carboxy terminated alkane thiol may be used to produce a surface that is 
capable of being activated through N-ethyl-N’-(3-dimethylaminopropyl) 
carbodiimide (EDC)/N-hydroxysuccinimide (NHS) coupling that can be modified 
with a large number of biomolecules, including antibodies to facilitate the 
immobilisation of materials from the biomolecular to the cellular scale and form the 
basis of many bioanalytical techniques and devices. However, in the case of nucleic 
acid biosensors, the formation of a substrate capable of hybridising a target nucleic 
acid is typically carried out through the use of a complementary thiolated 
oligonucleotide strand and exploiting their ability to self-assemble on coinage 
metals, in particular gold, in monolayers that are highly organised[60]. These 
provide ideal sensing platforms that retain electrical conductivity to a far greater 
degree than that of more closely packed alkanethiol monolayers. There are also 
examples of the use of mixed monolayers of alkanethiol and thiolated 
oligonucleotide in the formation of biosensors[48, 51]. This use of a heterogeneously 
produced surface facilitates the improved hybridisation of target to the immobilised 
capture nucleic acids on the surface of the electrode by reducing the effects of steric 
hindrance that are associated with a closely packed homogenous monolayer. Another 
study by Peterson et al proposed that higher density oligonucleotide SAMs may 
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impede the hybridisation of the target , and the  hybridisation efficiency, the 
percentage of total capture strands that are hybridised, is approximately 95% for a 
low surface coverage (2 x 1012/cm2) and approximately 15% for closely packed 




1.4.2. Oligonucleotide Hybridisation. 
 
The ability to control the hybridisation of nucleic acids is perhaps the most important 
aspect in the development of nucleic acid biosensors as the vast majority of detection 
schemes rely on the hybridisation of a target miRNA to an oligonucleotide capture 
probe. The features of oligonucleotides that control the thermodynamic properties of 
capture-target oligonucleotide hybridisation include oligonucleotide sequence, 
double helix conformation and nucleotide backbone composition. While there is no 
compositional flexibility in the sequence of the oligonucleotides used due to the 
specific base pairing required for successful hybridisation, the composition of the 
oligonucleotide backbone can be altered to control the thermodynamic properties of 
hybridised oligonucleotides, for example PNA and LNA. Therefore, it is of 
paramount importance that the oligonucleotide used of the hybridisation of miRNA 
target to a sensing platform is selected on the basis of its thermodynamic properties 
to give optimal miRNA target hybridisation.  
Perhaps the most important consideration when designing a hybridisation based 
oligonucleotide detection system is the sequence of individual oligonucleotides and 
the stability of their hybridised duplexes. Hybridisation between strands occurs via 
the Watson-Crick base pairing of nucleotides, where the purine bases guanine (G) 
and adenine (A) bond with the pyrimidine bases cytosine (C) and thymine (T) (or 
uracil (U) in the case of RNA) via hydrogen bonding, the geometry of which ensure 
the correct pairing of bases. The base pair content of hybridised oligonucleotides, 
along with strand length, is the most important factor in the determining the Tm (The 
temperature at which 50% of dsDNA will be dissociated to ssDNA conformation). 
Given a specific sequence of an oligonucleotide target and the complementary 
strand(s) to be hybridised to it, if the energy of this interaction is low, then the Tm 
will be low thus affecting the temperature at which the hybridisation can be carried 
out. The content of GC pairs have an additive effect on the stability of a double helix 
confirmation, thus oligonucleotides with high GC content will remain more stable at 
higher temperatures. Conversely AT or AU pairing has a destabilising effect on 
double helical confirmation of paired oligonucleotides and this can be observed in 
regions of high AT content that act as promoters for gene replication in a genome. It 
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was long believed that this was due to the hydrogen bonding characteristic of GC 
pairings, and that base stacking was a minor contributor to the stabilisation of double 
helical oligonucleotides. However, a publication by Yakovchuk in 2006 showed for 
the first time, the effect both hydrogen bonding and base stacking had on the stability 
of a double helix separately. The contributions of individual stabilising effects were 
observed experimentally using complementary polynucleotide sequences and 
creating very well defined nicks in these sequences that interrupt the base stacking of 
the effect of adjacent bases in the sequence. The result of this work indicated that the 
hydrogen bonding of GC pairs does not contribute to stability and that base stacking 
effects are in fact the primary stabilising factor, while AT/AU pairings are always 
destabilising[62]. For these reasons when designing oligonucleotide pairing the 
sequence of neighbouring base pairs must be considered in order to determine the 
stability of hybridised strand. The Tm of two complementary oligonucleotides is 
given by: 
?ܶ? =  ∆𝐻°∆ܵ° − ܴlnሺ[𝐶ͳ] − ሺ𝐶ʹ ʹ⁄ ሻ 
where C1 and C2 are concentrations of oligonucleotide and C1>C2. 
It is important to be aware of the fact that this model holds true for the Tm of 
synthetic polynucleotides that have regular repeating sequences as they melt in a 
simple approximate two state transition, however. naturally occurring 
polynucleotides with heterogeneous sequences will melt in a more complex manner 
with many stable intermediates, so statistical mechanics must be applied to perform 
accurate predictions of Tm[63]. ∆𝐻° and ∆ܵ° in this scheme are also calculated on the 
nearest neighbour model to take into account the contribution of the oligonucleotide 
sequence. By applying these kinetic and statistical models, it is possible to predict 
with a good deal of accuracy the Tm of two complementary oligonucleotides and in 
cases it may be found that the energies of these interactions are too low to facilitate 
hybridisation of miRNA and complementary strand in a manner that is efficient 
enough for the development of a ultrasensitive miRNA detection device. Therefore, 




However, systems with low affinities due to their sequence may be improved 
through the use of oligonucleotide analogues that form more stable duplexes. 
Interactions between RNA-RNA and RNA-DNA complexes form more stable 
duplexes than purely DNA based systems (for example where the miRNA target is 
reverse transcribed to DNA and hybridised to a capture DNA oligonucleotide), 
partially due to the “A helix” confirmation taken on in RNA hybridisation that is 
caused due to steric effects of the 2’-OH group in RNA. The electrostatic repulsion 
of the negatively charged phosphate backbones of target and capture 
oligonucleotides is also a contributing factor in hybridisation. This effect may be 
reduced to improve hybridisation between target and capture strands by using 
synthetic derivatives of nucleic acids that are charge neutral such as peptide nucleic 
acid (PNA). PNA differs from normal polynucleotides as it is composed of a 
sequence of nucleotides bound to a backbone of repeating N-(2-aminoethyl)-glycine. 
The lack of a negatively charged moiety within the backbone of PNA avoids the 
electrostatic repulsion effects experienced by naturally occurring nucleic acids. The 
elimination of this repulsive force increases the stability and therefore the Tm of any 
duplex containing a PNA strand. This leads to an improvement in the 
thermodynamically controlled hybridisation in nucleic acid detection systems based 
upon PNA probes, when compared to their DNA/RNA counterparts. Another 
alternative to purely DNA and RNA based systems is to employ locked nucleic acid 
(LNA) to improve the stability of duplexes. LNA is a synthetic derivative of RNA 
where the ribose member of the RNA backbone has been modified, connecting the 
2’oxygen with the 4’ carbon through a single carbon atom. This bridge forces the 
ribose to remain in the 3’endo conformation. The effect of this is to increase base 
stacking interactions in a duplex, making LNA containing duplexes more 
enthalpically favourable, compared to duplexes of unmodified nucleic acids. 
Suggestions have also been made that the rigid structure of the ribose unit in LNA 
may force a single strand into a pre-organised helix conformation, leading to a 
reduced loss of entropy when forming a duplex[64, 65].  
However, in the case of a solid phase sensing platform, where the target miRNA 
must be hybridised to a capture strand confined to a solid substrate, other 
considerations must also to made when assessing the thermodynamic properties of 
the interaction. An important factor to consider is the entropic penalties incurred due 
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to confining one oligonucleotide strand to the surface. The kinetics of hybridisation 
will be affected by the inhomogeneity of the sample and the requirement of the 
transport of target to the solid-liquid interface.  However,  there also the effects of 
limiting the probability of the oligonucleotides aligning in the correct manner for 





1.4.3. Detection Probe Strategies.  
 
Detection of miRNA often relies on hybridisation of miRNA to a probe and the 
detection of this event. Initial detection strategies relied on the use of a fluorescent 
beacons and detection was carried out through imaging, for example in microarrays. 
However, a single fluorescent probe may not produce enough signal through 
multiple excitation and emission cycles to be detected with a high degree of 
certainty, as well as the fact that many fluorophores will undergo photobleaching 
following a number of excitation and emission cycles[66]. However, catalytic 
probes, for example enzymes, can undergo a practically unlimited number of 
catalytic cycles without compromising their activity allowing for continuous 
detection and high signal to noise ratios even for small numbers of hybridisation 
reactions. For this reason, probes are often chosen that may produce an amplified 
signal due to their catalytic activity. Horseradish peroxidase (HRP) is often used as a 
catalytic probe in nucleic acid detection due to its cost effectiveness, the ease with 
which it maybe conjugated to a nucleic acid probe, the stability of the enzyme, and 
its relatively high catalytic efficiency of ~850s-1mM-1 at 25°C [67]. A generalised 
scheme for the use of HRP as a reporter molecule relies on the specific 
immobilisation of HRP to the surface of an electrode, through hybridisation of a 
conjugated nucleic acid sequence or through a change in the surface chemistry of the 
electrode as a result of miRNA hybridisation. The HRP is then used to generate a 
high local concentration of electrocatalytic substrate at the electrodes interface, for 
example ferrocyanide, phenols, ascorbic acid, etc. The oxidised reaction product may 
then be used as an electrochemical substrate, becoming reduced at the surface of the 
electrode through the application of a potential and the resulting reduction current 
may be detected. For example, Zhou used HRP as a detection probe for identifying 
the hybridisation of a miRNA to an electrode surface by carrying out the production 
of benzoquinone from hydroquinone and H2O2. In this strategy, a capture probe 
hairpin loop was immobilised to the surface of an electrode via a thiol group at its 5’ 
end. The hairpin loop was modified with biotin at its 3’ end and contained a region 
of complementarity to the miRNA target. Following hybridisation of the target to 
this region, the hairpin is forced to undergo a conformational change to become a 
linear strand exposing the biotin moiety. This allows a streptavidin-HRP conjugate to 
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become immobilised to the array through the interaction of streptavidin and biotin. 
As the dissociation constant of this interaction is of the order of 10-14 this implies 
that this binding is in a practical sense irreversible. The electrode was then capable of 
producing a current response directly proportional to the number of miRNA strands 
that were hybridised to the array through the catalytic activity of HRP and the 
electrocatalytic reduction of the resulting product[35]. While this offers an attractive 
solution for the detection of miRNA through an amplified signal, there are inherent 
restrictions in the use of enzyme probes, [68]. 
 
 
Figure 1.10. An example of the use of an enzyme probe to mediate an amplified electrochemical 
signal for the detection of miRNA developed by Zhou et al. Following a the hybridisation of the 
miRNA target to the stem loop probe, the probe undergoes a conformational change and biotin moiety 
of the probe becomes exposed at the surface of the electrode. The HRP-Streptavidin conjugate is 
bound to the duplex through the interaction of streptavidin and biotin and the HRP can then catalyse 
the formation of benzoquinone from hydroquinone and H2O2. The enzyme catalysed formation of 
benzoquinone can then be detected through amperometry Reproduced from Zhou, Y.L., et al., 
MicroRNA-21 detection based on molecular switching by amperometry. New Journal of Chemistry, 




While enzymes are useful in the detection of miRNA, a more robust catalytic probe 
may be required. Extensive research has been carried out in the development of 
nucleic acid detection strategies that rely on the employment of metal nanoparticles 
as a detection probe. Enzymatic probes generally contain only a single active site, 
meaning that only one reaction can be catalysed per probe at any time. Conversely, a 
metal nanoparticle is capable of carrying out electrocatalysis over its entire surface 
giving them a much greater activity to volume ratio[69]. In this sense, the 
nanoparticles may be considered to be acting as ultramicroelectrodes that carry out 
the electrocatalysis of a substrate to produce an electrochemical signal provided they 
are close enough to the electrode surface to allow efficient electron transfer. 
Therefore, only nanoparticles immobilised to the surface are capable of carrying out 
electrocatalysis. However, such an ultramicroelectrode array of immobilised 
nanoparticles would theoretically have an upper limit of detection due to the array 
becoming saturated by nanoparticles at high analyte concentrations. If an electrode 
exhibited very high levels of nanoparticle immobilisation due to a high concentration 
of analyte, for example miRNA, there may actually be a decrease in the observed 
catalytic activity of the nanoparticles. This would be due to a loss in the ability of 
each single nanoparticle to act as an independent ultramicroelectrode with adjacent 
diffusion fields overlapping and the overall current being controlled by linear rather 
than radial diffusion. Therefore, on a planar electrode, a cell immobilised on an 
electrode may be lysed and will release its miRNA fraction within a localised area. If 
hybridisation of miRNA targets to an electrode occurs in a localised region of the 
electrode, and subsequent nanoparticle immobilisation occurs densely in only a 
single region, the resulting electrochemical signal generated may not be a true 
indicator of the intracellular miRNA target concentration due to the overlap of 
diffusion fields of adjacent nanoparticles, leading to irreproducible results and a 
lower signal to noise ratio than might otherwise be realised.  
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1.5 Applications of Electrochemiluminescence in Biosensing. 
 
1.5.1. General Principals of Electrochemiluminescence. 
 
Electrochemiluminescence, also referred to as electrogenerated chemiluminescence 
(ECL), is the generation of radiative energy from the electrochemical formation of 
reactive species at the surface of an electrode from stable precursors[70]. In general, 
under an applied potential reactive intermediates are formed that undergo highly 
energetic electron transfer reactions that result in the formation of an excited state 
luminophore that subsequently undergoes radiative decay, resulting in luminescence. 
Following the first detailed report of ECL in the 1960s, the field of ECL has 
expanded rapidly with thousands of publications ranging from the fundamental and 
theoretical framework of the technique, to its application in numerous fields 
including microscopy, light emitting devices and biosensing[71]. 
As a technique of radiative signal generation, ECL holds many similarities with 
traditional chemiluminescence, in that both require high energy electron transfer 
reactions in order to generate excited luminophores. However, in chemiluminescence 
the generation of luminescence is maintained by manipulation of flow and mixing of 
solutions, whereas in ECL the generation of luminescence is controlled by the 
changing the potential of an electrode surface. Thus, one of the single greatest 
advantages ECL offers over other systems that rely on chemiluminescence is the 
simplified set up and ease of use. Systems that rely on chemiluminescence (HPLC, 
CE, FIA, etc.) will typically require multiple streams to accommodate the addition of 
reagents and precise control over flow rates within the system, leading to complex 
and expensive apparatus. In contrast, ECL requires only the addition of electrodes to 
the system to allow the generation of reactants, thus the set up for many ECL 
systems is remarkably simple by comparison, only requiring the addition of a 
potentiostat and the incorporation of an electrochemical cell into the system.  
The simplicity of an ECL set up is however, not its only advantage over 
chemiluminescence, or indeed other analytical techniques involving photodetection 
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of luminescence. In ECL the reactive intermediates required for luminophore 
excitation are generated in situ at the surface of the electrode by changing the 
potential applied to the surface of the electrode. Therefore, there is good control over 
both the temporal and spatial aspects of signal generation, meaning that the signal 
may be generated on command giving the opportunity to synchronise signal 
generation with the reaction being studied. Also, by incorporation of an array of 
electrodes into a system, ECL analysis may be multiplexed, for example in a 
biosensing application, where each individual electrode in an array could be 
modified for the detection of a different biomolecule and detections could be done 
rapidly and individually on a single sample. 
As ECL is a means for the conversion of electrical energy into photoluminescence, it 
requires no incident light source for excitation, therefore it avoids problems such as 
scattering and autofluorescence that other techniques suffer from. However, ECL has 
drawbacks as well, principally that it relies on the generation of a reactive 
intermediate at an electrode surface and therefore relies on a high rate of electron 
transfer to facilitate the chemiluminescent reaction, which must be considered when 
designing an electrochemical cell. This also implies that there may be an issue with 
mass transport diffusion in the sense that the generation of intermediates and the 
excitation of luminophores must occur within close proximity of the electrode 
surface. In schemes where luminescent probes are in solution, the diffusion of ECL 
probes to and away from the electrode surface during signal generation will dictate 
the signal output generated, thus the volume of the electrochemical cell and 
concentration of luminophore will need to be considered. In the case of surface 
confined probes, for example a typical sandwich type immunoassay where the 
electrode surface is modified with antibodies, the available electrode surface area is 
effectively decreased and therefore there is less working area for the generation of 
reactive intermediates for luminophore excitation. Another consideration of this is in 
the case of a co-reactant based system, where the reactive intermediate is generated 
from the breakdown of a molecule in solution, once the co-reactant radical is formed 
and subsequently consumed, the addition of more co-reactant for subsequent 
luminophore excitations is limited by the diffusive transport of spent co-reactant 
from- and new co-reactant to- the electrode surface. In a bid to limit these effects, 3-
dimensional nanostructured electrode surfaces may be designed with the aim of 
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improving mass transport diffusion, such as nanoparticles deposited to the surface of 
a working electrode in an ECL cell. In the case of spherical nanoparticles acting as 
the surface of an electrode, the structure of an electrode decreases in size to the point 
that the surface becomes smaller than the length of its diffusion distance and at this 
point the electrode enters a radial diffusion scheme.[72] At this point, the competing 
effects of linearly diffusing outward spent co-reactant and linearly diffusing inward 





1.5.2. Mechanisms for ECL Signal Generation. 
 
Electrochemiluminescence may be generated in a variety of ways, but traditionally 
the phenomena was observed and studied via the annihilation mechanism. This route 
of ECL involves the generation of reduced and oxidised radicals of a single 
luminescent species at the surface of an electrode. When both oxidised and reduced 
species come in contact electron transfer occurs and the previously reduced species, 
now exists in an excited state that subsequently decays through radiative emission, as 
seen in the general scheme below. 
A – e- => A•+          (1) 
A + e- => A•-          (2) 
A•- + A•+ => A• + A         (3) 
A• => A + hv          (4) 
 
This is the mechanism for a typical annihilation pathway for ECL. Here a potential is 
applied to an electrode for a fixed time, t1, and a reduced species is formed (1). The 
potential is then stepped in a positive potential direction to form the oxidised species 
(2). At this point both oxidised and reduced species exist at the electrochemical 
double layer and undergo annihilation (3), resulting in luminescence (4). 
This method for ECL was first studied using Rubrene in the early 1960’s[73], as it 
was known to undergo reversible oxidation and reduction and form reasonably stable 
anions and cations at accessible potentials. However, for the vast majority of 
annihilation set ups the reaction conditions involve the use of deaerated organic 
solvents to access the oxidation and reduction potentials required for the generation 
of reactive species, and thus, the application of annihilation ECL has been limited.  
In contrast to the annihilation ECL pathway, the vast majority of ECL experiments, 
especially where aqueous media is required, is achieved via the co-reactant pathway, 
whereby a suitable co-reactant is added to the electrochemical cell that may be 
oxidised and form a reactive intermediate. This intermediate is then capable of 
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carrying out electron transfer with the ECL luminophore to produce an excited state 
that decays subsequently via radiative emission. This mechanism was first studied 
with the oxidation of oxalate in an aqueous solution, see below. 
C2O42- - e- => [C2O4•-] => CO2•- + CO2      (5) 
A – e- => A•+           (6) 
CO2•- + A•+ => A• + CO2         (7) 
A• => A + hv          (8) 
In this reaction scheme, the same oxidising potential produces both the strong 
reducing agent CO2•- from the oxidation of oxalate (5) and the reduced luminophore 
A•+ (6) which can annihilate to give CO2 and an excited state luminophore A• (7) 
which will then undergo radiative decay (8).  The principal advantage of this is that 
both the co-reactant and the luminophore are oxidised under the same potential in a 
single step, avoiding the requirement for a broad potential window required for 
annihilation ECL, and thus this method of ECL generation is compatible with use in 
aqueous media. However, oxalate and its oxidation product CO2 are not compatible 
with physiological conditions and as such have limited application in the field of 
biosensing. 
For this reason the vast majority of co-reactant based ECL systems employ 
tripropylamine (TPA) as a co-reactant. The utilisation of TPA allows for the 
generation of an ECL signal through the co-reactant pathway under biomimetic 
conditions. In fact, there is a strong pH dependence on the efficiency of the TPA co-
reactant based system, with the highest ECL efficiencies being observed at a pH of 
~7.5 and therefore it has been invaluable in the field of ECL based biosensor 
development. Often paired with a transition metal polypyridyl complex, the expected 
pathway for excitation of a luminophore by TPA is the simultaneous oxidation of 
both the luminophore and the TPA at the electrode surface and a high energy 
electron transfer reaction between co-reactant and luminophore resulting in an 
excited state luminophore that returns to ground state via radiative decay. The 
forerunning proposed mechanism of action is shown in Figure 1.11 below. As 
shown, it is believed that upon oxidation of TPA, the cationic radical loses an α 
proton and subsequently becomes the strong reducing intermediate, TPA•. This may 
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then reduce the oxidised luminophore, shown here are the transition metal 
polypyridyl complex Ru(bpy)33+, to an excited state that may decay via radiative 
emission. However, this mechanism is disputed and experimental evidence suggests 
that the other pathways may be involved in the photoemission process, such as the 
reduction of the luminophore by TPA• to the 1+ state and a subsequent annihilation 
reaction with a luminophore in the 3+ state. 
 
 
Figure. 1.11. Proposed mechanism for TPA co-reactant mediated ECL generation with Ru(bpy)3. 
Reproduced from Richter, M.M., Electrochemiluminescence. Optical Biosensors: Today and 





Regardless of the complexity of the underlying mechanism, co-reactant based ECL 
has been invaluable in the development in the vast majority of literature reports of 
ECL based biosensing applications due to its inherent suitability to aqueous media. 
For example, for an annihilation reaction to be performed on the common ECL 
luminophore Ru(bpy)32+, the potential applied to the electrode would be required to 
be switched from ~1.2 V to ~-1.4V in order to complete the reduction of Ru(bpy)32+ 
to Ru(bpy)31+, which would not be attainable in aqueous media without the violent 
reduction of water and the evolution of hydrogen gas. However, there are several 
drawbacks to the use of TPA in ECL systems, notably the toxicity of the compound 
itself, as well as its poor solubility in water and the requirement for a relatively high 
concentration (50-100mM for most applications). Although, reports have shown 
these solubility issues may be addressed with the addition of surfactant to the system 
and have been shown to give exceptional increases in the ECL efficiency of the 
system, such as Triton x-100. 
In recent years there have also been reports of other methods of generating ECL 
signal besides the two typical methods discussed above. Hot electron-induced ECL 
for example, may be utilised to produce an ECL signal that allows for the detection 
of Ru(bpy)32+ at sub-nanomolar concentrations. This is carried out by the 
introduction of hot electrons (defined as electrons with Fermi energies far higher 
than that of a phase) to the electrolyte solution via an metal/oxide electrode. The 
oxide layer formed at the surface of the electrode acts as an insulator, preventing the 
transfer of electrons to the solution until a sufficient electric field has built up across 
the surface of the oxide layer and the Fermi level of the underlying electrode far 
exceeds the conduction band of the oxide layer, hot electrons may then tunnel 
through to the solution[74] where their strong oxidative properties may reduce 
components of the solution to product strong reductants for the generation of ECL. 
This example of charge driven ECL induction, was utilised by Ala-Kleme et al. to 
measure sub-nanomolar concentrations of Ru(bpy)3 [75]. However, the described 
ECL signal generation method would have poor suitability towards a biosensing 
application as there may be poor control over the exact nature of solution oxidation 
and the generation of radicals may be broad and non-homogenous, and result in side 
reactions damaging both luminophores and biomolecules present, as well as the 
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potentials applied to the electrode/insulator surface would be in vast excess of the 




1.5.3. Luminescent ECL probes. 
 
The variety of potential ECL compatible luminescent probes reported in the literature 
is as wide and varied as the applications that they may be applied to, but for the vast 
majority of clinical, industrial, and research based ECL applications the preferred 
probe of choice is often [Ru(bpy)3]2+. This preference is due to the physical and 
emissive characteristics of the dye, such as its extreme stability, solubility in both 
aqueous and organic media, high ECL efficiency, and broad stokes shift. 
The photophysical characteristics of Ru(bpy)32+ such as lifetime, quantum yield and 
emission wavelength are all ideal when designing an ECL system. The 
photoemission properties of Ru2+ polypyridyl complexes are reliant on the promotion 
of an electron of the metal centre to a π*-orbital through a metal to ligand charge 
transfer (MLCT) event and a fast intersystem crossing mechanism to enter a triplet 
excited state. From this state radiative decay may occur to result in what is formally 
phosphorescent emission, however, this is not the only route for excited state decay. 
While in the triplet excited state, deactivation may occur by occupation of a triplet 
metal centred state, which may lead to instability of the metal-ligand complex. For 
this reason it is desirable for the phosphorescent lifetime of the luminophore to be 
short and the lifetime of [Ru(bpy)3]2+ is comparably fast compared to that of other 
transition metal polypyridyl complexes. Alongside this, the quantum yield in water 
and ECL efficiency of Ru(bpy)32+ are 0.065 and 0.05 respectively, which allow for 
sensitive detection of luminophores. Perhaps one of the most pivotal photophysical 
characteristics of ruthenium polypyridyl complexes are their inherently large Stokes 
shifts (>100nm). This large gap between excitation and emission results in 
remarkably low levels of self-quenching. This allows assays to be developed 
whereby a high number of luminophores may be confined to a small area, for 
example the surface of a nanoparticle but only limited self-quenching will occur. 
The versatility of the ligand substitutions on Ru2+ polypyridyl complexes also opens 
the door to a whole host of possibilities when designing ECL luminophores for 
biosensing applications. Relatively simple synthetic pathways have been reported in 
the literature for the addition of novel ligands to Ru-bis-bipyridine Cl2 precursors to 
change the properties of the luminophore to broaden use to various applications. For 
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example in the case where the covalent conjugation of a luminophore to a 
biomolecule is desired in order to create an ECL probe in a biosensing application, 
the addition of a ligand like 2-(4-caboxyphenyl)imidazo[4,5-f][1,10-phenanthroline], 
or PIC-COOH has been reported in the literature to facilitate a wide number of 
bioconjugations while maintaining photoluminescent properties comparable to that 




1.5.4. Applications of Electrochemiluminescence in Biosensing. 
 
Since the initial report of enzymatic biosensor in the early 1960s[76], the field of 
ECL mediated biosensing has exponentially expanded its application to a wide 
number of fields and applications including trace analysis, pharmaceutical studies 
and clinical diagnostics[77]. For the latter of these the impact ECL has had in the 
fields of both immunosensing and nucleotide probe assays has been exceptional and 
this trend towards the use of ECL in minimal disease detection is largely due to the 
inherent advantages of ECL such as broad dynamic range and ultralow sensitivity.  
From the initial commercialisation of ECL immunosensing in the 1990s[78], the 
field of ECL immunosensing has grown considerably in both the number of clinical 
targets it has been applied to and the methods for signal transduction and 
enhancement. In fact, the remarkable limits of detection achieved by ECL in recent 
times may well be seen a driving force and forerunner for further research in the field 
of minimal disease detection. For example, in the case of Triiothiothyronine, a 
hormone with a potential to be a biomarker for thyroid function, a potential clinical 
application for its detection has been reported by Chou et al.[79] utilising a working 
electrode consisting of graphene oxide nanosheets modified with silver 
nanoparticles. This scheme involves the immobilisation of the analyte, 
triiodothyronine, via streptavidin binding to the surface of the electrode from serum 
samples, utilising graphene oxide as both a highly conductive surface and good 
surface for high probe loading. This method boasted a detection limit of 50 fg/ml and 
a linear range of 100 fg/ml – 1ng/ml with high specificity. 
The clinical applications of ECL in biosensing are however, not limited to use on 
biomolecules and there have been reports of ECL being utilised in the detection of 
inorganic serum contaminants for disease detection, such as heavy metal serum 
analysis. In the case of lead, a poisonous metal linked with a number of potentially 
life threatening neurological disorders, current methods for the detection and 
determination of lead concentration can be both costly, time consuming, complex in 
both sample preparation and detection, and poorly suited to a point of care setting. 
However, Gao et al.[80] reported a simple aptasensing platform for the ultrasensitive 
detection of lead from serum samples. The design, Figure 1.12, utilises a self-
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assembled monolayer of catalytic DNA-zyme, GR-5, which has a high specificity for 
lead binding and may catalytically cleave phosphodiester bonds of hybridised 
nucleic acid strands following lead ion binding. In this scheme the DNA-zyme is 
hybridised to a RNA strand and then the electrode is incubated with Ruthenium tris-
(1,10-phenanthroline)2+,[(Ru(phen)3]2+, which readily intercalates double stranded 
oligonucleotides. The electrode is then washed and placed in a serum sample spiked 
with lead and upon lead binding, the DNA-zyme cleaves the thioester bond of the 
hybridised RNA strand and this cleavage destabilises the hybridisation complex, 
releasing Ru(phen)3. The ECL intensity of Ru(phen)3 is then measured using TPA as 
a co-reactant and this is used to infer the serum concentration of lead. This method 
has led to the detection of lead down to a limit of 900 fM. 
 
Figure. 1.12. Schematic representation of lead detection scheme. Self-assembled monolayer of 
thiolated miRNA is hybridised to the surface of an electrode  GR-5 (purple) is hybridisation to this 
strand.  Hybridisation complex is then loaded with Ru(phen)3 intercalating ECL probe and upon 
binding of lead to the DNA-zyme, RNA is cleaved and the hybridisation complex is destabilised, 
releasing Ru(phen)3. Ru(phen)3 is then detected through ECL and intensity is used to infer lead 
concentration in serum. Reproduced from Gao, A., Tang, C.X., He, X.W., and Yin, X.B., 
Electrochemiluminescent lead biosensor based on GR-5 lead-dependent DNAzyme for 




DNA has not only been used as a method for high sensitivity detection, but also as 
an analyte itself. In a scheme proposed by Dong et al.[81], a hairpin loop of DNA 
loaded with Ru(bpy)3 is immobilised to the surface of CdSe quantum dots on the 
surface of electrode with a hybridisation site complementary to that of a DNA target 
analyte. Upon hybridisation of DNA target to its complimentary site, the hairpin 
undergoes a conformational change releasing the bound luminophore. The catalytic 
CdSe nanoparticles on the surface of the electrode can then act as a co-reactant for 
the generation of ECL signal to result in an ultralow limit of detection limit of 190 
aM in human serum. 
This example of the use of nanotextured electrode surfaces to facilitate the 
ultrasensitive detection of minimal disease detection is also observed in a scheme 
proposed by Hao et el.[82] where the nanotextured surface in this case acts to 
amplify the ECL signal generation through resonance energy transfer between 
luminol decorated gold nanoparticles and CdS semiconductor nanocrystals. In 
Figure 1.13. a schematic representation of this detection strategy is observed. The 
surface of CdS nanocrystals are modified with an oligonucleotide strand containing 
three distinct binding sites. The site shown in red is complementary to a miRNA 
target, miR-21 – one of the most upregulated miRNAs in solid tumours.  Upon 
hybridisation this heteroduplex is then excised by a duplex specific nuclease. The 
electrode is then incubated with two nanoparticle bound oligonucleotide strands, one 
to bind to the green and red regions (Au probe 1) shown and one to bind the green 
and blue regions shown (Luminol Au probe). When the red region of the 
oligonucleotide has been excised following miR-21 hybridisation, the Au probe 1 
strand cannot bind and the Luminol Au probe hybridises. This strand functions to 
quench the ECL intensity of the underlying CdS nanocrystals and instead intensify 
the signal from luminol. Whereas the Au probe 1 strand serves to enhance the ECL 
intensity of CdS nanocrystals when no excision of the red region, and thus no 
hybridisation of miR-21, has taken place. This dual amplification in opposite 




Figure. 1.13. Scheme for ultrasensitive miR-21 detection, relying on the excision of heteroduplexed 
miRNA and oligonucleotide. The rate of excision controls the ratio of amplified ECL from CdS from 
Au probe 1 and quenched CdS and enhanced luminol ECL intensity from L Au probe 2. Reproduced 
from Hao, N., Li, X.L., Zhang, H.R., Xu, J.J., and Chen, H.Y., A highly sensitive ratiometric 
electrochemiluminescent biosensor for microRNA detection based on cyclic enzyme amplification and 






1.7. Mammalian Cell Capture and in-situ Lysis 
 
1.7.1. Mammalian Cell Capture. 
 
In the scheme of detection of circulating tumour cells for the detection of cancer, the 
is often a need to perform the capture of whole cells from plasma to a surface prior to 
the detection step necessary for a positive diagnosis. The capture of cells to a solid 
support may be performed in two ways, non- specific capture and specific capture. In 
the non specific capture scheme, a surface, for example the surface of an electrode, is 
often modified with a biomaterial capable of forming a strong interaction with a 
peptide expressed on the surface of the cells to be captured. The most widely studied 
peptide for the non specific capture of mammalian cells is the arginine-glycine-
aspartate, or RGD, peptide[83]. Throughout the literature there are a great deal of 
reports of a wide variety of cell types captured onto numerous supports, and the 
popularity of this peptide use is largely due to both the stability of the short peptide 
sequence in both solution and in a surface confined regime, the ease with which the 
peptide may be functionalised to a surface, for example by forming a self assembled 
monolayer onto a noble metal surface like gold through a thiol group, and the wide 
variety of targets that the RGD peptide may successfully bind. 
The primary target for RGD binding are integrin proteins that are ubiquitously 
expressed in the extracellular matrix of all mammalian cell types[83]. The formation 
of self assembled monolayers of non specific capture peptides provides researchers 
with a scaffold to which cells may be immobilised in biomimetic conditions, and can 
be used to carry out real time detection of  cell capture. In a recent study by Etayash 
et al[84]. microcantilevers were functionalised with self assembled monolayers of 
RGD peptide to carry out the capture and detection of human adenocarcinoma cells 
in real time by measuring the deflection of light focused on the cantilever before and 
after the arrival of cells onto the cantilever surface. This method provided a simple 
method for the real time detection of cells whereby the capture of cells could be 
measured in real time and the formation of the capture surface could be carried out in 




However, this method of performing cell capture in a non specific manner suffers 
from the drawback that prior to cell capture, samples of cells must be purified, due to 
the broad specificity of the capture peptide. Therefore in the vast majority of cases, 
this method for detection would not be compatible with a clinical assay. Therefore 
the most common approach is to perform highly specific cell capture through the 
formation of a layer of target specific antibodies on the detection surface. Here, the 
drawback is often that the functionalisation of a surface with a target specific 
antibody requires multiple steps, and the complexity of monoclonal antibody  
manufacture, as well as the cost of monoclonal antibodies, dwarf the labour involved 
in the synthesis of short non specific peptides such as RGD. However, the benefits of 
highly specific cell capture often outweigh these perceived difficulties.  By tailoring 
the antibody modified surface to the desired cellular target, cells of a specific type 
may be captured onto a surface from a complex sample. The formation of the capture 
surface is often carried out by the initial modification of the capture surface with a 
material to which the specific antibody may be adhered. In a study by Sherman et al. 
this way carried out by the formation of a streptavidin covered surface to which 
biotinylated anti-CD20 antibodies could be immobilised, this then resulted in the 
formation of a surface whereby cells could be captured specifically from complex 
samples[85]. 
In context of the detection of neuroblastoma cells, the identification of cell specific 
antigens is the most important factor in specific cell capture. As neuroblastoma cells 
arise from neuroectodermal tumours, they have a unique extracellular matrix, unlike 
that of typical circulating cells and as such may be specifically captured on this basis. 
The disialoganglioside, GD2, is a extracellular glycosphyingo lipid of neural 
cells[86, 87]. In recent times it has been the target of anti-neuroblastoma  antibody  
therapies[87, 88] due to its high degree of tumour- selective expression on cell 
surfaces. This presents an ideal target for the specific capture and subsequent 
detection of circulating tumour cells. In a recent study[89], the specific capture of 
neuroblastoma cells from bone marrow samples was facilitated by the use of such 
anti-GD2 antibody modified surfaces resulting in the specific capture of 144 cells 
from ten samples, with a sensitivity of a single tumour cell per 106 white blood cells, 
providing an incredibly powerful tool for the detection and downstream genetic 
analysis of neuroblastoma cells. 
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1.7.2. Methods for in situ lysis 
Often, following the successful capture of cells and subsequent detection, there may 
be a need for downstream analysis of the intracellular contents of the captured cell. 
Therefore following cell capture, a method for the in situ lysis of captured cells is 
often adopted in order to further characterise and profile pathogens such as 
circulating malignancies on an individual basis. The most common approach is to 
apply a lysis buffer containing a reagent that will disrupt the membrane of the cell 
and result in the cell of the cell and release of its intracellular contents for 
analysis[90]. This reagent based lysis method, while simple to implement, may result 
in contamination of the sample and complicate the detection of the analyte. 
Therefore, it may be advantageous to develop a system for the disruption of cell 
membranes through a reagent free means. A means of doing this compatible with an 
electrochemical detection system is to generate a basic environment at the surface 
where the cell has been captured by the application of a negative potential to this 
surface[91]. This utilises the localised formation of OH- ions as a lytic reagent from 
the saline solution that the cells are immersed in and results in the rupture of the cell 
membrane and release of the cells intracellular components. This method was used 
by Lee et al in the development of a platform for the extraction and detection of 
DNA from cells captured at an electrode surface. This method however is not suited 
to the detection of RNA due to its sensitivity to basic environments. 
A simpler approach is to carry out the physical disruption of the cell membrane by 
force, by spinning cells in a microfluidic compact disc until disruption of the 
membrane occurs. This approach was adopted by Kim et al. as a method for the 
reagent free disruption of cell membranes[92] and is an attractive method for the 
disruption of cell membranes as the microfluidic platform may then be designed with 
chambers for further downstream analysis. However, in the case of this system 
where a high shearing force is generated to disrupt the cell membrane, the 
intracellular components of lysed cells will forced away from the cell at high speed 
and mixed with the components of adjacent lysed cells, resulting in a homogenised 
mix of all cells in the sample, and would not be suitable where it is desirable to study 
the intracellular components of lysed cells on a singular basis, such as in the scheme 
of profiling individual cells on their miRNA expression for example. 
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A far more simple, elegant, reagent free solution is to form osmotic shock of 
captured cells on a surface by the introduction of a hypotonic solution[93]. This 
results in the influx of water to the captured cells and eventually the rupture of the 
cell membrane from the pressure evolved from within the cell. As this method 
involves merely changing the osmotic potential of the saline solution that the 
captured cells are surrounded by, it has no potential for sample contamination from 
buffers. It also avoids the high sheering forces and wide changes in pH discussed in 
the previous examples that would not be compatible with in situ miRNA profiling of 
individual cells. Lastly, by controlling the change in osmotic balance the rate of cell 
lysis may be tightly controlled to rupture the cell membrane in a mild manner, which 
may prove to be a useful tool in the localisation of the intracellular miRNA fraction 
of a single cell to an nearby area, thus allowing the intracellular content of a single 
cell to be probed.  
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1.7. Conclusion.  
 
In conclusion, Chapter one presents a review of the relevant literature related to 
electrochemical methods that may be implemented for the ultrasensitive detection of 
cellular and genetically based biomarkers. This chapter uses neuroblastoma as an 
example of the  clinical challenges that are faced in medical diagnostics and 
theranostics. Following on from this, miRNA is introduced and the involvement of 
miRNA in regulation of cellular processes and is explored. Through this it is 
demonstrated how miRNA are excellent biomarkers for disease and the varying 
degrees of disease states that may be probed as a result of the changing expression 
levels of miRNA. 
This chapter then continues on to explore the various methods exploited for the 
detection of miRNA, initially exploring the existing techniques used in biochemical 
analysis, for example RT-qPCR, microarray analysis, etc.. These methods are then 
contrasted with electrochemical methods that have recently been reported for 
miRNA detection, such as impedance based and amperometrically based detection 
methods. In the majority of electrochemically based methods discussed here, the 
sensitivity of detection far surpasses that of standard biochemical analysis. Following 
this, the underlying mechanics of hybridisation based and amperometrically based 
detection methods are discussed due to their relevance to the following body of 
work. 
This literature review then deals with electrochemiluminescence and its use in the 
detection of minimal disease markers. The fundamentals of 
electrochemiluminescence are introduced initially and then a detailed review on the 
various methods of electrochemiluminescent signal generation is presented. The 
applications of ECL in the detection of minimal disease are then reviewed, showing 
recent examples of ECL based methods for the detection of both organic and 
inorganic biomarkers, finally concluding with examples of ECL being used in the 
ultrasensitive detection of genetically based biomarkers, and the various methods 
through which this may be achieved. 
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The final section of this literature review then looks at the methods available for the 
non-specific and specific capture of cells, with examples of how neuroblastoma cells 
may be specifically captured and then subsequently lysed for the analysis of their 
intracellular contents. Possible lysis procedures are explored with critical analysis of 
how each may be suited to the detection of miRNA from single cells and how the 
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2. Label-Free Impedance Detection and PtNP Mediated Detection of 




In recent times a considerable amount of research interest has been devoted to the 
electrochemical detection of pathogenic cells from within a host.[1-5] 
Electrochemical approaches have advantages including the speed of analysis, 
accuracy of results, potential for miniaturisation and relatively power use and cost, 
when compared to traditional optical detection. The field of electrochemical cellular 
pathogen detection has also gathered attention for label free detection following 
initial cell capture, reducing production and material costs and lead time when 
developing detection systems[5, 6]. 
Electrochemical Impedance Spectroscopy (EIS) in particular has recently been 
identified as a useful label free electrochemical detection method of captured cells 
due to the fact that a physical change in the surface of the electrode, i.e., resistance 
and capacitance are measured[1, 5]. This approach to detection of cells therefore 
could eliminate the need for labelling strategies. This would lead to the development 
of a scheme that only requires incubation of cells at the electrode surface and 
electrochemical detection. This capability would significantly improve the analytical 
turnaround time for clinical point of care settings as well as reducing the user 
expertise required compared to the labelled strategies of fluorescent microscopy.  
Therefore is is the overall aim of the work detailed in this chapter to create a 
platform where the capture of cells from solution may be facilitated. This involves 
the formation of a uniform surface that may facilitate efficient specific cell capture, 
while remaining capable of carrying out the accurate detection of captured cells by 
an electrochemical means, for example EIS. The approach detailed in this chapter 
relies on the capture of neuroblastoma cancer cells from suspension and detection of 
this event in phosphate buffered saline due to a proportional change in the impedance 
characteristics of the working electrode. The resistance (R) of the circuit in this case 
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is a useful parameter in the determination of the circuits change in impedance as it is 
the resistance associated with the transfer of charge from one phase to another (in 
this case from liquid electrolyte to the solid electrode surface). The changes in the 
characteristics of the electrode surface for example, capture of cells to the surface, 
will then give changes in the value for R proportional to the change in the number of 
cells captured. Therefore, the number of cells captured on the surface of an electrode 
will have a direct effect on the resistance associated with transfer of charge between 
the solution and electrode, provided that the distance over which the resistance is 
being probed is adequate to ensure the biological cells are contributing to the 
measured resistance. It is well understood [2, 5, 7] that the concentration of 
supporting electrolyte within the electrochemical cell plays an important role in the 
distance probed by EIS in the dielectric medium.  In particular, with decreasing 
electrolyte concentration the sensitivity of impedance detection of cells at the surface 
of the electrode is enhanced due to the relatively long distance probed, as the 
thickness of the electrochemical double layer increases with decreasing electrolyte 
concentration[8]. Therefore,  it is important to optimise the concentration of 






(a) (b)  
(c) (d)  
   (e)  
Figure 2.1. Illustration of electrode fabrication scheme and subsequent cell capture and detection. In 
(a) a planar gold electrode is modified with a monolayer of 3MPA. (b) shows the activation of the 
carboxyl termini with EDC-NHS so that in (c) antibodies may be covalently bound to the surface of 
the electrode. In (d) cells are incubated and subsequently captured on the to surface to be detected by 
electrochemical impedance spectroscopy, while in (e) antibody conjugated nanoparticles are applied 
to the cell surface for amperometric detection of cells. 
 
As shown in Figure 2.1, in this work, a bare planar gold electrode is modified with a 
self-assembled monolayer of 3-mercaptopropionic acid (3MPA) in order to give an 
electrode surface that can be modified with antibodies for cellcapture. The carboxy 
termini of the monolayer surface are then activated via the EDC-NHS coupling in 
order to couple amino groups within a capture antibody to the surface, resulting in an 
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electrode surface covalently modified with a cure antibody specifically targeted to 
the antigen of interest, in this case the GD2 ganglioside expressed on the surface of 
the neuroblastoma cells[9, 10]. The electrode is then incubated in a known 
concentration of cells for 30 minutes to facilitate specific antibody/antigen mediated 
cell capture of neuroblasts to the surface of the electrode and following this the 
electrode is washed with Dulbecco’s Phosphate Buffered Saline (DPBS) in order to 
remove non-specifically bound cells. The electrode is then placed in an 
electrochemical cell and the captured cells detected by measuring the change in 
electrochemical impedance of the circuit before and after cell capture. However, as 
this strategy relies on the specific capture of cells from suspension over a short 
period in a static environment, it is important to note that capture efficiency would 
not be expected to approach 100% without the implementation of a specialised 
system for improving the efficiency of cell capture, for example, a microfluidic flow 
device that forces cells in suspension to come in contact with the electrode surface 
for improved cell capture. Therefore, it is important to correlate the impedimetric 
response with the actual number of cells captured on the surface. Here, the total 
number of cells on the surface of each electrode was confirmed by visualisation of 
the cells through staining and fluorescent microscopy. This allowed the correlation 
between the number of cells captured and the impedance change to be determined. 
This is important since the surface coverage of cells may not depend linearly on the 
suspension concentration. 
The inherent properties of a label free detection system limit its sensitivity and limit 
of detection.  For this reason, the results from the label free cell capture detection 
assay were compared to that of a study carried out using a label, in this case an 
antibody conjugated platinum nanoparticle (PtNP-Ab). The aim of this detection 
strategy was to bind electrocatalytic platinum nanoparticles to the surface of cells 
captured on the electrode and determine the number of cells on the surface by 
measuring the current associated with electrocatalysis. The performance of this assay 
could be then compared to a label free system in order to determine the efficacy of 
label free detection to carry out precise and accurate measurements of the number of 






2 mm diameter conventional gold disc electrodes were purchased from IJ Cambria, 
Wales, UK. Anti-human GD2 monoclonal mouse IgG antibodies were purchased 
from Santa Cruz Biotechnology. Platinum nanoparticles 70 nm diameter (CAS no. 
7440-06-4) were purchased from Sigma Aldrich. Sk-N-AS Neuroblastoma cell line 
was provided by the research group of Prof. R. Stallings in the RSCI Dublin. All 
other reagents, unless specified otherwise, were purchased from Sigma Aldrich. All 
aqueous solutions were prepared with milli-Q water. 
 
2.2.2.Instrumentation: 
A three electrode electrochemical cell was used throughout this work consisting of a 
platinum wire as a counter, a Ag/AgCl reference electrode and a 2 mm diameter gold 
disc working electrode. Cyclic voltammograms were recorded in  a 5mM solution of 
ferrocene methanol (FcMeOH) as a solution phase redox probe, with 1 mM DPBS 
acting as a supporting electrolyte. All AC impedance and impedance measurements 
were carried out at open potential in 1mM DPBS in a frequency range of 1 MHz to 
0.1 Hz with an amplitude of 25mV vs Ag/AgCl. All electrochemical measurements 
were carried out using a CHI 760E potentiostat within a faraday cage. Fluorescent 
microscopy images were carried out using an Olympus IX81 inverted fluorescent 
microscope. EDX of platinum nanoparticles was carried out using an INCA Operator 
EDX system coupled to a Hitachi S5500 Field Emission Scanning Electron 
Microscope. All mammalian cell culture was carried out in a biosafety level II 
laminar flow cabinet and cell counts were obtained using a standard haemocytometer 







2.3.1. Fabrication of Capture Surface. 
Initially, each gold disc electrode was polished with descending sizes of aluminium 
oxide particles (5ȝm, 1ȝm, 0.3ȝm and 0.05ȝm) on a polishing pad for 5 minutes at 
each stage and sonicated in ddH2O between polishing stages. The microscopic 
surface area of each electrode was then measured using cyclic voltammetry in 10 
mM H2SO4 vs. Ag/AgCl and the surface roughness was determined. The AC 
impedance and impedance vs. time of each bare electrode was then measured. 
Electrodes were then placed in a 5mM ethanolic solution of 3MPA for a minimum of 
16 hours and then washed with copious amounts of ddH2O. Again AC impedance 
and Impedance vs time measurements were carried out. A 5mM solution N-
Hydroxysulphosuccinamide sodium (NHS) + 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC) was made up and 
electrodes were placed into this immediately and allowed to react for 30 minutes. 
Electrodes were then washed with ddH2O and treated with 20ȝl of 200mg/ȝl solution 
of Anti-GD2 IgG for 2 hours. Following this the AC impedance and impedance vs. 
time measurements were carried out. 
 
2.3.2. Mammalian Cell Culture and Capture.  
Sk-N-AS cells were cultured using Eagle’s Minimal Essential Media (EMEM). 
When being resuspended from an adherent state, cells were treated with 1X 
AccutaseTM to preserve extracellular adherent bodies. The cells were then counted 
using a haemocytometer and drop cast onto electrodes in EMEM for a minimum of 
30 minutes. Electrodes were then washed x4 with supplemented Dulbecco’s 
Phosphate Buffered Saline (DPBS) to remove unbound cells and extracellular 
material. Cells were fixed in 3.7% w/v paraformaldehyde in order to avoid osmotic 
lysis in the hypotonic electrolyte solution of the electrochemical cell and following 




2.3.3. Imaging of Captured Cells. 
Fixed cells were treated with a 5ȝM solution of DiOC6 dye (3,3’-
dihexyloxacarbocyanine iodide (Ȝmax=484nm)) in DPBS for 30 minutes and then 
imaged using fluorescent microscopy. Cell counting was carried out using the cell 
counting function of ImageJ imaging software. 
 
2.3.4. PtNP Cell Detection Assay. 
Antibody conjugated platinum nanoparticles (PtNP) were fabricated by suspending 
platinum nanoparticles (50-70nm in size) in a 5mM ethanolic solution of 3MPA for a 
minimum of 16 hours. PtNP were then washed with DPBS by centrifugation (rcf = 
5000G, t = 2 minutes) and removal of supernatant for four subsequent wash cycles 
and finally resuspended in a 5mM EDC-NHS solution in DPBS for 30 minutes. 
Following this, PtNP were once again centrifuged, the supernatant was discarded and 
the nanoparticles were resuspended in a 10mg/ml Anti-GD2 DPBS solution and 
incubated at 37°C for 2 hours. Antibody conjugated PtNP were then stored at 4°C for 
no longer than one week before use. 
Following the captureof Sk-N-As cells to the surface of an electrode and washing of 
the cells with DPBS, the antibody conjugated PtNPs were applied to the cells and 
incubated at 37°C for a minimum of 1 hour prior to washing with DPBS to remove 
unbound PtNP. Subsequently cells were fixed with 3.7% w/v paraformaldehyde. The 
electrodes were then once again washed with copious amounts of ddH2O and then 
placed in an electrochemical cell, with 0.01M H2SO4 as a supporting electrolyte. The 
amperometric i/t curve technique on the CHI 760E system was used to monitor the 
current produced at an applied potential of -250mV vs Ag/AgCl. For 600 seconds a 
baseline current was allowed to stabilise and at 600 seconds the program was paused 
and H2O2 was injected into the cell to give a final concentration of 200ȝM with 
moderate agitation to ensure a homogeneous solution, the program was resumed and 
a current increase was observed. At 2400 seconds the program was ceased and the 




2.4. Results and Discussion 
 
2.4.1 Capture platform fabrication 
In order to fabricate an antibody modified electrode surface for the capture of cells, 
polished planar electrodes were placed in an ethanolic solution of 3MPA for a 
minimum of 16 hours to form a monolayer surface of carboxyl termini that may be 
coupled to antibodies. As the 3MPA molecule is relatively short compared to other 
traditional monolayer forming molecules such as dodecanethiol and 16-mercapto-
hexadecanoic acid, a change in the surface electrochemistry of the gold electrode 
was difficult to observe in a cyclic voltammogram, as 3MPA is simply too short to 
significantly change the rate of electron transfer to/from a redox species in solution. 
As a result, the voltammograms below show little or no passivation of the gold 
surface in Figure 2.2. that would result in lower peak currents and larger peak-to-
peak, Ep, values for the ferrocene methanol probe (FcMeOH) 
However, by measuring the electrochemical impedance of the electrode before and 
after the formation of the thiolated monolayer, a large change can be observed. In 
Figure 2.3. it is clearly shown that the resistance (R) associated with the electrode 
decreases greatly following a 16 hour incubation in 3MPA from a value of 1956Ω to 
506Ω. This trend of the electrodes resistance decreasing following the formation of 
an alkanethiol monolayer appears to be counterintuitive and does not corroborate 
previous reports in the literature.  
This negative change in electrode resistance, while unexpected, was observed 
reliably for each electrode in this study, and thus is not considered to be anomalous. 
The change in impedance observed may be explained by detritus on the electrode 
prior to incubation in the ethanolic 3MPA monolayer solution. Alkanethiol 
monolayer depostitions have been shown in the literature to be able to clean loosely 
bound materials from the surfaces of coinage metals, such as gold, and therefore the 
data suggests that incubation in the monolayer deposition removed materials from 
the surface of the electrode that had contributed to the anomalously high impedance 
of the bare gold electrode. 
74 
 
It may also be the case that this change in impedance may be explained in terms of 
the effect of a change in capacitance of the electrode rather than resistance. For an 
electrochemical cell where, 
Rtotal = Rmonolayer + Rsolution 
in the case where a supporting electrolyte of a very low ionic strength is used, the 
Rtotal value would be expected to be almost equal to that of the Rsolution value as it is 
the major contributing factor to resistance. However, if the changes in capacitance 
are considered, for a cell where, 
Ctotal = 
1C௠௢௡௢ + 1C𝑆௢௟௡ 
Here the Ctotal value will be heavily influenced by the smaller value capacitance in 
the circuit, which would be expected to be the highly ordered, minimally defective 
monolayer of 3MPA. Thus the impedance measured in this case may be 
predominantly influenced by the capacitance of the monolayer and thus a negative 
change in impedance is observed. 
Another possible explaination for this change in impedance may be the change in the 
surface chemistry of the gold electrode following modification with an alcohol 
terminated monolayer. In a publication on the binding of PNA and DNA self-
assembled monolayers on the surface of gold electrodes by Prabhakar et al. [11], a 
similar trend was observed where following modification of a bare gold surface, the 
measured resistance of an electrode decreased. The authors in this case gave the 
explanation that the charged nature of the modified electrode may attract ions from 




Figure 2.2. Cyclic voltammogram of an electrode before (Blue) and following 3MPA monolayer 
formation (Red) carried out in a 5mM FcMeOH solution in 10 mM DPBS vs. Ag/AgCl at a scan rate 
of 100 mV/s,  
 
Figure. 2.3. Nyquist plot of impedance of an electrode before (Blue) and after 3MPA monolayer 
formation (Red) carried out at open potential with an amplitude of 25mV vs Ag/AgCl in  1mM DPBS 





























Following the formation of the monolayer surface, the carboxyl termini of the 3MPA 
monolayer subunits were activated with EDC-NHS,  and following this anti-human 
GD2 monoclonal mouse IgG antibodies were covalently bound to the surface. As 
before, visualisation of this process was incompatible with cyclic voltammetry. As 
shown in Figure 2.4., in this case the surface coverage and irregular shape and thus 
inefficient packing of the antibodies does not facilitate the passivation of the 
electrode surface to the extent that is appreciable in a cyclic voltammogram. The 
antibodies themselves, also are not observable directly by voltammetry and are only 
possibly observed as a small shift in peaks due to a change in the overall charge of 
the electrode surface. However, once again the change in surface chemistry of the 
electrode may be observed through electrochemical impedance spectroscopy. 
In Figure 2.5. a reduction in R from 506 Ω to 382 Ω can be observed following the 
covalent modification of the electrode surface with antibody. This 123 Ω difference 
in R is associated with the formation of a monolayer of antibodies on the surface of 
the electrode. This was carried out in parallel with a control where the electrode was 
subject to similar modification step, but no antibody was applied and the electrode 
was instead incubated in clean buffer, also in Figure 2.5, giving rise to little or no 
change in the impedance measured at the electrode surface. However, when the full 
data set of electrodes used in the assay is considered, the deviation of -123.7Ω, while 
unexpected, must be considered statistically relevant. For 5 electrodes tested 
throughout the manufacture of this capture platform, the shift in impedance from a 
thiol monolayer to an antibody conjugated surface was always negative. The mean 
shift in impedance for this modification step was -148.4 Ω with a standard deviation 
of 23.4 Ω. 
It is expected that the lack of electrode passivation seen in the cyclic voltammograms 
before and after antibody modification is proof that the inefficient packing of the 
antibody facilitates movement of electrolyte solution to and from the electrode 
surface and thus does not increase the resistance of the circuit. The lack of an 
increase in impedance following antibody modification, which may have been 
seemed counter intuitive and anomalous is possibly a result of the inefficient packing 
of macromolecules like IgG. Considering their relatively large size of 145kDa, they 
are not expected to exhibit a similar degree of uniform monolayer formation 
observed for self-assembled monolayers. The bulky nature of macromolecules also 
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results in a leaky, non-uniform interface at the electrode surface that would be 
expected to result in only small shifts in impedance. 
Regardless, the conjugation of anti GD2 IgG to the surface of an electrode is reliably 
observed in this study as a net drop in measured impedance, and this decrease in 
measured impedance may be used as a positive indicator of covalent modification of 
the electrode with antibody. 
 
Figure 2.4. Cyclic voltammogram of an electrode before and after antibody conjugation carried out in 
a 5mM FcMeOH solution of DPBS vs. Ag/AgCl at a scan rate of 100mV/s showing no appreciable 


















Figure 2.5. Nyquist plot of impedance of an electrode before (Blue) and after (Red)antibody 
conjugation, and controls before (green) and following (purple)incubation in conjugation buffer 
carried out at open potential with an amplitude of 25mV vs Ag/AgCl  in 1mM DPBS over a frequency 

















2.4.2. Capture of Sk-N-As Human Neuroblastoma Cells and Label Free 
Electrochemical Impedance Detection. 
Following fabrication electrodes were stored in DPBS at 4°C for no more than 48 
hours before use. Before use, the electrodes were heated to 37°C and washed with 
DPBS. Sk-N-As were cultured as stated above and counted using a standard 
haemocytometer and serial diluted in into 1ml aliquots of 105, 104, 103, 102 and 101 
cell per 50µl concentrations. Following this, electrodes were incubated with 50µl of 
cell suspension ranging from 105 to 101 cells for 30 minutes and then washed with 
DPBS. Figure 2.7. and Figure 2.8. show impedance and cyclic voltammograms for 
each electrode. Following exposure to the cells in suspension, a large change is 
observed in both the cyclic voltammetry and impedance responses of the electrode 
indicating that cell capture had been successful.  
Figure 2.6. shows that from the voltammograms of antibody modified electrodes to 
those of electrodes following cell capture there is an appreciable depression in the 
magnitudes of the reversible redox reaction of FcMeOH for higher cell 
concentrations. This is an indication of cell capture that can be understood in terms 
of passivation of the electrode surface area by captured cells. However, the 
voltammetry is not sensitive enough at lower cell concentrations to provide 
conclusive proof of cell capture and only poorly characterises the extent to which 
capture was successful, meaning that a total cell count from this data would be liable 
to produce errors in electrode passivation recorded versus cells captured at the 
electrode surface. It is also interesting to note the observed broadening of distance 
between oxidative and reductive processes following the capture of cells to the 
surface of the electrode. For Figure 2.6 (A), following the incubation of the electrode 
with 105 cells, the separation between Epc and Epa broadens to 110 mV (Red) from a 
separation of 73 mV prior to cell capture (Blue), which may be indicative of a 
decreased rate of electron transfer following cell capture. This change in Epc and Epa 
separation may also be observed in Figure 2.6 (B), albeit to a lesser extent of 81 mV 





Figure. 2.6.A&B Cyclic voltammogram of two electrodes before (Blue) and after cell capture (Red) 
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Figure 2.7. and Figure 2.8. show the impedance responses before and following 
capture of cells to the surface of the electrode. Prior to capture of cells, electrodes 1 
to 5 have R values of 425 Ω, 441 Ω, 347 Ω, 385 Ω, and 381 Ω, with a mean value of 
396.7 Ω and a standard deviation of 37.2 Ω. All R values for electrodes fall within 
one standard deviation of the mean with the exception of electrode 3, falling just 
outside this range, indicating a narrow band of R values for electrodes modified with 
an antibody monolayer. However, following the incubation and capture of cells to 
the surface of the electrode, the R values shift to a higher resistance corresponding 
with the number of cells applied to the electrode surface during incubation. 
However, once these increases in R are recordedand graphed (Figure 2.9) it can be 
observed that there is a poor correlation to the initial number of cells incubated with 
each electrode. 
  
Figure 2.7. Nyquist plot of impedance of electrodes 1 – 5 with electrode 6 shown as control before 
cell capture carried out at open potential with an amplitude of 25mV vs Ag/AgCl  in 1mM DPBS over 



















Figure 2.8. Nyquist plot of impedance of electrodes following incubation with cell numbers ranging 
from 105 to 101, with electrode 6 as control, carried out at open potential with an amplitude of 25mV 
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Figure 2.9. Graph showing the relationship between the change in impedance of each electrode before 
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Following impedance and voltammetry measurements, the electrodes were incubated 
in DiOC6 dye for 30 minutes and then imaged using an inverted fluorescent 
microscope in order to get a definitive cell count for each electrode and determine 
the total number of cells captured in each case. The images in Figure 2.10. show 
clearly that in all electrodes cell capture has been successful. Images were processed 
using ImageJ software and a cell count was taken for each electrode. Note that for 
the electrode incubated with 105 cells here, due to poor image quality and heavy 
grouping of cells a reliable count could not be achieved. 
It is clear that  Figure 2.10. (A) has the highest number of cells applied to the 
surface, corroborating the data from impedance measurements in Figure 2.9. 
However, the relationship between change in resistance and the number of cells on 
each electrode is not perfectly linear and deviations are seen at the lower end of the 
graph. In Figure 2.10 (E) only 2 cells were found to be captured on the surface, 
however the change in R following the capture of just two cells was shown to be 
32.3Ω, giving a per cell value for contribution to resistance of 16.1Ω, which is far 




(A): 105 cells     (B): 104 cells  
  
(C):103 cells     (D): 102 cells  
  
(E): 101 cells  
 
Figure 2.10. Fluorescent microscopy images of electrodes following incubation with varying 
concentrations of cells (105 - 101), staining with 25µM DiOC6 dye and fixing. Electrodes were 




To further probe the efficacy of this label free impedance based detection approach, 
the study was repeated in order to get a more complete picture of the relationship 
between measured impedance response and number of cells captured on the surface 
of an electrode and in Figure 2.11(A) & (B) the results of this are shown with no cell 
controls shown in red. It is clear here that there is a statistically relevant difference in 
the ΔR. Of the three control electrodes used in the study, following incubation in cell 
free media the mean change in impedance measured was 14.3Ω, where σ = 4.9Ω. A 
statistically significant difference in impedance measured after cells is considered to 
be 3σ + control, or 29Ω. Therefore, in this case, the change in impedance of 32Ω 
observed for 2 cells captured to the electrode surface is considered to be statistically 
relevant, albeit close to the limit of detection. 
 In Figure 2.11 (B) the measured change in impedance per cell captured is plotted 
against the number of cells captured to determine a linear range where the number of 
cells captured may be quantified. The large differences in the  ohm per cell values 
between high and low cell counts may indicate the linear range for this assay may be 
in the range of > 100 cells, suggesting this approach may have issues with the 
reliable and quantitative detection of minimal residual disease biomarkers. This data 
suggests that there is a high margin for error associated with attempting to assign a 
per cell value at low (< 40) numbers of captured cells. This may be due to the fact 
that due to the variable shape of captured cells. As the change in impedance is 
related to the number of cells on the surface, each cell will not have an equal 
contribution to impedance as the surface area covered by each cell is different for 
each cell. This distribution of sizes of cells however, would be expected to average 
out at higher numbers and therefore the linear range for this assay may be seen to be 







Figure. 2.11(A) & (B). Figure (A) plots the no. of cells captured to each electrode vs. the measured 
change in impedance with no cell control shown in red. Figure (B) shows the number of cells captured 
vs. the measured change in impedance per cell. 
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2.4.3. Platinum Nanoparticle Mediated Cell Detection. 
While label free detection of cells has been demonstrated in the previous section, the 
sensitivity of this approach may not be adequate for applications that require the 
ability to reliably quantify the number of cells captured. The following section 
presents the results of labelling cells, post capture, with an electrocatalytic label 
capable of generating a measureable current proportional to that of the number of 
cells captured at the electrode surface. Here platinum nanoparticles capable of 
electrocatalytically reducing hydrogen peroxide were used. This was carried out as a 
comparison to the study of impedance detection of cells in a bid to improve the 
stringency of assay results and provide a greater degree of accuracy in the process of 
cell detection. Here, the electrocatalytic reduction of hydrogen peroxide at a fixed 
potential will result in a current that is proportional to the number of catalytic 
nanoparticles and thus the number of cells on the surface of the electrode. However, 
it should be noted that this effect will be only be reproducible if the number of 
electrocatalytic nanoparticles on each cell is the same. 
The processes of fabricating an electrode surface for cell capture and carrying out 
capture of cells that have been discussed previously were carried out in the same 
manner for this study to the point of cell incubation. Once the incubation time was 
complete, the electrodes were washed with DPBS to remove any weakly bound cells 
and placed in supplemented-DPBS based suspension of antibody modified platinum 
nanoparticles for 30 minutes at 37°C. The nanoparticles were modified with anti-
human GD2 mouse IgG antibodies in a similar fashion to that of the electrodes 
mentioned in previous sections. Figure 2.12 shows the results of EDX analysis of 
antibody conjugated nanoparticles dried onto a planar gold on silicon substrate. The 
spectrum shows strong x-ray emissions for both gold and platinum. The map of 
platinum emission generated by the software however clearly shows the localisation 
of platinum to the large structure of dried. The lack of observed signals for possible 
dopants or surface tarnishing materials dissuades any argument that the surface of 



















Figure 2.12. EDX analysis of PtNP-Ab dried onto gold substrate performed with an INCA Operator 
EDX system coupled to a Hitachi S5500 FeSEM at an accelerating potential of 20 kV 
14/07/2015 17:01:58 
Project: PtNP 
Owner: Inca Operator 
Sample: PtNP Dried to Gold Substrate 
Type: Default 
Comment: Antibody conjugated Platinum nanoparticles dried to the surface of a 
planar gold substrate for EDX analysis. 
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Following the incubation of electrodes with PtNP, the electrodes were placed in an 
electrochemical cell of 10 mM H2SO4 under an applied potential of -250mV vs. 
Ag/AgCl and following the injection of H2O2 the current due to the electrocatalytic 
reduction of H2O2 by the PtNPs was determined using the amperometric i/t curve 
function of a CHI760E potentiostat program. As the  
Figure 2.13. shows the i-t curves generated for electrodes A to E during detection 
runs following an injection of hydrogen peroxide resulting in a total peroxide 
concentration of 2mM within the electrochemical cell. Table 2.1 Shows the current 
evolved for electrodes A - E during the detection program with the total number of 
cells applied, the number of cells counted on the electrode post detection and the 
current per cell evolved over the detection program. Figure 2.14. shows the plot of 
the current evolved due to peroxide reduction versus the number of cells on the 
electrode. 
 
Figure 2.13. i-t curves generated for electrodes captured with cells that were labelled post capture with 
PtNP-Ab. Curves were generated under a constant potential of -250mV vs Ag/AgCl in 10 mM H2SO4. 
Following a minimum of 100 seconds program was paused and an injection of H2O2 to result in a 
concentration of 2 mM H2O2 within the electrochemical cell. 1900 seconds after the injection is made 




















Table 2.1. Results for the PtNP based detection of cells showing cells captured to the electrode as well 
as the current evolved during the detection program and current per cell value for each electrode. 
Electrode A B C D E  Control 
Total Cells 
Applied 
100000 10000 1000 100 10 0 
Cells 
Captured 
1637 1109 187 36 9 N/A 
Δi (µA) 38.51 27.9 4.3 1.43 0.36 0.11 
Δi/cell 
(µA) 
0.0235 0.0243 0.0233 0.0367 0.0407 N/A 
 
 
Figure 2.14. Graph showing the relationship between the Δi of an electrode and the number of cells 
captured to the electrode surface. At higher counts, linearity is observed, however at low counts 
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From these results it is clear that detection of captured cells through labelling with 
antibody conjugated platinum nanoparticles has been successfully carried out 
showing a linear correlation between, approximately 23.5nA per cell for samples 
captured with approximately 1600 to 180 cells. However, at lower cell counts per 
electrode (below 50 cells) the observed current per cell increases sharply. For 
example, electrode E, where 9 cells are captured generates  a current  of 0.36µA, 
which is approximately 50% higher than that expected on the basis of the higher 
coverage data, 0.21µA. 
There are several processes that may contribute to the increased current per unit cell 
at low cell counts. First, the underlying gold surface of the polished planar electrode 
is weakly electrocatalytic to the reduction of hydrogen peroxide as well, resulting in 
a small current associated with each individual electrode that is negligible when a 
surface is covered in a high concentration of cells but will become the main 
contributor to the current response when no cells are present. Second, similarly to the 
results observed for the label free assay, the polymorphic nature and size of captured 
cells may play a role in the signal observed for each cell. The varied shape and size 
of each cell on the surface of an array may lead to discrepancies in the number of 
PtNP electrocatalysing the reduction of peroxide on the surface of the electrode. 
Often in a population of cancer cells, the size distribution of cells is broad and highly 
varied, often due to abhorrent cell cycle arrest resulting in binucleated cells [12]. It 
would be intuitive to assume that the larger cell would result in twice the amount of 
current as it would have twice as many nanoparticles bound to its surface. On a scale 
of many cells, these statistical size differences would be expected to be averaged out, 
but at lower cell counts, only a small proportion of binucleated cells would result in 
considerable errors in measured cell number. The physical shape of a cell on the 
surface of the electrode will also determine the distance of bound nanoparticles to the 
surface of the electrode and thus the electrical communication between the PtNP and 
the electrode. During capture of cells to the surface there may be small fragments of 
cell membrane in solution that contain GD2 and as a result are also captured to the 
electrode surface. Such fragments maybe too small to observe by fluorescent 
microscopy, but nevertheless have the capacity to become labelled with PtNP and 
will become electrocatalytically active. These smaller fragments may not contribute 
markedly to the current produced by the electrode at high cell counts as they may be 
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too scarce due to the lower degree of free space on the surface of an electrode with a 
high cell count, but for an electrode with a large surface area of free antibodies the 
additive effect  on the electrode surface may produce a measurable current. Finally, 
the distance between adjacent cells and thus PtNPs must be considered. The surface 
of a PtNP the catalysis and subsequent diffusion of the catalytic substrate and 
products diffuse radially from the PtNP surface. This radial diffusion of materials to 
and from the PtNP surface controls the current produced by a single nanoparticle. 
However, as PtNP are brought into closer proximity of one another, the overlap of 
radial diffusion fields may lead to a decrease in the catalytic output and thus the 






The capture of cells to an electrode and their subsequent detection has been 
successfully carried out. The label free method based on measuring changes in the 
overall cell impedance due to  the capture of cells increases linearly for cell counts 
between 40 and 443 cells. In this range the results show that an increase in resistance 
at the electrode of approximately 2.6 ohm per  cell, with a standard deviation of 0.36 
ohms. In Figure 2.11. (A) is it is clear that the calibration plot is biphasic and this is 
may be explained in terms of the changes in not simply the background resistance of 
the circuit being high, but instead changes in both capacitance and resistance when 
going from a low cell count to a high cell count. As explained previously in this 
chapter, the total impedance measured for the electrochemical cell will be dependent 
on both resistance and capacitance, and in cases where cell counts are low, accurate 
determination of the resistance associated with cells on the surface may be hampered 
by small changes in the capacitance of the large electrode surface. Then as higher 
cell counts are obtained on the electrode surface, the effect of shrinking the electrode 
surface area will result in changes in resistance being the dominant factor in the 
measured impedance for the electrochemical cell.  
The labelled method, based on the measurement of current generated by captured  
electrocatalytic PtNP on the surface of captured cells, in comparison, offers assay 
results with a greater degree of accuracy at the high end of the scale, with a mean µA 
per cell value of 23.7 nA/cell, and a standard deviation of 0.5 nA, or 2.23%. 
However, this assay suffers from inaccuracies at the lower end of the scale with a 
deviation from the mean mentioned above of 17 nA/cell or 71.72%. This deviation at 
lower cell counts is far greater than the standard deviation observed for this data set 
and is likely this could be due to discrepancies in the extent to which each individual 
cell is labelled giving rise to greater current per cell values observed or increased 
spacing between electrocatalytic PtNP at low cell counts that will lower the effect of 
overlapping diffusion fields. There may also be a small baseline current that is 
negligible at high cell counts. It should also be noted that the overall current 
magnitude of 360 nA for electrode E is quite low, making it difficult to measure 
accurately with a macroscopic electrode. 
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When compared to the observed inaccuracy at the captured cell counts <10 for the 
label free impedance based detection method, 11.7 Ω/cell, the PtNP labelled assay 
still outperforms the label free assay, with regards to accuracy, by almost an order of 
magnitude. This data suggests that at very low captured cell counts the quantitative 
detection of captured cells is unreliable, possibly due to the contribution to measured 
impedance of cellular secretions becoming adhered to the surface or components of 
the complex growth media. As before, as high cell counts, these contributions appear 
negligible but limit the ability to quantitate low cell counts reliably. 
In summation, the labelled assay performs best for reliable quantitation of captured 
cells on the surface of the electrode. However, neither method is suited to accurate 
quantitation of a total cell count at low (<10 cells) counts. Both methods have 
displayed the ability to perform reliable qualitative detection of captured cells at 
dynamic ranges of 100-1000 cells and show reasonable quantitation of cells counts 
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Currently, there is a great deal of interest in biosensor fabrication and its application 
in the detection of minimal (residual) disease and theranostics [1-7].To this end, 
miRNA may be useful biomolecular targets. First, since they occur ubiquitously 
across all cell types and tissues[8], miRNA based detection systems have the 
potential to be applied to not only the detection of disease from any host cell 
regardless of phenotype, but they may also be applied to the detection of pathogenic 
disease in the instance of bacterial or fungal infection[9]. Second, as miRNA 
expression is one of the controlling factors of gene expression and thus phenotype, 
expression profiles of miRNA may be used to not only identify disease, but also give 
specific information about the disease state and therefore allow the tailoring of 
treatment plans to individual cases for efficient disease management[10, 11]. The 
third advantage of miRNA based biosensor systems is the chemical similarity of 
individual targets due to the relatively simple structure of nucleic acids when 
compared to other biomolecular targets such as proteins. However, while the general 
structure and scheme of detection may be conserved across all potential targets, the 
sequence of each individual target miRNA offers exceptional target specificity. This 
allows for the design of simple immobilisation strategies, purely by fabricating a 
capture oligonucleotide complementary to the target miRNA, avoiding the labour 
intensive antibody production and screening associated with other biomolecular 
biosensors. While the vast majority of miRNA based biosensors require 
amplification of the target miRNA[10, 12, 13], electrochemically based detection 
methods offer the ability to provide fast, ultrasensitive analysis, requiring only a 
fraction of the time that may be needed for either the isolation and preparation of 
histological samples in the case of cancer identification and classification.  
The following section describes an amperometric biosensor applied to the childhood 
cancer, neuroblastoma. As with other amperometrically based miRNA detection 
schemes reported in the literature, this approach will rely on the hybridisation of a 
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miRNA target to a capture oligonucleotide on the surface of an electrode to bring 
about a current response that can be accurately measured. However, the specific 
advantage of this approach is the possibility to carry out cell capture, cell lysis and 
detection of miRNA at the electrode surface, thus creating regions on the electrode 
surface where intracellular miRNA is concentrated following lysis and reducing the 
dilution effects of lysing cells in bulk solution prior to hybridisation and detection. 
Another possible advantage to this approach would be the possibility of determining 
the expression profile of miRNA within each individual cell, by lysing the cell into a 
single microcavity. The total intracellular content of a specific miRNA target may be 
exposed to and subsequently hybridised to capture strands on the inner surface of a 
single microcavity allowing the miRNA concentration to be determined. An 
amperometric biosensor relies on the transduction and detection of a current resulting 
from an interaction of the sensor with its target biomolecule, in this case a miRNA, 
miR-132. miR-132 was chosen due to its upregulated expression levels observed in 
differentiating neuroblastoma cells. In a study by Chen et al, neuroblastoma cells 
treated with retinoic acid to promote differentiation exhibited a 2.67 fold increase in 
expression and were the most increasingly expressed miRNA observed during 
differentiation[14]. As a result, miR-132 can be used as a biomarker for this disease. 
In this scheme, a gold electrode is modified with a self-assembled monolayer of 
thiolated capture oligonucleotides complementary to an 11nt segment from the 5’ 
terminus of the target miRNA. The remaining 11nt of the 3’ terminus of the miRNA 
target is reserved for hybridisation with a second thiolated oligonucleotide strand 
complementary to this segment referred to as the probe. Following the hybridisation 
of the miRNA target to the capture oligonucleotide, a platinum nanoparticle 
uniformly decorated with probe oligonucleotide is bound to the array through 
hybridisation of the probe to the target miRNA (see Figure 3.1.). Once the platinum 
nanoparticles have been immobilised on the array, a potential is applied to the 
electrode and the current generated by the electrocatalytic reduction of hydrogen 
peroxide by the bound platinum nanoparticles measured which depends on the 
concentration of miRNA in the sample. This provides the basis the amperometric 
detection of miRNA. 
Thus the aim of the following body of work detailed in this chapter is to create an 
electrode surface where the specific capture of neuroblastoma cells, their subsequent 
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lysis, and the detection of their intracellular miRNA target fraction  may be detected 
and measured. By forming a three dimensional electrode surface that may be 
selectively chemically modified in different steps, ie cell capture and lysis on the 
exterior of the microcavity and  miRNA detection on the interior of the microcavity, 
the intracellular miR-132 fraction of lysed cells may be concentrated to a  
dedicated detection surface in very close proximity following lysis.  
 
(A)  (B)  
(C)  (D)  
E)  (F)  
Figure 3.1. Fabrication of a fully modified microcavity array begins with the deposition of 
polystyrene template spheres to the surface of a gold-silicon wafer (A). Gold is then electrodeposited 
through the template spheres until microcavities are formed around the template spheres(B). The array 
is placed in an ethanolic solution of 3MPA until a monolayer is formed on the surface(C). The array is 
then placed in THF to remove the polystyrene template revealing the bare surface of the inner 
cavity(D). The array is placed in a 1μM solution of thiolated capture RNA until a monolayer is 
formed (E). The array is carboxy-termini of the 3MPA are then activated through EDC-NHS coupling 
and anti-GD2 antibodies are conjugated to the upper surface. 
 
Figure 3.1. shows the electrodeposition of gold around a template of polystyrene 
spheres that gives rise to a three dimensional gold microcavity surface on an 
electrode. The primary advantages of this surface shape over traditional planar 
electrodes is that the surface may be modified in stages to produce two spatially 
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separated regions on the electrode capable of carrying out two separate functions; the 
exterior surface for capture of neuroblastoma cells and the interior of the microcavity 
for the hybridisation miRNA target and detection by electrocatalytic platinum 
nanoparticles. Initially polystyrene template spheres are deposited onto the surface of 
an electrode in suspension and allowed to dry, giving rise to layers of polystyrene 
template spheres packed onto the surface of the gold electrode. The electrode is then 
placed in a gold electrodeposition solution and a potential is applied to the electrode 
resulting in the deposition of gold around the layer of polystyrene template spheres 
on the electrode surface. Deposition is monitored by measuring the charge passed 
through the circuit. Once deposition is complete, the electrode is removed from the 
deposition solution and washed to remove excess polystyrene spheres, however, the 
polystyrene template spheres within the electrodeposited cavities remain in place. 
The electrode is then immersed in a solution of 3-mercaptopropionic acid (3MPA) 
and a self-assembled monolayer forms on the gold surface, however, this monolayer 
formation is restricted to the top surface of the cavity array as access to the interior 
surface of the microcavities is blocked by the polystyrene template spheres. 
Following this process, the electrode is washed and the polystyrene spheres are 
dissolved with tetrahydrofuran exposing a clean interior surface of the microcavity. 
This interior surface of the microcavity is then modified with a self-assembled 
monolayer of capture RNA oligonucleotide that is complementary to a portion of the 
miRNA target. Finally, antibodies specific to extracellular antigens expressed on 
tumour cells are conjugated to the carboxyl groups of the 3MPA monolayer through 
EDC-NHS coupling. This coupling method relies on a carboxylic acid that has been 
activated by the EDC-NHS to become coupled to an amine. As the nucleic acids 
within the microcavity are spatially separated from the carboxylic acids of the 
monolayer on the outer surface of the microcavity array, and the oligonucleotides 
possess no carboxylic acid units, no cross-coupling or antibody-oligonucleotide 
coupling would be expected. The coupling method is also carried out in a 
physiological temperature and pH and therefore is not expected to degrade 
oligonucleotides in the microcavity array.  
The fully modified electrode is then incubated in a suspension of Neuroblastoma 
cells to allow capture of cells to occur. Osmotic lysis using ddH2O is carried out on 
the captured cells and hybridisation of the target miRNA to the capture 
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oligonucleotide is allowed to occur. After a fixed time to ensure kinetic control over 
hybridisation, the electrode is washed to remove any remaining lysed cell fragments 
and unhybridised miRNA and placed in a solution of uniformly decorated probe 
platinum nanoparticles (PtNP) and the probes hybridise to the target miRNA. 
Following a wash to remove any unhybridised probe PtNP, the electrode is then 
placed in an electrochemical cell and the current produced under an applied fixed 
potential is measured to establish a baseline current produced by the microcavity 
array. Following this, an injection of hydrogen peroxide is made into the cell and the 
current is measured again. As platinum nanoparticles will readily catalyse the 
reduction of hydrogen peroxide at the applied potential, a current increase will be 
observed. The increase in current, attributed to the electrocatalytic reduction of 
hydrogen peroxide by PtNP, is directly related to the number of immobilised 
platinum nanoparticles on the array and therefore should be proportional to the 
intracellular concentration of miRNA target. 
However, the ability of this detection scheme to carry out highly selective 
ultrasensitive detection of miRNA relies on several key factors. Initially the capture 
of neuroblastoma cells to the surface of the microcavity array must be followed by 
lysis in such a manner that the miRNA target is free to diffuse into modified 
microcavities within the array. Also the uniformly labelled electrocatalytic 
nanoparticles must diffuse into the microcavities in sufficient numbers to produce a 
signal for every capture-target hybridisation event. The production of a detectable 
signal from each of these single electrocatalytic nanoparticles on the surface of the 
array relies on good electrical conductance between the nanoparticle and the surface 
of the microcavity array. Finally, the signal from immobilised catalytic nanoparticles 
must be detectable against the background current produced by the underlying gold 
microcavity surface. For this to be possible the microcavity surface must ideally be 
completely electrochemically inert for the reduction of peroxide with the current 







Gold-silicon wafer substrates were purchased from AMS bio. Techni Gold® 25 ES 
gold plating solution was purchased from Technic Europe. 5μm and 3μm polystyrene 
spheres were purchased from Bangs laboratories and 1μm polystyrene spheres were 
purchased from Polysciences. RGD custom thiolated capture peptide was purchased 
from Celtek. Anti-human GD2 monoclonal mouse antibody was purchased from 
Santa Cruz Biotechnology. All reagents, unless specified otherwise, were purchased 
from Sigma Aldrich. All solutions were prepared with double distilled water. Sk-N-
AS Neuroblastoma cell line was provided by the research group of Prof. R. Stallings 
in the RSCI Dublin. Oligonucleotide sequences were purchased from Eurogentec and 
sequences were as follows: 
Capture:  3’ HS-AUU GUC AGA UG 5’ 
Target:         5’ UAA CAG UCU ACA GCC AUG GUC G-3’ 
Probe:           3’ U CGG UAC CAG C – SH 5’ 
 
3.2.2. Instrumentation 
A three electrode electrochemical cell was used consisting of a platinum wire as a 
counter, a Ag/AgCl reference electrode and a gold working electrode fabricated from 
gold-silicon wafers with a 5x5mm working area. Electrodeposition, voltammetry and 
amperometry were carried out on a CHI 760D potentiostat. SEM images were 
obtained using a Hitachi S3400 scanning electron microscope and FeSEM images 
were obtained using a Hitachi S5500 Field Emission Electron Microscope. All 
mammalian cell culture was carried out in a biosafety level II laminar flow cabinet. 
AFM characterisation of substrates was carried out on a Vecco Bioscope II system 






3.3.1. Microcavity Preparation 
Working electrodes were prepared by scribing and breaking gold-silicon sheets into 
15x5mm pieces. 50μl of a 1% w/v suspension of 5μm polystyrene spheres was drop 
cast onto a 5x5mm area of the electrode by masking the remaining electrode area. 
The suspension of polystyrene spheres pipetted onto the gold electrode surface was 
then allowed to dry. The electrode was then placed in 10ml of Techni Gold™ plating 
solution and a potential of -900mv was applied to the working electrode for various 
times. Microcavity growth was monitored by the accumulation of charge and 
confirmed by scanning electron microscopy. 3μm and 1μm cavity arrays were 
prepared in a similar fashion.  
 
3.3.2. Microcavity Modification 
Following the growth of microcavities, electrodes were placed in an ethanolic 
solution of 1mM 3-mercaptopropionic acid (3MPA) for a minimum of 8 hours to 
ensure full monolayer formation on the outer surface of the microcavity array. The 
electrode was then washed with ddH2O and placed in tetrahydrofuran (THF) 
overnight to dissolve and remove polystyrene spheres. The electrodes were then 
washed with THF, ethanol and copious amounts of ddH2O. A 5mM solution of N-
Hydroxysulphosuccinamide sodium (NHS) + 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC) was made up and 
electrodes were placed into this immediately and allowed to react for 15-30 minutes. 
Electrodes were then washed with ddH2O and treated with 20μl of 200mg/μl solution 
of Anti-GD2 IgG for 2 hours. Following the conjugation of antibodies to the top 
surface of the cavities, the electrodes were placed in a solution of thiolated capture 
oligonucleotide for a minimum of 8 hours. 
RGD modification: Due to the prohibitive cost of antibody modified electrodes, a 
synthetic peptide (referred to from here as RGD) containing the –R-G-D- peptide 
recognition sequence was used for the non-specific capture of cultured 
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Neuroblastoma cells As the broad superfamily of integrin proteins expressed on a 
cells surface that bind these RGD sequences are expressed ubiquitously through 
mammalian cell types, this form of cell capture is thought to be non specific. 
However, as the cells used in this work were derived from pure cultures of human 
neuroblastoma, there was no expectation of contamination expected from other cell 
types. Modification of cavities with RGD was carried out by placing electrodes in an 
ethanolic solution of 1mM:5mM RGD and thiolated polyethylene glycol (PEG) for a 
minimum of 8 hours and following this the polystyrene template spheres were 
removed with THF and the inner microcavity surface was modified with thiolated 
capture oligonucleotide. 
3.3.3. Probe PtNP fabrication. 
A 100mg/L solution of 70nm PtNP were made up ddH2O. The maximum  
theoretical oligonucleotide loading of nanoparticles was 7.8x1012 oligos/cm2, as 
calculated using the  mean particle size and an estimate of the surface coverage of a 
close packed nucleic acid monolayer[15]. 1μM stock thiolated probe oligonucleotide 
was aliquoted into a suspension of PtNP and left on a rocking plate under moderate 
agitation for a minimum of 8 hours to produce nanoparticles uniformly 






3.3.4. miRNA hybridisation and PtNP immobilisation and detection. 
The modified microcavity arrays were placed in a solution of the miRNA target  
ranging from 1μM to 1pM for 5 hours and washed with copious amounts of DPBS 
before being placed in a suspension of PtNPs modified with probe strand nucleic 
acids overnight. (Note: no significant, ≥3bp, complementarity was observed between 
capture and probe strands. As both strands were immobilised to the 
electrode/nanoparticle at opposite ends,  the possibility of forming duplexes is 
between these two strands was prohibited as they would both be oriented in the same 
direction, with respect to their 3’ and 5’ ends.)  The arrays were then once again 
washed with copious amounts of DPBS and then placed in an electrochemical cell, 
with 0.01M H2SO4 as a supporting electrolyte. The amperometric i/t curve technique 
on the CHI 760D system was used to monitor the current produced from an applied 
potential of 100mV vs Ag/AgCl. For 600 seconds the current stabilised to an 
approximate range of 1-10x10-7 amps due to non-faradaic current and at 600 seconds 
the program was paused and H2O2 was injected into the cell to a final concentration 
of 200μM with moderate agitation to ensure a homogeneous solution, the program 
was resumed and a current increase was observed. At 2400 seconds the program was 
ceased and the final current was measured. 
 
3.3.5. Neuroblastoma Cell Culture and Capture 
Sk-N-AS cells were cultured using Eagle’s Minimal Essential Media (EMEM). 
When being resuspended from an adherent state, cells were treated with Accutase to 
preserve extracellular adherent bodies. The cells were then counted using a 
haemocytometer and drop cast onto electrodes in EMEM for a minimum of 
45minutes. Electrodes were then washed x4 with supplemented Dulbecco’s 
Phosphate Buffered Saline (DPBS) to remove unbound cells and extracellular 
material. In cases where cells were to be imaged by SEM, cells were fixed in 3.7% 
v/v glutaraldehyde and dehydrated with an ascending concentration of acetone every 





3.4. Results and Discussion 
 
3.4.1 Microcavity Array Fabrication and Cell Capture. 
 
In order to fabricate a substrate that could capture neuroblastoma cells and 
amperometrically detect  hybridised miRNA-132, a three dimensional, conductive 
platform was first formed by electrodepositing an array of gold microcavities onto a 
gold coated silicon wafer through a template of polystyrene spheres using a fixed 
potential. The process, known as nanoscale lithography (NSL), allowed the liquid 
phase deposition of a single layer of cavities. The deposition of gold microcavities 
was monitored coulometrically.  This charge was correlated with  structural data 
from SEM and atomic force microscopy as well as cyclic voltammetry. Cyclic 
voltammograms of a 5x5mm substrate before and after microcavity deposition are 
shown in Figure 3.3. In the voltammograms, there are well defined gold oxidation 
peaks at approximately 800 mV vs Ag/AgCl. There is also a less well defined anodic 
peak between approximately 1075 mV and 1500 mV vs. Ag/AgCl resulting from 
reduction of the gold oxide surface[16]. The charge associated with reduction of gold 
oxide is approximately 390µC cm-2 and so by integrating the area under the gold 
oxide reduction peak in the cyclic voltammograms it is possible to measure the 
microscopic surface area of the gold electrode[17]. Therefore using the equation; 𝐴𝑝39Ͳ 𝑥 ͳͲ−6 = 𝑆𝑢𝑟݂𝑎𝑐݁ 𝑎𝑟݁𝑎 ሺ𝑐𝑚2ሻ 
Where Ap is the area of the peak at approximately 800 mV vs Ag/AgCl, the mean 
surface areas of the planar gold and the gold microcavity array were thus 
experimentally determined to be 025 (σ = 0.003) cm2 and 0.85 cm2 (σ = 0.06 cm2) 
respectively (where n = 3), indicating the surface area of the gold electrode has 
increased significantly which is consistent with the formation of a three dimensional 
surface. However, this increase in surface area appears to be greater than expected as 
the surface area of the electrode, following the formation of hemispherical cavities 
on the entire surface would be expected to approach double the original surface area. 
This is due to the fact that the surface area of a hemisphere is given as 2πr2 whereas a 
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planar circular surface of the electrode, to which a microcavity would be deposited 
would be given as 2πr2. This suggests that following the electrodeposition of 
microcavity arrays, a much higher degree of surface roughness is observed, giving 
rise to a much greater measured surface area. Figure 3.2. shows SEM and AFM 
images of 3μm microcavity arrays. SEM was used confirm the electrodeposition of 
microcavity arrays and the degrees of ordering of the microcavity array. From these 
images it is clear that while parts of the microcavity array spontaneously pack in an 
efficient order, disordered, defective areas exist. AFM images show that the cavity 
depth measured for the microcavities is 1.5μm from the base of the microcavity to 





    
 
 
Figure 3.2. Scanning Electron Microscopy images obtained with a probe current of 35 µA and 
accelerating voltage of 20 kV showing the progression of microcavity electrodeposition.  Atomic 
force microscopy data showing the formation of a three dimensional microcavity array comprised of 
microcavities with a depth of 1.5μm  
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Figure 3.3. Cyclic voltammetry of a planar gold-silicon wafer carried out in 10mM H2SO4 vs 
Ag/AgCl at a scan rate of 100 mV/s before (blue) and after (red) the electrodeposition of a 5µM gold 
microcavity array to the surface. The increase in the oxide peak at approximately 800mV from planar 
gold to the microcavity array is indicative of an increase in the microscopic electrode surface area. 









Following the electrodeposition of gold to form the microcavity array, excess 
polystyrene spheres are rinsed from the surface of the microcavity array. However, 
the spheres in direct contact with microcavities are retained. In order to functionalise 
the newly formed microcavity arrays for cell capture and miR-132 hybridisation the 
microcavity arrays were placed in an ethanolic solution of 1mM 3MPA for 8 hours 
to ensure the formation of a monolayer on the upper surface of the microcavity array 
while the retained polystyrene spheres in the microcavities protect the interior of the 
microcavities for selective modification in a later step. The short chain length of 
3MPA has minimal hindrance on electron transfer from the surface of the electrode 
to the supporting electrolyte, which is a desirable trait here as electrocatalysis at 
platinum nanoparticles requires good conductivity between the surface of the 
electrode and the nanoparticles. However, due to this, quantitation of monolayer 
formation is difficult as the monolayer formed has only a minor blocking effect on 
the surface of the electrode. Therefore, for initial proof of monolayer formation at the 
exterior surface of the microcavity array, a microcavity array was modified with 16-
mercaptohexadecanoic acid (MHDA) in a bid to demonstrate the spatially separate 
modifications to the microcavity array, i.e., antibodies for cell capture on the upper 
surface and capture nucleic acids on the cavity interiors. The 16 carbon chain 
effectively blocks the surface of the electrode giving a measurable decrease in the 
gold oxide reduction peak observed in a voltammogram and allowing accurate 
measurement of monolayer formation. The formation of a MHDA monolayer was 
confirmed with voltammetry. A decrease in the area of the gold oxide reduction peak 
in the cyclic voltammogram corresponded to the formation of a MHDA monolayer 
blocking the available surface of the gold microcavity array (Figure 3.4.). Using the 
peak for gold reduction in the voltammogram the microscopic surface area of the 
electrode was determined to be 0.044cm2 and 0.0065cm2 before and after monolayer 
formation respectively, ie. Approximately 83% the exterior surface of the array  has 
been passivated, or 0.0435cm2 of MHDA monolayer surface formed.  
Following monolayer formation, the polystyrene template spheres were removed  by 
dissolving the polystyrene with THF, exposing the clean gold surface within the 
microcavity. The removal of polystyrene template spheres was confirmed by cyclic 
voltammetry and SEM imaging. As the deposited gold microcavity array is in direct 
contact with the polystyrene spheres it was deposited around, the inner surface of the 
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microcavities was inaccessible to the MDHA solution during monolayer formation 
and therefore monolayer formation only occurs on the upper surface of the 
microcavity array. This is observed in the difference between the gold oxidation 
peaks of cyclic voltammograms following the deposition of the MHDA monolayer 
and following the removal of the polystyrene template spheres from the microcavity 
array. In cyclic voltammetry following the removal of polystyrene template spheres 
the gold oxidation peak increases area from 1.716x10-5 C to 1.626x10-4 C 
corresponding to an increase in the exposed gold surface area of the microcavity 
array from 0.065cm2 to 0.417cm2. This indicated that following the removal of 
polystyrene template spheres an unmodified gold surface was exposed, leading to the 
conclusion that monolayer formation had been restricted to the exterior surface of the 
microcavity array. A separate control was carried out to assess the possibility of 
MHDA being stripped by THF, that would skew the electrochemical surface area 
measurements carried out before and after polystyrene removal. This was carried out 
by taking a gold electrode with a surface fully modified with a self-assembled 
monolayer of MHDA and subjecting the electrode to the polystyrene removal 
procedure. Cyclic voltammograms were carried out before and following treatment 
of the electrode with THF and by comparison, the voltammetry concluded that no 
monolayer damage occurs from interactions between the MHDA alkanethiol 
monolayer and THF. Therefore, it was concluded that the increase in gold surface 
area observed following the removal of polystyrene template spheres was solely due 
to the exposure of interior surfaces of the microcavities, which remained unmodified 
due to occlusion of the microcavities by polystyrene template spheres. 
By subtracting the surface array of the microcavity array before polystyrene removal 
from the surface area following polystyrene removal the newly exposed inner 
surfaces of the microcavity array was estimated to be 0.411cm2. Using this figure it 
was possible to estimate the number of cavities in the array that were available for 
modification. Assuming the formation of hemispherical microcavities, the inner 
surface of a single microcavity is 1.41x10-7cm2, and then there would be an expected 
2.9x106 microcavities in the array for modification. For an ideal microcavity array of 
5x5mm, the maximum number of hexagonally close packed 3μm diameter 
microcavities that could fit on this surface would be 3.2x106
.
. This figure is based on 
the area of the 3μm circular opening of a microcavity being 7.07cm2, and the 
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maximum packing efficiency of a circles on a planar surface being 0.907. The 
discrepancy between the observed number of microcavities in the array (2.9x106) 
and the maximum number of microcavities possible (3.2x106) may be explained by 
several factors. Firstly, the estimated total number of microcavities is based on all 
microcavities in the array being identical with an ideal height of exactly 1.5μm. A 
minor deviation in the height to which all cavities were grown around the 
polystyrene template sphere of ±50nm or 3.33% of the cavity height would result in 
deviations from this value in the order of ± 1.00x105 microcavities. Another source 
of discrepancies between the number of estimated and observed microcavities lies in 
the manner in which the polystyrene spheres are arranged on the surface of the 
electrode. As the polystyrene template spheres are drop cast onto the surface in a 
liquid suspension, packing of spheres on the surface of the electrode is entirely 
random and hexagonally closely packed microcavities are not seen throughout the 
entire surface due to the differences in rates at which spheres settle from suspension. 
The number of microcavities detected through voltammetry is also solely based on 
the number of microcavities that have not been modified by the monolayer. 
Therefore, throughout washing and handling processes following initial microcavity 
electrodeposition, some polystyrene template spheres may become dislodged or 
loosened from the microcavity, prior to, or during, the monolayer modification, 
leading to such microcavities becoming electrochemically inert. However SEM 
imaging has shown that the vast majority of polystyrene spheres are retained during 
the electrodeposition of  the gold and the overall number of polystyrene spheres lost 
would be expected to be very low. Lastly, electrodeposition of microcavities at the 
edges of the electrode (within approximately 50μm of the edge) will often result in 
the formation of microcavities with roughened inner surfaces. This may account for 
approximately 4% of the 5x5 microcavity array. Roughened inner surfaces may 
result in poor contact between the polystyrene template sphere and the inner 
microcavity surface, exposing portions of the inner surface of the microcavity to the 
monolayer solution. 
Following the removal of polystyrene template spheres the microcavity inner 
surfaces were modified with 1μM thiolated capture RNA strand in order to form a 
monolayer capable of hybridising, and thus immobilising, miR-132 to the surface of 
the microcavity array for eventual detection. As before, the remaining unmodified 
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gold surface area was measured in order to determine the coverage of RNA capture 
monolayer. The area of the microcavity interiors before modification was 0.411cm2 
(from above) and following the treatment of the interior surfaces of the microcavities 
with thiolated capture RNA strand the remaining surface area of the microcavity 
array was determined by cyclic voltammetry to be 0.280 cm2, therefore the total 
coverage of thiolated capture RNA was 0.131cm2 of the electrode or 31.8% of the 
available surface within the microcavities. This is a significantly lower percentage 
coverage of oligonucleotide monolayer coverage than that observed for the 
alkanethiol monolayer formed on the outer surface of the microcavity array. This 
lower coverage may be attributed to the reduced capacity of larger molecules such as 
oligonucleotides to form regular and defect free monolayers as they are subject to 
steric interferences of adjacent constituents, particularly on a concave surface where 
steric interference from adjacent oligonucleotides would be amplified to some extent. 
However, as shown by Peterson et al, tightly packed monolayers of oligonucleotide 
can be detrimental to achieving maximal hybridisation of target due to steric effects 
of adjacent constituents within the monolayer. Assuming that the incomplete 
monolayer does not consist of regions of dense islands coupled with unmodified 
areas, the  low coverage of thiolated RNA monolayer should provide adequate space 
for efficient hybridisation[18]. Following the formation of the RNA monolayer, the 
free carboxy termini of the 3MPA monolayer were then activated by EDC-NHS and 
anti-GD2 IgG was coupled to the surface. The disialoganglioside GD2 is a 
glycosphingolipid expressed on the membrane of neuroectodermal tumours[19] and 
was chosen as an antigen for antibody immobilisation on the basis of its prolific 





Figure 3.4. Cyclic voltammograms of a microcavity array at varying stages of modification in 10mM 
H2SO4 between 1500 and -200 mV at a scan rate of 100 mV s-1 vs. Ag/AgCl. Changes in the 
microscopic area of the microcavity array can be seen as changes in the charge related to the reduction 
of gold oxide. From the newly formed microcavity array (blue) to the formation of a MDHA 
monolayer (red) a decrease in the surface area can be observed. The removal of the polystyrene 
template (green) then leads to an increase in total surface area as the clean inner surface of the 
microcavities is exposed. Finally a decrease in the total surface area is observed as the capture RNA 










According to Wu et al[20] GD2 ganglioside comprises approximately 12% of the 
total cellular ganglioside content of human neuroblastoma. Considering that the total 
ganglioside content of neuroblastoma cells is approximately 400pmol/106 cells[21], 
then it can be assumed that each cell will express on its surface approximately 
48amol of GD2 targets, or 2.9x108 GD2 molecules per cell. Confocal imaging has 
shown that the average true imprint of captured cells to be approximately  
117 μm2 per cell (See Figure. 3.8.) and if it is assumed that this accounts for half of 
the cells total area following capture (i.e. 50% of the cells extracellular surface area 
is in contact with the array), then it can be assumed that the region of the cell in 
contact with the electrode surface will contain 1.45x108 GD2 gangliosides, or half of 
the total cellular content of GD2 targets. Given that the average cellular imprint on 
the area is approximately 117 μm2 this would lead us to expect a GD2 distribution of 
approximately 1.24x106 per μm2,  or 1.24 GD2 antigens per nm2 
A study by Celikkol-Aydin et al[22] has shown that effective antibody mediated cell 
capture to a substrate is observed only when the surface coverage of antibody on the 
substrate approaches a closely packed monolayer. Therefore, it is important to be 
able to determine if the amount of antibody applied to the  upper microcavity surface 
is sufficient to form a closely packed surface of antibody molecules. During 
fabrication, the electrode surface is treated with 4μg of IgG, which corresponds to 
approximately 1.6x1013 units that are potentially bound to the electrode.  As 
previously calculated, the total surface area of MDHA monolayer formed on the 
surface of the electrode is 0.0435cm2. This gives rise to an expected IgG distribution 
on the upper surface of the electrode of 3.52x1014 units per cm2 or 3.52units 
available in solution per nm2
 
of MDHA monolayer. This would imply that a 
complete monolayer of antibody may be  formed on the surface of the electrode as, 
considering that the diameter of an IgG molecule is widely reported in the literature 
to be between 20 and 40nm wide [23, 24], the amount of antibody units available is 
in great excess.  
As calculated above, in the region of the electrode in contact with the cell there is 
expected to be approximately 1.24 GD2 antigens per nm2 present. Considering the 
high affinity of the IgG for its antigen target and the abundance of antigen expressed 
per nanometre of cell surface, it can be concluded that cellular capture by IgG occurs 
rapidly once the cell has come in contact with the surface of the electrode and that 
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the controlling factor of cell capture is the proximity of the cell to the electrode 
surface. Therefore, it would be expected that over a time course maximum cellular 
adhesion will coincide with the time taken for cells to come in contact with the 
surface of the microcavity array, with the limiting factor for adhesion being steric 
hindrance of adjacent cells. 
However, there are several key practical aspects of cell capture that may adversely 
affect the overall coverage and activity of the coupled IgG and therefore the efficacy 
of the cell capture. Initially, due to the sensitivity of polypeptide conformation to pH, 
the coupling of IgG to the 3MPA monolayer via EDC-NHS coupling must be carried 
out at a physiological pH and therefore there is a marked reduction in the reaction 
efficiency, as the optimum pH for the activation of carboxyl groups by EDC NHS is 
most efficient between pH 4 – 6, and is often performed in MES buffer. The 
conjugation of amines to activated carboxyl groups is then assisted by a slightly 
basic environment, at pH 8 [25]. This will lead to a reduction in the number of 
reactive 3MPA units available for the antibodies to bind to, possibly lowering the 
number of IgG units coupled to the array. Another key factor of this process is the 
orientation of the IgG following coupling and the activity of the IgG following the 
process. It is also important to consider the distribution of GD2 antigens on the 
surface of the cell. It has been shown that the vast majority of surface expressed 
gangliosides are confined within dense regions of the cell membrane known as lipid 
rafts. Lipid rafts are large regions of the cell membrane highly populated with 
signalling lipids, such as gangliosides, that also contain higher than average 
concentrations of cholesterol, causing the raft region to be quite rigid. As a result, 
GD2 gangliosides will be concentrated within a region on the cell membrane and 
will have a lower probability of interacting with IgG on the surface of the electrode. 
The rigidity of lipid rafts also leads to an inhibition in the lateral diffusion of 
gangliosides along the membrane such that antibody-antigen interactions will not be 
possible without near perfect alignment. 
To assess the efficacy of antibody immobilisation, a static cell capture assay was 
carried out in which the microcavity arrays were incubated with neuroblastoma cells 
in parallel, an unmodified microcavity array was used as a control and a microcavity 
array modified with a non-specific capture oligopeptide, RGD. The assay is referred 
to as static as it does not have a flow component and all cell suspensions are placed 
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on the electrodes with no agitation/stirring. Following incubation with cells the 
arrays were washed with DPBS and fixed with 2.5% v/v glutaraldehyde. The 
microcavity arrays were then dehydrated and gold sputter coated for SEM imaging. 
Figure 3.5. shows the SEM images obtained from this experiment. From these 
images it is seen that the anti-GD2 antibody is capable of capturing cells. It is clear 
that 15 minutes of incubation is sufficient for initial cell capture, giving an estimated 
capture efficiency, i.e. 5.5% of the cells applied to the array were captured. 
Following 30 minutes this capture efficiency increases to approximately 8.7%, with 
similar values of 20% and 22% being obtained at 45 and 60 minutes, respectively. 
The similarity of these values indicates that following 45 minutes of incubation the 
number of cells becoming captured  to the array reaches an apparent saturation point. 
This may be explained by reaching the maximum occupancy of the array. SEM 
images may prove to be misleading when observing the capture of cells on the 
surface of the array as cells treated for imaging appear retracted and are not truly 
indicative of the surface area taken up by the cell. Size comparisons with confocal 
imaging show that cells appear to be between ~12μm in diameter giving rise to the 
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Figure. 3.5. SE SEM images of cells captured to microcavity arrays modified with anti-GD2 IgG (left) compared 
with microcavity arrays lacking a cell capture agent (right). A clear difference is seen in the capture efficiencies 
of microcavity arrays that have been modified with anti-GD2 IgG compared with those of unmodified 
microcavity arrays.  
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By comparison, in control samples, where no antibody modification was carried out, 
a dramatic difference is observed in the number of cells captured on the array. Very 
few cells are found in the control array due to non-specific physisorption. However, 
these physically absorbed cells contribute to a capture efficiency of only 0.6%, 2.3%, 
and 3.4% over 15, 30, and 45 minutes respectively. At longer incubation periods of  
one, two and three hours a significant number of cells can be seen adhered to the 
surface of the array due to physical adsorption, which would be expected for 
adherent cells such as the Sk-N-As cell line.  
In a study parallel, the efficacy of an RGD oligopeptide monolayer for cell capture 
was assessed. From these images it can be seen that the RGD oligopeptide performs 
cell capture marginally more efficiently than the anti-GD2 antibody. This is assumed 
to be due to the broad range of extra cellular targets available to the RGD peptide. 
The arginine-glycine-aspartate (RGD) sequence within the oligopeptide is implicated 
in the recognition and binding of integrin proteins, a broad class of extracellular 
membrane proteins[26], and therefore is capable of interacting with many different 
targets to facilitate cell capture. However, due to the broad range of interactions the 
RGD oligopeptide is capable of it is not effective in carrying out the specific capture 
of tumour cells and is not suitable for use in a diagnostic device. However, as the 
cells used at this stage are prepared from pure cultures of human neuroblastoma, the 
decision was made that the use of the RGD oligopeptide for initial proof of concept 
was the most practical option due to its relatively low cost, ease of preparation and 




3.4.2. Viability of Captured Cells. 
 
It is important to determine whether cells remained alive and viable following cell 
capture. In order to observe this, initially microcavity arrays were incubated with a 
fixed number of neuroblastoma cells for different amounts of time and then washed, 
fixed and prepared for SEM imaging in order to observe changes in cellular 
morphology as time progressed which would be indicative of living cells. Figure 3.7. 
shows SEM images of cells incubated on the surface of microcavity arrays for one, 
two and four hours. While cells in these images are fixed and dehydrated, which 
leads to changes in overall cellular morphology, a clear trend can still be seen of 
cells moving from a round to a dendritic morphology over a period of four hours, 
indicating that captured cells remain viable as they are capable of cellular processes 
such as cytoskeletal rearrangement required for changes in morphology.  
Next it was decided to observe whether these cells would remain viable for long 
periods following cell capture to the microcavity arrays and this was done by initially 
capturing cells to the surface of a microcavity array for eight hours. Cells were then 
removed from the surface of the microcavity array by trypsinization and cultured in a 
multiwell plate overnight alongside a control sample of cells. As aerobic respiration 
and proliferation in cells occurs, resazurin, the blue dye component of Alamar 
Blue®, is irreversibly reduced to the red fluorescent resorufin. The progression of 
this reduction can be used to monitor the growth of cells and thus give indications 
about the viability of cells. Hence, the following day after cell capture Alamar 
Blue™ was introduced to the culture for eight hours and then the fluorescent 
intensity of each well was recorded using a plate reader.  
Figure 3.6. shows the relative fluorescent intensities of samples of cells that had 
been captured to microcavity arrays for eight hours and then removed from the 
surface of the microcavity array by trypsinisation and cultured in a multiwell plate 
with resazurin. Fluorescent intensities for each sample indicate the amount of 
resorufin in each well due to aerobic respiration of cells. The number of cells in 
control wells equal those initially applied to the microcavity arrays as difficulties 
arise in determining the exact number of cells captured to arrays and subsequently 
recovered from arrays following immobilisation. This is due to the fact that imaging 
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and quantifying captured cells requires fixing and dehydration for imaging in SEM 
which would result in the death of cells. From this data it can be observed that while 
the fluorescent intensity of resorufin increases with the number of cells initially 
applied to the microcavity array, resorufin production is considerably lower than that 
of control samples, a sample of cells removed from a microcavity array initially 
treated with 75000 cells performs almost equally to that of a control sample or 25000 
cells. A similar trend is observed in the sample produced from the microcavity array 
treated with 100000 cells as it appears to perform equally to that of a control sample 
of 65000 cells. This may be accounted for by the capture efficiency of cells 
previously to the surface of the array previously observed. As well as this, the 
subsequent trypsinizations can weaken or damage cells which may lead to a small 
percentage of cells dying from transfer between the microcavity array and the 
multiwell plate. Also in the process of trypsinization from the surface, viable cells 
may have been lost in transfer from the chip to the multiwell plate. Nevertheless, 
from these results it is clear that previously captured cells have maintained a degree 
of viability comparable to that of control cells. Therefore, it may be concluded that 
cells remain viable following immobilisation to the microcavity arrays, and the 
difference in the fluorescent intensity between samples of cells that had been 
captured to microcavity arrays and control cells is likely to be due to the number of 
cells captured initially and then retrieved following trypsinization.   
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Figure 3.6. Spectrophotometric data from Alamar Blue™ assay of Sk-N-AS cells captured to 
microcavity arrays for eight hours and trypsinized from the surface, and control cells for comparison, 
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Figure 3.7. SEM images of antibody captured Sk-N-AS neuroblastoma cells on 5μm cavities 
following 1, 2 and 4 hours of incubation. Cells as time progresses cells are shown to be reverting from 
a spherical to a dendritic morphology typical of cultured neuroblasts giving preliminary indications 
that captured cells remain viable. 
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3.4.3. Cell Lysis and PtNP Detection. 
 
In order for the intracellular concentration of miR-132 to be measured, in-situ cell 
lysis must be carried out to release the intracellular contents of the captured 
neuroblastoma cells, including their intracellular miRNA fraction, into the 
microcavity modified with capture RNA. Several lysis options were considered for 
the in situ lysis of captured cells. An ideal approach to lysis of cells in situ will cause 
100% cell death, while avoiding the use of cytotoxic agents that may dysregulate the 
expression of miRNA within captured cells. The approach must also avoid the use of 
reagents that cause the degradation of RNA and also have some control of the 
activity of ribonuclease released from the cell following lysis. Another desired trait 
would be to cause the lysis of cells from within the underlying cavity, such that the 
intracellular miRNA fraction is exposed directly to the modified cavity below it, 
limiting the possibility of the miRNA target diffusing away from the array. Initially, 
electrochemical methods of effecting lysis from the underlying cavity array were 
considered. A mechanism proposed by Lee et al for the electrochemical disruption of 
cellular membranes by the generation of OH- at the cathode would be capable of 
directly lysing a cell into a modified cavity. However, due to the sensitivity of RNA 
to basic conditions, this method is not compatible for use with RNA detection 
strategies as it would lead to both the degradation of intracellular miRNA as well as 
the degradation of the immobilised monolayer of capture RNA within the 
microcavity[27]. Enzymatic release of lipases from within the cavity was also 
considered, by using a mixed monolayer of immobilised capture RNA strands and 
lipases cross linked to the surface of the cavity by a oligopeptide linkage that may be 
cleaved by extracellularly expressed proteolytic enzymes from the captured cells. 
However, an approach such as this would require specifically engineered and 
chemically modified lipase to contain a recognition site for proteolytic release and a 
site for immobilisation to the surface of the microcavity which would lead to a 
greatly increased cost manufacture cost for each microcavity array. The mixed 
monolayer bulky enzymes and capture RNA may also impede the hybridisation of 
target miRNA to the capture RNA. Another consideration would be have to be made 
for the timing of lipase release from the surface of the microcavity. As the 
considered scheme would involve the use of extracellularly expressed protease to 
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affect the release of lipase from the surface of the microcavity, the extracellular 
expression of protease would have to be controlled to a time following the 
immobilisation of the cell to the surface of the microcavity, as early cleavage and 
release of lipase from the surface would result in diffusion of lipase out of the cavity 
and lysis of cells prior to immobilisation. 
A far simpler approach was to carry out lysis by osmotic imbalance[28]. This was 
carried out by first washing the array with DPBS to remove any media and detritus 
from the array and the array was then wick dried and incubated in a hypotonic 
solution. The use of a hypotonic solution generates an osmotic imbalance between 
the intracellular and extracellular environments leading to an influx of water within 
the cell leading to the cells eventual lysis. As this method is virtually reagent free it 
is considered minimally damaging to the miRNA fraction of the neuroblastoma cell.  
As this method involves lysis by osmotic imbalance, sufficient osmotic pressure 
must be generated by a hypotonic solution in order to affect sufficient cell lysis. For 
this reason, care must be taken when transferring the microcavity array with the 
captured cells to the hypotonic solution so as to transfer as little media with the 
microcavity array as possible. This can be done with small washes with phosphate 
followed by wick drying with sterile filter paper. This allows the use of a minimal 
hypotonic solution in order to reduce dilution of intracellular miRNA following 
lysis. This method also however does not cause the direct lysis of cells into the 
underlying microcavity and as a result may be subject to the loss of miRNA target by 
diffusion away from the microcavity. Following lysis, the intracellular miRNA will 
also be exposed to many extracellularly expressed ribonucleases that will lead to the 
degradation of the target. To avoid this, the hypotonic lysis solution was made up 
with RNaseZAP™, a powerful ribonuclease inhibitor, and RNase free water and 
lysis was carried out in a sterile biosafety level II laminar flow cabinet. The efficacy 
of osmotic lysis was determined by SEM and confocal microscopy. Figure 3.8. 
shows confocal images of cells treated with DiOC6 and DRAQ-7 prior to and during 
the lysis process. DiOC6 is a fluorescent cytosolic stain used to image cells. DRAQ-
7 is a commercially available cytotoxicity stain that is used to indicate the disruption 
of the cellular membrane. Prior to lysis, cells were treated with both stains and at t=-
1 minute virtually no intracellular uptake of DRAQ-7 is observed. At t=0 cells were 
treated with deionised water and imaged at t=1 minute and every 2 minutes 
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following this to monitor lysis. From the images in Figure 3.8., at t=1 accumulation 
of DRAQ-7 within some nuclei is beginning, indicating the disruption of the 
membrane of these cells. At t=5 minutes a higher degree of DRAQ-7 uptake 
indicative of ~70% of cells is observed. At t=5 minutes, an increase in the 
fluorescent intensity of DRAQ-7 within nuclei is observed, indicating further 
permeation of the cell membrane and t times of t=15minutes and t=25 minutes an 
even greater degrees of fluorescent intensity is observed and virtually 100% of 
cellular nuclei now have accumulated DRAQ-7 indicating disruption of the cellular 
membrane and cell death.  
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Figure 3.8. Confocal images of cells at x400 magnification treated with DiOC6 (green) and DRAQ-7 
(red) dyes illuminated with a 488 nm Argon laser to show the progression of lysis by osmotic 




Similarly SEM imaging has shown the method of osmotic lysis to be highly effective 
as virtually no intact cells could be observed following lysis and only small 
fragments of debris remained. Progressing from this, lysis and hybridisation were 
allowed to occur in a single step in a sterile environment for a minimum of six hours. 
After this time the microcavity arrays were placed in a suspension of uniformly 
decorated probe RNA platinum nanoparticles (proPtNP) at a concentration of 
100mg/L (corresponding to approximately 7.13x1013 particles per litre or a 
concentration of 1.2x10-11 moles/litre or 12pM) for a minimum of eight hours to 
allow the hybridisation of the free 3’ end of miR-132 to the probe strands on the 
proPtNP, immobilising the catalytic nanoparticle to the surface of the array. As the 
hybridisation of nanoparticle to the free end of the target miRNA strand was 
kinetically controlled by the availability of target hybridised to the surface, it was 
deemed that even in situations where the concentration of target was in excess of the 
concentration of PtNP, the hybridisation of nanoparticles to the surface would still 
follow a linear proportionality to the concentration of miRNA applied to the array. 
Microcavity arrays, following the PtNP immobilisation step, were then imaged to 
determine whether PtNP hybridisation to the surface had been successfully carried 
out. Figure.3.9. shows a FeSEM image  of nanoparticles immobilised within the 
surface of a microcavity indicating that hybridisation was successful and 
electrochemical detection should be then attempted. The nanoparticles immobilised 
to the surface through hybridisation with miR-132 could now be detected through the 
electrocatalytic reduction of H2O2 when a potential of -250mV was applied to the 
microcavity array. A potential of -250mV for the reduction of peroxide by platinum 
was chosen based on the onset of aqueous solvent reduction seen for platinum in 
cyclic voltammetry, in a bid to maximise the driving force for H2O2 reduction. 
Initially, seven microcavity arrays were incubated with from one to one hundred 
thousand neuroblastoma cells as well as a control that was incubated in sterile media. 
Following lysis and proPtNP hybridisation the microcavity arrays were placed in an 
electrochemical cell and an amperometric detection program was run on each 
individual microcavity array. The program consisted of the amperometric 
measurement of current versus time under a constant applied potential over a time of 
2400 seconds. The initial current, prior to the injection of peroxide, is expected to be 
the current associated with the evolution of hydrogen from aqueous solvent at the 
131 
 
negative potential of -250mV, which may be observed as the onset of the limit of a 
potential window for aqueous solvent in a cyclic voltammogram of an electrode 
containing platinum. A sharp increase in current generated following the injection of 
peroxide is associated with the hydrolysis of hydrogen peroxide. For the initial 600 
seconds the initial current was allowed to decrease to a stable minimum. At 600 
seconds the program was paused and H2O2 was injected into the electrochemical cell 
to make up a concentration of 200mM H2O2 within the electrochemical cell, with 
minor agitation to ensure homogenous occupancy of the H2O2 within the 
electrochemical cell. The program was then immediately resumed and the current 
produced due to the electrocatalytic reduction of H2O2 was observed over the 1800 
seconds. Figure 3.10. shows the i/t curves for the PtNP detection runs carried out on 
each microcavity chip, treated with a range of cells from 106 – 100 cells and a control 
and Figure 3.11. shows a plot of the current produced by each microcavity array vs 
the number of cells applied. In this study, it could be seen that the highest 
concentration of cells applied to the microcavity array produced a current of 
approximately 2150µA, which was only about 50% of the target free control, which 
produced a current of approximately 4250µA. Taking the results of this assay as a 
whole it can be seen that a linear correlation between the number of cells applied to 
the microcavity array and the current produced from each array could not be 
established. There were several possible explanations of these results to be 
considered. First, due to the outward nature of cell lysis carried out in this 
experiment by osmotic imbalance, it is possible that miRNA target was not capable 
of diffusing into the cavity below the cell if the fragments of the cell or lysate debris 
blocked the inner surface of the microcavity. Secondly, due to the small volume of 
the microcavity the diffusion of materials into the microcavity will occur at a lower 
rate than that of bulk diffusion and this will hinder the hybridisation of miRNA 
target to capture RNA monolayer contained in microcavities, or adjacent 
microcavities in the case that outward lysed cells block microcavities below them, 
however, as microcavities are hemispherical in shape and therefore have a wide 
opening relative to the cavity size, the effect of this would be expected to be 
minimal. Another consideration was that the intracellular miR-132 fraction of a cell 




Figure 3.9. FeSEM image of microcavity surface at 20000x magnification using accelerating voltage 





Figure 3.10. i/t curves for peroxide detection of immobilised PtNP in 10 mM H2SO4 at a potential of  
-250 mV vs Ag/AgCl for microcavity arrays ranging from 106 – 100 cells and  no cell control. At 600 
seconds the program is paused and an injection of H2O2 is made to 200mM, when the program is 
resumed a sharp current increase is observed. At 2400 seconds the program is stopped and the final 

























Figure 3.11. Final currents from PtNP detection runs vs total number of cells applied to microcavity 
arrays. Currents generation was carried out by the injection of H2O2, to a final concentration of  200 
mM under an applied potential of -250 mV vs Ag/AgCl. 1800 seconds after the peroxide injection the 
















In order to reduce the complexity of the assay, experiments were performed using  
solutions of miR-132 as opposed to complex cellular samples. In this work, the 
arrays were exposed to  miR-132 solutions with concentrations ranging from 1μM to 
1aM derived from a synthetically produced stock and the detection assays were then 
run as before. Shown in Figure 3.12. below are the currents generated by hydrogen 
peroxide reduction over the detection program plotted against the known 
concentrations of miR-132 applied to the surface of the array, showing that the 
current generated by the microcavity array does not increase proportionally the 
concentration of miR-132 applied to the array. There were several possible reasons 
for this deviation from the expected. Initially, it was considered that these results 
may have been explained in terms of the denaturing of duplexes due to wash steps 
with dionized water, as this would result in the destabilisation of duplexes. For this 
reason the wash buffer was changed to DPBS and carried out again, however, this 
appeared to have no change in the observed results. It was hypothesised that the large 
discrepancies in the results were due to the background reduction of H2O2 by the 
underlying gold substrate, as gold is also electrocatalytically capable of reducing 
hydrogen peroxide, albeit at a much lower rate, however the total surface area of 
gold in the microcavity array may be large enough when compared to the PtNP, such 
that a considerable contribution to current evolution is made by gold. 
It was also hypothesised that the potential applied to the array was causing excessive 
reduction of H2O2 at the microcavity, more so than that observed for a polished 
planar electrode and as the further negative a potential applied to a gold electrode is, 
the greater the increase in its ability to electrocatalytically reduce the aqueous 
solvent of the electrochemical cell. If a lower potential could be used to minimise the 
catalytic activity of the array surface yet still preserve the catalytic activity of PtNP, 
this may lead to a signal generated from PtNP alone and thus a current per unit 
nanoparticle and subsequently per target RNA strand on the surface of the 
microcavity could be established. To address these issues changes were made to the 
set-up of the program and the microcavity array fabrication process. Initially, the 
potential applied during the electrocatalytic detection was changed from-250mV to -
100mV. While this change in potential yielded a lower current response for 
microcavity arrays compared to those performed at -250mV, it did not facilitate the 
establishment of a linear relationship between current produced during detection and 
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miR-132 concentration. Another possible explanation for the lack of a proportional 
response between current evolved during miRNA detection and concentration of 
miR-132 applied to the microcavity array was that, as the detection progressed, the 
background reduction of H2O2 at the microcavity surface led to the stripping of 
monolayer materials from the surface, leading to an increase in the available 
underlying surface area where H2O2 reduction could occur. 
 
Figure 3.12. Currents evolved from amperometric i/t curves carried out on microcavity arrays in 
10mM H2SO4  with 200mM H2O2 at an applied potential of -100mV vs. Ag/AgCl over a range of 
miR-132 concentrations from 1μM to 1aM showing no linear correlation to miRNA concentration. 
Error bars were generated from repeated independent electrodes where n = 3. 
 
These assay results appear to demonstrate that there is a fundamental process 
occurring that is resulting in a current that is measured, independent of the 
concentration of miRNA target applied to the surface. The vast majority of detection 
runs performed under these conditions showed i-t curves that appeared to be 
increasing in magnitude throughout the experiment (see Figure 3.13. as example), 



















to a steady state current over time which was expected. Therefore, it was 
hypothesised that under the experimental conditions the reduction of peroxide at the 
surface of the microcavity array was effectively stripping the surface materials of the 
microcavity array as the detection program progressed. This stripping would  
increase the active surface area of microcavity, resulting in further background 
reduction of hydrogen peroxide and an increase in current. In order to assess the 
possibility that peroxide strips the miRNA monolayer  during detection runs 
voltammetry was carried out on a monolayer blocked microcavity array prior to and 
following a detection run using ferrocene methanol as a solution phase redox probe 
to determine if the amount of exposed microcavity surface had increased. Figure 
3.14. shows the voltammograms for a bare microcavity array, the array following 
modification by an alkanethiol monolayer, and following a detection run carried out 
on the array. 
 
Figure 3.13. Example of i/t curve for peroxide detection of immobilised PtNP in 10 mM H2SO4 at a 
potential of -100mV vs Ag/AgCl. At 600 seconds the program is paused and an injection of H2O2 is 
made to 200mM, when the program is resumed a sharp current increase is observed. At 2400 seconds 













Figure 3.14. Cyclic voltammograms in 0.5mM FcMeOH vs. Ag/AgCl at a scan rate of 100 mV/s  of a 
bare microcavity array (black), the microcavity array following modification with an alkanethiol 
monolayer (blue) and the microcavity array following amperometric i/t curve carried out in 10mM 
H2SO4 with 200mM peroxide under an applied potential of -100mV vs. Ag/AgCl (Red).  
 
 
These results show that following a detection run in 200mM H2O2 the exposed 
surface area of the microcavity array increased, which was observed as an increase in 
the anodic/cathodic peak maxima in Figure 3.14. The voltammetry of the monolayer 
modified microcavity and that of the microcavity following an i-t curve in 200mM 
H2O2 at 100mV vs. Ag/AgCl, shows an increase in cathodic peak maxima of 14.6µA 
to 24.7µA, an increase of 69.1% from before detection to after detection. In fact the 
peak current following detection is 77.6% that of the unmodified microcavity. 
Therefore, it was determined that the reduction of peroxide at the electrode surface 
was causing the surface of the microcavity array to be stripped of its surface 
components exposing the underlying gold surface which in turn was leading to 
increased peroxide reduction. In a bid to minimise the extent of monolayer stripping 
by peroxide electrocatalysis, lower concentrations of peroxide were investigated. 
















show that the current associated with reduction and oxidation of ferrocene is not 
significantly changed by the peroxide detection step when the concentration of 
peroxide is lower, i.e., between 2mM and 200μM.  This result suggests that at lower 
concentration reduction of peroxide does not cause as extensive  stripping of the film 
deposited on the interior microcavity surface. Also, the i-t curves do not show the 
systematic increase over time observed for  higher peroxide concentrations.  These 
data suggest  that at the layers may be stable when low concentrations of peroxide 
are reduced. Significantly, Figure 3.16. shows that no appreciable increase can be 
seen in the oxidation and reduction peaks of the voltammograms of microcavity 
arrays following detection in 200μM peroxide and therefore it was deemed that at 
this concentration of peroxide a linear correlation between miR-132 concentration 
applied to the microcavity array and current produce by the probe PtNP could be 
established. An assay was run with microcavity arrays incubated with concentrations 
of miR-132 ranging from 1μM to 1pM of miR-132, and proPtNP.  However, this 
assay proved unsuccessful and no linear relationship between current produced and 




Figure 3.15. Currents evolved as a result of amperometric i/t curves carried out using gold 
microcavity arrays as working electrodes in 10mM H2SO4 with varying concentrations of H2O2 at -
250 mV vs. Ag/AgCl.Error bars (not visible for 2 mM and 200μM) were generated from repeated 
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Figure 3.16. Voltammograms of microcavity arrays carried out in 2mM FeMeOH with 10 mM H2SO4 
as supporting electrolyte from 0 to 600 mV vs. Ag/AgCl at a scan rate of 100 mV/s before and 
following amperometric i/t curves carried out in varying concentrations of H2O2 to investigate 
stripping of functional materials from the surface of the electrode.  
 
At this point it seemed that the underlying gold substrate was the cause of 
discrepancies in current produced by the reduction of peroxide as all other attempts 
to change the assay parameters, such as reducing the applied potential during i-t 
curves from -250mV to -100mV and changing the concentration of peroxide used 















The only remaining logical source of background signal, and thus error in measured 
peroxide reduction current catalysed by PtNP alone, was the underlying microcavity 
array itself. By comparing the results of miRNA detection assays carried out on both 
planar gold electrodes and microcavity arrays under the same conditions, (H2O2 
concentration, applied potential, miRNA concentration, etc.), and normalising the 
results to the size of the electrodes electrochemical surface area, a value for current 
per cm2, or J, could be determined. Figure 3.17. shows that values for J for 
microcavity arrays, compared to those for planar gold electrodes under the same 
assay conditions differ drastically. As the value for J in the microcavity samples both 
appears to be independent of concentration of miR-132 applied to the surface of the 
array, and is also greater than the current/ cm2 produced for a planar gold electrode 
which was incubated with 1μM miR-132, it was suggested that current measured is 
independent of the number of PtNP applied to the surface of the microarray and that 
in the current set up, detection of current associated with the electrocatalytic 
reduction of H2O2 by PtNP is not possible. From this data and as well as data 
previously mentioned, it seems likely that electrodeposited gold is rougher than 
polished planar electrodes and therefore behaves differently. Specifically, increasing 




 Figure 3.17. Values for current per cm2 recorded for miRNA assay carried out on microcavity arrays 
(Blue) compared with those recorded for planar gold electrodes (Red). Error bars were generated from 






















Indeed, through high resolution imaging by Field emission Scanning Electron 
Microscopy (FeSEM) it was observed that the inner surfaces of the microcavities 
within the array exhibit significant roughness (Figure 3.18.). Even when their 
intrinsic electrocatalytic properties of these nanoscale imperfections may be inferior 
to the captured nanoparticles, their vastly larger area means that they will dominate 
the current associated with peroxide reduction making current very insensitive to the 
nanoparticle coverage/target concentration. It is interesting to note that while the 
presence of a roughened surface is detrimental to the measurement of a reliable 
amperometric signal due to enhanced electrocatalytic activity, increased roughening 
on a surface may be a favourable trait for spectroscopically based miRNA detection 
methods. For example, a roughened metal surface can result in surface enhanced 
raman spectroscopy (SERS) effects[30], which actually improve the sensitivity of 
detection. So while gold microcavity arrays may have been shown here to be 
incompatible with amperometric detection, they may be suited to the amplification of 




Figure. 3.18. Secondary emission FeSEM image of 1μm cavity at 120000x magnification under an 




One possible solution to the excessive background reduction of peroxide at the 
roughened microcavity surface would be to anneal the surface by applying a 
sufficiently high temperature to reduce surface roughening without changing the 
microcavity structure. In an unpublished study by Jose in 2010[31], the effects of 
thermally annealing microcavity arrays were assessed for creating a smooth 
microcavity surface. In agreement with literature available on melting point 
depression, this study found that temperatures between 100°C and 500°C may be 
sufficient for the annealing of surface defects in the nanoscale. However, the study 
showed that at the higher end of the temperature scale, important structures of the 
microcavity array were lost due to excessive melting. In accordance with the results 
from these investigations, a maximum annealing temperature of 200°C was chosen 
and microcavity arrays were characterised by cyclic voltammetry before and after 
being placed in an oven for two hours at temperatures of 100°C, 150°C and 200°C. 
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Following this thermal annealing process, i-t curves were run as before in 200μM H-
2O2 to determine whether the annealing processes would have a profound effect on 
the minimization of excessive background reduction of H2O2 at the microcavity 
surface. This data was then compared with the data from the cyclic voltammograms 
from before, and following, thermal annealing to determine whether an significant 
change in microcavity surface current density was achieved. 
Figure 3.19. shows cyclic voltammograms of microcavity arrays before and 
following temperate annealing resulting in a reduction of the microscopic surface 
area of the microcavity array by approximately 15%, 22% and 30% for temperatures 
of 100°C, 150°C and 200°C respectively. These results gave the indication that 
nanoscale imperfections in the surface of the microcavity array had been successfully 
annealed due to the phenomenon of melting point depression while still retaining the 
much larger microscale structures of the microcavities themselves. The voltammetry 
data also suggests that annealing had occurred on a chemical level due to the change 
in apparent shape of the gold reduction peak observed at approximately 1100 – 1500 
mV. As observed most prominently in electrode 2, the shape of this reduction peak 
appears to shift towards a less positive value.  This reduction peak of gold is in fact 
not a single broad peak, but a complex amalgamation of several peaks for the various 
crystal structures that gold may exist in on the surface. This shift towards a less 
positive potential for gold reduction is indicative of the formation of low index gold 
faces and is typical in the process of annealing[32]. 
This reduction in surface roughness was expected to have a profound effect on the 
background current produced by the reduction of H2O2 by the microcavity array. 
However, Table 3.1. shows that the decrease in the current due to the reduction of 
peroxide, Δi, was comparable to the loss in microscopic surface area, indicating that 
while temperature annealing was effectively reducing surface area, the current 
density of the microcavity array remained unchanged This indicated that the 
observed phenomenon of decreased microscopic surface area was not due to 
annealing of nanoscale defects and instead was due to the loss of microcavity surface 
area through melting of gold surface microstructures. Interestingly, the microcavity 
array termed “electrode 2” did show some improvement, as the change in as the ratio 
of Δi/ΔA is greater than a value of one (see Table 3.1), indicating that annealing may 
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have taken place. However, significantly more effective reduction of the background 
current would be needed in order for low concentrations of miRNA to be detected. 
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Figure 3.19. Cyclic voltammograms of 3µm microcavity arrays carried out in 10 mM H2SO2 vs 
Ag/AgCl at a scan rate of 100 mV/s before and following attempts to temperature anneal the 
nanoscale roughness of cavities. Through integration of the gold oxide reduction peak the microscopic 
surface area of the microcavity arrays were measured and shown to have decreased. This observation 
would suggest that nanoscopic imperfections in the surface of the microcavity array that are 
considered to be the cause of background peroxide reduction have been annealed together due to the 

















Table 4.1. Table of data from temperature annealing experiments showing the comparative changes in 
microscopic surface area of the microcavity array and the change in background current produced by 







































Microcavity arrays for the selective immobilisation of neuroblastoma cells have been 
fabricated and are capable of performing as platforms for the immobilisation and in 
situ lysis of human neuroblastoma cells. Preliminary results of FeSEM imaging 
showed PtNP immobilised within the inner surface of the microcavity array 
following cell lysis, indicating the successful hybridisation of miRNA hybridisation.  
However, the current, expected for electrocatalytic reduction of hydrogen peroxide 
by the bound PtNPs, did not increase with increasing target concentration as 
expected.  Significantly, decreasing the detection potential, or reducing the 
concentration of peroxide, did not improve the sensitivity.  Further electrochemical 
and electron microscopy investigations suggest that  nanoscale surface roughness in 
the electrodeposited microcavities results in the excessive electrocatalytic reduction 
of H2O2. Attempts to improve the surface morphology of the microcavities by 
thermally annealing the cavity arrays failed to decrease the background current to the 
point where the miRNA target could be detected with high sensitivity.  
However, the microcavity surface can capture cells and allow them to be lysed.  
However, the miRNA concentration cannot be quantified using electrocatalytic 
detection of platinum nanoparticles.  Nanotextured surfaces such as gold microcavity 
arrays are ideal substrates for fluorescent plasmonic enhancement of 
fluorophores[33] and as such, could be used as a platform for the enhanced detection 
of miRNA through optical means such as super resolution microscopy. The 
conductive gold microcavity arrays may also be an ideal platform for 
electrochemiluminescent detection of miRNA. 
In recent years electrochemiluminescence (ECL) has gathered increasing interest in 
biosensing applications due to its simplified set up, high sensitivity, low background 
signal and speed of analysis[34].  Future work in this field could therefore be focused 
on the conjugation of a luminophore to a probe strand of RNA for use in the 
hybridisation to a free end of a miRNA strand immobilised to the inner surface of a 
microcavity array, in a similar way to the method described previously for probe 
strand modified PtNP immobilisation. In this scheme, cell immobilisation, cell lysis 
and target hybridisation would be carried out as described previously. The 
luminophore labelled probe would then be hybridised to the free end of the target 
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miRNA and under an applied potential and in the presence of a co-reactant species 
the luminophore could produce a luminescent signal. As the mechanism of ECL 
relies on the electrocatalytic oxidation of a co-reactant to generate a luminescent 
signal, the roughened surface of electrodeposited microcavities may prove to be 
advantageous to signal detection. This gives the potential for not only a means of 
detecting a miRNA target specific to the type of cell that is to be studied, for 
example neuroblastoma, but with microfabrication of fibre optic sensors and 
precision spatial confinement of signal collection (to a single microcavity), this 
method could theoretically be used to determine the miRNA profile of individual 
cells by carrying out detections within single microcavities. This approach would 
then have the potential to exploit the optical properties of metal surfaces may also be 
further exploited for the detection of immobilised ECL luminophore. 
In summation the future direction of this research could be directed at combining the 
effects of surface enhanced fluorescence and ECL to enhance the luminescent signal 
of a luminophore bound probe oligonucleotide for ultrasensitive detection of miR-
132 from captured and lysed human neuroblastoma cells. As previously shown, the 
specific objectives of neuroblastoma cell immobilisation and in situ lysis have been 
well characterised and with only minor augmentation of the miRNA detection 
scheme, an electrochemical/optical detection method for the detection of miR-132 
has been chosen that better suits the cell immobilisation platform created and shows 
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4. Detection of miR-132 by Electrochemiluminescence. 
 
 
4.1.  Introduction. 
 
In recent times there has been a great deal of reports in the field of biosensor 
research that utilise the technique of electrochemiluminescence for signal 
transduction and by association biomarker detection[1-7]. The vast majority of 
reports utilising ECL as a biosensing method are based on immunoassays for protein 
and peptide based biomarkers.[1-5] However, there are also reports of nucleic acid 
based biosensors [8-11]. Nucleic acid based biosensors have advantages over their 
antibody based immunoassay counterparts, not least of which is the ability to 
synthesise capture and probe sequences. The regular structure of nucleic acid chains, 
when compared to that of macro polypeptides such as antibodies, makes nucleic acid 
immobilisation systems attractive approaches to biosensor design. Strands of nucleic 
acids complementary to the nucleic acid target, e.g.. a miRNA, are simple to design 
and produce, and their target binding characteristics are relatively straightforward to 
predict. In contrast, due to the complex nature of the 3D structure of polypeptide 
chains, as well as the fact that the hypervariable regions of antibodies may contain 
hundreds of peptide subunits,  antibodies have a highly complex binding site leading 
to difficulties in predicting the how a target may be captured on the surface of a 
sensor. 
Another advantage nucleic acid based biosensors often have over their antibody 
based immunosensing counter parts is their intrinsic ability to keep the probe analyte 
in very close proximity to the surface of biosensor. The typical length of a miRNA 
molecule is approximately 22bp, which will have a physical length of between 5 and 
7 nm[12]. Therefore, in the case of an ECL based miRNA sandwich assay, the 
distance between the probe molecule, an ECL luminophore, and the surface of the 
electrode will be < 10 nm. In contrast, antibodies are typically in the range of 10 – 40 
nm in size[13], and therefore in a sandwich assay scheme similar to that of the 
scheme described in this work, employing a capture and probe antibody to 
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immobilise and label the target respectively will result in the ECL luminophore 
being several tens of nanometres from the surface of the electrode. This is a very 
important consideration with regards to ECL, as the overall efficiency of the reaction 
is heavily dependent on the rate of electron transfer between the luminophore and 
electrode and the diffusive rate of the co-reactant from the electrode upon oxidation 
of the luminophore[14]. 
This push in the direction of ECL based biosensing is at least partially due to the 
inherent advantages of ECL, especially the low background signal. As ECL is a 
method for the conversion of electrical energy to radiative energy, there is no 
potential for signal contamination from the excitation method, such as light 
scattering or auto fluorescence observed in other spectroscopic techniques[15]. The 
technique may also be multiplexed for the detection of many different biomolecules 
and signal acquisition is fast, leading to the high throughput analysis of complex 
samples. 
To this end, the aim of the work carried out in the following chapter was to create an 
electrochemiluminescent system for the ultrasensitive and highly selective detection 
of miRNA targets through a hybridisation sandwich assay on a nanotextured 
electrode surface, that may facilitate the enhancement of electrochemiluminescent 
signal. As previously mentioned, the expression of miR-132 is upregulated in 
neuroblastoma cells and thus a system was devised that could potentially increase the 
sensitivity of ECL based miRNA detection by exploiting surface effects of the 
electrode surface itself. Recently reports have emerged of surface enhanced 
electrochemiluminescence (SEECL) being employed to increase the light output of 
an ECL luminophore[7, 16]. It is well understood that strongly enhanced 
electromagnetic fields may be excited when noble metal nanostructures are irradiated 
electromagnetically, for example, monochromatic light focused onto metal 
nanoparticles on a surface[17, 18]. This electromagnetic field  is the result of a 
delocalised coherent oscillation of electrons at the interface between the surface of 
the nanoparticle and the surrounding dielectric medium, eg. air, solvent, etc., and is 
referred to as a surface plasmon[19]. This enhanced electromagnetic field will 
enhance the spectroscopy of molecules placed within it [19], giving rise to a signal 
enhancement that may be exploited for the purpose of detecting ultralow 
concentrations of materials for example. This approach for signal enhancement is 
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known broadly as surface enhanced spectroscopy and is the underlying mechanism 
for a number of analytical techniques such as surface enhanced raman spectroscopy 
(SERS)[18], metal enhanced fluorescence (MEF) and surface enhanced infrared 
absorption spectroscopy (SEIRAS)[20]. It is precisely this mechanism that is 
exploited by SEECL. Lakowicz et al. first reported the enhancement of ECL by a 
surface plasmon, postulating that in this case it is the emission of the luminophore 
that excited the surface plasmon, as opposed to a beam of incident light in the case of 
MEF for example[21]. This radiative plasmon model relies on the resonant energy 
transfer between the luminophore and the plasmon itself and is therefore heavily 
dependent on the distance between the two. Wang et al. [16] demonstrated this 
distance dependency, showing that an approximately 8 fold increase in ECL signal 
could be achieved by separating nanoparticles and luminophores by approximately 7 
nm. Thus it is the aim of the following body of work detailed here, to exploit this 
distance dependent effect to improve miRNA detection, by exploiting the chain 
length of the miRNA itself. 
Figure. 4.1. shows the fabrication of the proposed miRNA detection platform. A 
self-assembled monolayer of 16-phosophonohexadecanoic acid is formed on the 
surface of an Indium Tin Oxide (ITO), is used as a template through which metal 





(A)  (B)  
(C)  (D)  
(E)  (F)  
Figure.4.1. Schematic representation of electrode fabrication and miR-132 detection strategy. A 
planar ITO electrode (A) is functionalised with a self-assembled monolayer of 16-
phosphonohexadecanoic (B). Metal nanoparticles are then electrodeposited through the monolayer (C) 
and then a self-assembled monolayer of thiolated capture oligonucleotide is formed on the surface of 
the metal nanoparticles (D). The electrodes are then incubated in a solution of miRNA target and a 
portion of the target, miR-132, hybridises to the capture strand on the nanoparticles (E). An 
oligonucleotide-luminophore probe is then allowed to hybridise to the free end of the miRNA target 
(F) and this probe is then detected through electrochemiluminescence. 
 
By applying a brief over potential, up to -1600 mV for 20 ms to the ITO electrode in 
a suitable deposition solution, for example 1mM HAuCl4 in the case of gold 
nanoparticles, nucleation sites are formed in defect sites in the monolayer surface 
that will facilitate nanoparticle growth. Immediately after this nucleation potential is 
applied, a moderate negative potential, between -100mV and -200mV depending on 
particle size required, is applied to the electrode surface for a fixed time and 
nanoparticles are formed at nucleation sites. This approach to nanoparticle formation 
ensures good control over the size and distribution of nanoparticles formed, as 
nanoparticles will preferentially grow at the pre-nucleated sites, and are unlikely to 
nucleate and grow through the 16 carbon monolayer at the relatively moderate 
potential applied during the nanoparticle growth phase[22]. Thus each nanoparticle is 
formed under the same conditions for the same duration leading to a desirable size 
distribution.  
Following on from this the nanoparticles are functionalised in a single step for the 
capture and subsequent detection of miRNA targets by the application of a 3’-
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thiolated strand of nucleic acid 11bp long and complementary to the 5’ end of the 
miRNA target, referred to herein as the capture strand. As the metal nanoparticles 
here are of coinage metals (Au, Ag, Pt) the 3’-thiolated ends of the capture strands 
will readily bond to the surface of the nanoparticles resulting in the formation of a 
monolayer of capture strands that will facilitate the immobilisation of miRNA targets 
from solution. Upon incubation of the electrode with the desired miRNA target, 
miR-132, 5’ end of this target will hybridise to a capture strand on the surface of the 
nanoparticle resulting in an immobilised miR-132 with a free single stranded 3’ end. 
This 3’ end is then free to hybridise to another nucleic acid strand, this time 
functionalised at its 5’ end with the ECL luminophore, a ruthenium polypyridyl 
complex, referred to here as the probe strand. As the probe strand will have a 
sequence complementary to that of the 3’ end of miR-132, any unbound probe strand 
will be washed from the array, thus the number of ECL luminophores on the surface 
of the electrode will be proportional to the number of miR-132 strands immobilised 
on the electrode and thus subsequently proportional to the concentration of miR-132 
in solution. The electrode is then placed in a custom ECL cell and undergoes anodic 
cycling, to produce an ECL signal.  
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4.2.  Experimental. 
 
4.2.1. Materials. 
Planar gold electrodes and ITO/Glass sheets were purchased from IJ Cambria, 
Wales, UK. Ruthenium (II) (bis-2,2-bipyridyl)-2(4aminophenyl) imidazo[4,5-
f][1,10]phenanthroline was prepared by Dr. Ciarán Dolan of Dublin City University. 
All other solvents and reagents were purchased from Sigma Aldrich. All aqueous 
solutions were prepared using deionised water. Oligonucleotide sequences were 
purchased from Eurogentec and identical to those mentioned in Chapter 3. 
 
4.2.2. Instrumentation. 
A three electrode electrochemical cell was used throughout this work consisting of a 
platinum wire as a counter, an Ag/AgCl reference electrode and a working electrode. 
All electrochemical measurements were carried out using a CHI 760E potentiostat 
within a faraday cage. Confocal microscopy was carried out using a Leica TSP8 
Confocal/STED microscope system. FeSEM images were obtained with the use of a 
Hitachi S5500 Field Emission Scanning Electron Microscope. ECL measurements 
were carried out with the use of a CHI660c potentiostat coupled to an Oriel 70680 
photo multiplier tube equipped with a high voltage power supply with an applied 






4.3.1.  Nanotextured Electrode Surface Preparation 
Working electrodes, composed of Indium Tin Oxide (ITO) on a glass substrate, were 
cut to a size of 17x7mm and cleaned by ultrasonication in methanol for 15 minutes. 
Electrodes were then immersed in a solution of 2mM 16-phosphonohexadecanoic 
acid in methanol for a minimum of 16 hours to form a self-assembled monolayer on 
the surface of the electrode. The electrodes were then washed and wrapped with 
hydrophobic Teflon to produce a working area on the electrode of 7x7mm. The 
working area of the electrode was then immersed in a nanoparticle deposition 
solution and a nucleation and growth potential were applied to the electrode in 
separate steps of -1600mV and -100mV respectively. Deposition of gold 
nanoparticles was carried out in 1mM HAuCl4 in 100mM NaCl, deposition of 
platinum nanoparticles was carried out in 1mM KPtCl6 in 100mM H2SO4, and silver 
nanoparticle deposition was carried out in 1mM AgNO3 in 100mM HNO3 with 
15mM citric acid. 
 
4.3.2. Surface Modification of Nanoparticles with C16-Ru 
Nanoparticle modified electrodes were placed in an ethanolic solution of 16-
mercaptohexadecanoic acid for a minimum of 8 hours to form a self-assembled 
monolayer on the surface of the nanoparticles. The amino functionalised, 
luminescent dye was then coupled to the carboxyl termini of this monolayer using 




4.3.3. Preparation of oligo-Dye probe conjugate. 
A 1:1 10mM solution of sodium 4-((4-(cyanoethynyl)benzoyl)oxy)-2,3,5,6-
tetrafluorobenzenesulphonate (CBTF)  and dye was prepared in dimethylsulphoxide 
(DMSO) and stirred at room temperature for 1 hour. Following this, an aliquot of the 
reaction mixture was removed and diluted to a concentration of 100 ȝM in phosphate 
buffered saline (PBS). A 100 ȝl aliquot of this was then combined with 100 ȝl of 
100 ȝM thiolated probe oligonucleotide and diluted to a final concentration of 1 ȝM 
oligonucleotide and stirred at room temperature overnight.  
 
4.3.4. Capture oligonucleotide monolayer formation and miRNA target 
hybridisation and detection.  
Nanoparticle modified electrodes were placed in a 1ȝM solution of thiolated 
oligonucleotide (capture) for a minimum of 12 hours to form a self-assembled 
monolayer on the surface of the metal nanoparticles for target miRNA hybridisation. 
The electrodes were then incubated in a solution of miRNA target in PBS for 8 hours 
and then washed with PBS to remove non-specifically bound target. The electrodes 
were finally placed in a 1ȝM solution of probe oligo-dye conjugate overnight. 
Following this, the electrodes were washed with PBS to remove non-specifically 
bound probe and mounted into custom electrochemical cells for ECL. ECL was 





4.4. Results and Discussion. 
 
 
4.4.1. Determination of ECL Dye Efficiency. 
Initially, work was carried out to identify a metallo-organic dye for use with ECL, 
that may also be functionalised for use in miRNA detection assay. Important aspects 
of the dye such as solubility in aqueous media, potential for conjugation to a probe 
RNA strand, and most importantly ECL efficiency were determined. The ECL 
efficiency of the dye would be a key aspect in controlling the dynamic range of the 
assay with a target limit of detection in the sub-picomolar range. The dye, 
[ruthenium (II) (bis-2,2-bipyridyl)-2(4aminophenyl) imidazo[4,5-
f][1,10]phenanthroline] (ClO4-)2, (referred to as RuPICNH2 from here on) was 
selected on the basis that it was soluble in aqueous solutions and contained an amine 
group on the pic ligand that could be used as a site for conjugating the dye to a nuclei 
acid. 
In order to determine the ECL efficiency of the dye, the redox activity and ECL 
output of the dye must be correlated to that of a similar compound that may be used 
as a standard.  For ruthenium polypyridyl compounds the standard most widely 
implemented in the literature is Ruthenium (II) Tris-2,2-bypyridine (RuBpy3)[15]. It 
is widely accepted that the ECL efficiency of this is 0.05 and is typically used as the 
standard for ECL efficiency calculations of similar ruthenium polypyridyl complexes 
due to its relatively high efficiency[15]. 
Solution phase ECL was carried out using conventional planar glassy carbon 
electrode of 3 mm in diameter. A standard 3 electrode system was employed, with an 
Ag/AgCl reference electrode and a Pt wire for an auxiliary electrode. In order to 
measure the working area of the glassy carbon working electrode a cyclic 
voltammogram was carried out in 2mM ferrocene methanol solution with 100mM 
phosphate buffer as supporting electrolyte, and cycled between 800 mV and -200 
mV. In Figure 4.2. an example of these CV obtained is shown. This was carried out 




Figure. 4.2. Cyclic voltammogram of a 3 mm diameter glassy carbon electrode between 800 and -200 
mV Vs. Ag/AgCl carried out in 2mM FcMeOH and 100mM phosphate buffer as supporting 
electrolyte at a scan rate of 100 mV/s. 
 
In this voltammogram a redox process is observed centred at approximately 200 mV 
and was used to assess the condition of the electrode throughout the process of 
determining the ECL efficiency of the dye. This process was used to monitor 
changes in the electrochemical surface area of the electrode as the surface area of the 
electrode is proportional to the charge associated with each process. Therefore the 
any deviations in size of the electrode surface through modification, polishing, 
fouling, etc. could be accounted for. Furthermore this provided a method for 
normalising results obtained from individual electrodes. By integrating the area 
under oxidation and reduction peaks (Apc and Apa), the charge associated with each 
process was measured at 3.41e-5 C and 3.32e-5 C, respectively. This indicated that the 
process was almost perfectly reversible, as Apc/Apa resulted in a value of 0.97, where 
a value of 1 would be expected for a perfectly reversible process. Furthermore 
separation between anodic peak current (Ipa), 230 mV, and cathodic peak current 
(Ipc), 162 mV, was 68 mV at a scan rate of 100 mVs-1, indicating a good rate of 













number of electrons involved in the process[23]. These parameters were used to 
monitor the condition of the electrode throughout the ECL efficiency determination. 
In Figure 4.3. the solution phase voltammetry data for RuPICNH2 is shown. In order 
to determine the ECL efficiency correctly, a concentration of RuPICNH2 was 
required that could be used for both ECL, to determine the ECL output of the dye 
when reacted with a co-reactant, and redox voltammetry, in order to determine the 
charge associated with the oxidation of the dye under these conditions. However, due 
to the relatively poor redox voltammetry observed for RuPICNH2 in aqueous 
conditions, as well as the high background current and capacitance observed in 
aqueous solution, it was difficult to determine the charge associated with the 
oxidation of RuPICNH2 during the ECL reaction. In a bid to increase the signal to 
noise ratio of RuPICNH2, the charge associated with the oxidation of the compound 
during ECL was estimated through fast scan rate voltammetry at a low dye 
concentration of 20 ȝM. In Figure 4.3. the voltammetry of RuPICNH2 performed in 
100 mM phosphate buffer vs. Ag/AgCl at scan rates between 20 Vs-1 and 7.5 Vs-1 






Figure 4.3. Solution redox voltammetry shown for 20ȝM RuPICNH2 in 100mM phosphate buffer. 
Voltammetry was carried out using a 3 mm diameter glassy carbon electrode and a potential window 
of 600 – 1500 mV vs. Ag/AgCl at scan rates between 20 and 7.5 V s-1. The single electron oxidation/ 
reduction process of RuPICNH2 is observed at approximately 1100 mV vs. Ag/AgCl. 
 
The Apc measured for the oxidation at variable scan rates was then used to construct 
a curve relating the  charge passed to the scan  rate. Thus the charge passed due to 
the oxidation of RuPICNH2 at a scan rate of 100mV s-1 was estimated to be 
approximately 4.83e-8 C. 
However, due to the high scan rate used to generate a measurable current associated 
with RuPICNH2 oxidation, it may be the case that the current generated is primarily 
due to surface adsorbed species  In the case of a diffusive, or solution based, 
voltammetry regime, the Ipc would be proportional the square root of the scan rate 
(ʋ1/2), whereas in a surface confined regime the Ipc would be proportional to the scan 
rate (ʋ)[24].  To probe this, a plot of log ʋ vs. log Ipc was generated and is shown in 
Figure. 4.4. This would be the basis for determining if the charge measured was as a 
result of oxidation of surface confined RuPICNH2 or solution based (diffusive) 
species. As seen here the slope for this proportionality is greater than the value of 0.5 



















the charge measured contains a contribution from surface confined RuPICNH2, and 
this data cannot be used to determine the efficiency of RuPICNH2 as an ECL 
luminophore. 
 
Figure.. 4.4. Plot of log ʋ vs. Log Ipc for RuPICNH2 aqueous voltammetry data. Voltammetry was 
carried out using a 3 mm diameter glassy carbon electrode and a potential window of 600 – 1500 mV 
vs. Ag/AgCl at scan rates between 20 and 7.5 V s-1 vs. Ag/AgCl. 
 
In order to overcome the issue with low RuPICNH2 concentration and poor signal to 
noise ratio of the individual oxidative process, a different voltammetric technique 
was employed, differential pulse voltammetry (DPV). In DPV, a series of regular 
voltage pulses are measured along a linear potential sweep. Prior to each pulse, the 
current is measured and the resulting change in current is plotted as a function of 
potential. This then allows the measurement of current arising from redox processes 
from exceptionally low concentrations of analyte as the measurement of charging 
current is minimised and current measured is only due to faradaic processes[25]. 
This technique was therefore applied to 25µM solutions of RuPICNH2 and RuBpy3 in 
10mM PBS vs. Ag/AgCl using a 3mm diameter glassy carbon working electrode and 
y = 0.7404x + 1.1766 
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a platinum wire as counter electrode. A potential increment of 5 mV was employed 
and voltage amplitude of 50 mV and pulse period of 50 ms. In Figure. 4.5. the 
resulting voltammograms are observed for both RuPICNH2 and RuBpy3.  
 
Figure. 4.5. Differential pulse voltammetry data for 25µM RuPICNH2 and 25µM RuBpy3 in 10mM 
PBS with a 3 mm diameter glassy carbon working electrode and platinum counter electrode, carried 
out vs. Ag/AgCl. Oxidation of both compounds is observed at approximately 1100 mV. 
 
 
As seen in Figure. 4.5., with the exclusion of non-faradaic current, the charge 
associated with the oxidation of both ruthenium compounds at a concentration of 
25µM could be measured and was shown to be 9.95e-2 µC and 8.11e-2 µC for 
RuPICNH2 and Rubpy3 respectively. 
Now that the charge associated with the oxidation of both compounds could be 
accurately measured, the same working electrode was then placed in a solution of 25 
ȝM RuPICNH2 and 10mM PBS with 100µM tripropylamine (TPA) as co-reactant 
















was measured. In Figure. 4.6. the ECL output for both compounds in is shown. Here 
the onset of ECL is observed at approximately 800 mV coinciding with the oxidation 
of co-reactant and the oxidation  of both compounds is observed at approximately 
1100 mV as a sharp increase in ECL intensity. For both compounds the max ECL 
intensity occurs at approximately 1400 mV. The mean maximum ECL intensity for 
both RuPICNH2 and RuBpy3 was 2.329A.U. and 7.255A.U., respectively. With these 
values the ECL efficiency of RuPICNH2 could then be determined, using RuBpy3 as 
a standard, with the following equation; 
 ɸ𝐸𝐶𝐿 =  ɸECL0 ሺ i𝑄 . 𝑄0𝐼0 ሻ  
where ɸECL0 is the efficiency of RuBpy3, I and I0 are the ECL intensity of 
RuPICNH2 and RuBpy3 respectively and Q and Q0 are the charge passed due to the 
oxidation of RuPICNH2 and RuBpy3 respectively. As a result, the ECL efficiency of 
RuPICNH2 was determined to be 0.013. This efficiency is therefore approximately 






Figure 4.6. ECL output of solution of 2ȝM Ru(bpy)2PIC-NH2 in 10mM PBS with 10mM TPA as co-
reactant Vs. Ag/AgCl at a scan rate of 100 mV/s. The onset potential of ECL signal is observed to be 
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Ru(bpy)2PIC-NH2 - Run 1
Ru(bpy)2PIC-NH2 - Run 2
Ru(bpy)2PIC-NH2 - Run 3
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4.4.2. miRNA Assay on Conventional Gold electrodes. 
To develop the miRNA assay,  the probe strand of nucleic acid had to be conjugated 
to the luminophore so that the ECL intensity could be measured in a nucleic acid 
sandwich assay. The probe strand, a 11bp DNA strand, has a nucleic acid sequence 
complementary to the 3’ end of the miRNA target, miR-132, and also possesses a 
free thiol group at its 5’ end. This free thiol group could be used as a site for the 
conjugation of the RuPICNH2 luminophore. 
For this conjugation reaction to take place a reactive cross linker is required. The 
most commonly applied method of thiol conjugation is the use of maleimide 
derivatives. [26] However, traditional bifunctional crosslinkers for amine to thiol 
conjugation, such as succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-
carboxylate (SMCC) were deemed to be unsuitable. This was largely due to the 
instability of the compound itself and its tendency to hydrolyse in aqueous 
media[27]. It has also been reported to have a remarkable instability in plasma[28]. 
Due to the low concentration of DNA probe that would be used in the reaction, as 
well as the inherent difficultly in purifying and drying a DNA conjugate to the point 
where it would be a stable solid that could be stored for extended times, a crosslinker 
was required that would give a high yield and remain stable in solution for at least 
the duration of the assay incubation time. 
The crosslinker sodium-4-((4-(cyanoethynyl)benzoyl)oxy)-2,3,5,6-
tetrafluorobenzenesulfonate (CBTF) shown in Figure. 4.7,  was recently reported by 
Kolodych et al[29]. This hetero bifunctional crosslinker has two reactive groups, an 
ester and a reactive cyanoethynyl group, that will bond to amines and thiols 
respectively. At the ester end of the compound, a tetrafluorobenzenesulfonate group 
acts as a leaving group to facilitate the formation of an amide between ester and 
amine. Then the compound is capable of reacting with a thiol to result in a 
remarkably stable conjugate. The reaction is carried out in two steps, first RuPICNH2 
is dissolved in DMSO with a molar equivalent of CBTF and stirred for 
approximately 10 minutes at room temperature. An aliquot of this reaction mixture, 
equal to molar equivalent of DNA-thiol to be conjugated, is then added to the 
thiolated DNA in PBS (pH 7.4) and stirred for a minimum of 60 minutes. The ability 
to carry out this reaction in such mild conditions cannot be understated, especially 
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when taking into consideration the instability of DNA under adverse pH or high 
temperature conditions. The remarkably short reaction time of approximately 70 
minutes is also highly advantageous for working with unstable biological conjugates. 
 
Figure 4.7. Reaction Scheme for the Conjugation of thiolated probe oligonucleotide strand to 
RuPICNH2 luminophore via CBTF crosslinker. First step of the reaction is carried out in DMSO at 
room temp. for a minimum of 10 minutes followed by addition to an biomimetic aqueous solution of 
oligonucleotide and reacted for a minimum of 60 minutes. Reproduced from Kolodych, S., Koniev, 
O., Baatarkhuu, Z., Bonnefoy, J.Y., Debaene, F., Cianferani, S., Van Dorsselaer, A., and Wagner, A., 
CBTF: New Amine-to-Thiol Coupling Reagent for Preparation of Antibody Conjugates with 
Increased Plasma Stability. Bioconjugate Chemistry, 2015. 26(2): p. 197-200 
 
As the thiolated DNA probe strand was expensive (€200 / 100 nmol aliquot) and 
considering the difficulty that would have been associated with the purification of 
the RuPICNH2-DNA conjugate, and also the remarkably low expected yield, 
purification was not attempted. Due to the nature of the assay that the reaction 
mixture would be used in, the possible contaminants were not seen as a problem as 
unconjugated RuPICNH2 luminophore would be washed from the electrode surface 
along with the tetrafluorobenzenesulfonate. There remained the possibility that 
unconjugated DNA may be present in the reaction mixture, but the high efficiency of 
bond formation between thiol and cyanoethynyl, it was deemed that this fraction of 
the DNA would be negligible. 
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Once the RuPICNH2 luminophore was conjugated to the probe strand established, 
the efficacy of the proposed miRNA based ECL assay was determined. A polished 
conventional gold electrode was incubated in a solution of thiolated capture strand 
DNA to form a monolayer of capture strand as previously established in Chapter 3. 
Once the monolayer was formed, the electrode was then incubated in a solution of 
miR-132 for 3 hours and then washed and incubated in a 1ȝM solution of 
RuPICNH2-DNA conjugate for 5 hours (see Figure 4.1.).  
Following this, the electrode was washed with copious amounts of PBS and placed 
in an ECL cell containing 50mM TPA as co-reactant and the resulting ECL output of 
the electrode is shown in Figure. 4.8. below. Here, the onset of TPA oxidation is 
visible at approximately 700 mV and the maximum ECL intensity is observed at a 
potential of approximately 1200 mV. 
The study was then broadened to the use of multiple independently prepared 
electrodes in order to determine the effect of changing miR-132 concentration would 
have and whether or not the technique could be applied to the quantitative analysis of 
miRNA. A range of miR-132 concentrations was chosen between 1 ȝM and 10 pM, 
and incubated with the electrode as before. A control for the assay was also prepared 
in a similar fashion, but the electrode was incubated in clean buffer with no miRNA 
target. The ECL output of each electrode was then measured in 10mM PBS and 





Figure 4.8. ECL data for miR-132 detection assay carried out on planar gold electrodes in 10mM 
DPBS and 50mM TPA as co reactant. ECL signal was generated by cyclic voltammetry between 200 





































From the data above it can be observed that a linear correlation can be observed 
between the log concentration of miR-132 applied to the surface of the electrode and 
ECL intensity of each electrode. Shown in red is the ECL intensity for a control 
electrode, which was incubated in PBS and in the absence of miRNA target. This 
was used to determine the degree of ECL intensity arising from non-specifically 
bound luminophore. If all data points are normalised to this value, the log function of 
this graph is then given as; 
y = 0.0267ln(x) + 0.7824 
By extrapolating this line to the x-axis (y=0) this was then used to estimate a 
theoretical limit of detection of the assay,which was determined to be 2.543e-13 M 
of miR-132, or 254.3 fM. 
The overall ECL intensity might be expected to be directly proportional to the 
concentration of miRNA applied to the electrode. However, this is not the case, as 
the result do not show that a ten-fold increase in the concentration of miR-132 target 
incubated with the electrode, does not yield a ten-fold output in ECL intensity 
observed, as the ECL output is proportional to the number of miR-132 targets 
immobilised to the surface, which is itself a function of the association constant 
between the capture and target nucleic acid strands (5.598x109 M). Also, the 
hybridisation of miR-132 to the capture oligonucleotide strand is hindered further 
due to the steric effects of hybridisation in a densely packed monolayer on the 
electrode surface. As the capture oligonucleotide monolayer becomes more densely 
hybridised, the hybridisation of additional miR-132 will become thermodynamically 
unfavourable due to steric hindrance in the monolayer environment. According to 
Peterson et al.[30] a densely packed monolayer of oligonucleotides may be subjected 




4.4.3. Metal Nanoparticle Electrodeposition and Characterisation. 
While the assay  for the quantification of miR-132 was successful, there is an interest 
in seeing if plasmonic enhancement could further reduce the limit of detection. 
Therefore, a nanotextured surface was produced on the electrode which could 
increase the ECL intensity and perhaps improve the signal-to-noise ratio. Firstly, the 
increased electrode surface area may provide a larger surface for both TPA oxidation 
and miR-132 immobilisation and probe hybridisation. Secondly, 3-dimensional 
nanotextured surfaces exhibit improved mass transport kinetics, which could result in 
faster rates of TPA oxidation and therefore improved rates of luminophore 
excitation. But by far the most promising method for luminescent signal 
enhancement would be from the surface plasmon enhancement of the luminophore 
by the nanotextured surface. It has been widely reported in the literature that 
nanotextured surfaces, such metal nanoparticles immobilised to an electrode, have 
the potential to improve the luminescence of dye molecules located in close 
proximity so that they are directly influenced by the surface plasmon of the 
nanoparticle. In fact this forms the basis for the majority of surface enhanced 
spectroscopy, and in more recent times reports of this surface enhancement being 
applied to ECL have appeared. Therefore, a new electrode design consisting of a 
transparent and conductive indium tin oxide (ITO) surface onto which nanoparticles 





In order to from nanoparticles on the surface of electrodes, ITO working electrodes 
were first cut to 17x7mm dimensions and ultrasonicated  in methanol for 15 minutes. 
The electrodes were then placed in a 1mM solution of 16-phosphonohexadecanoic 
acid for a minimum of 16 hours to form a self-assembled monolayer on the surface 
of the ITO through which nanoparticles could be electrodeposited. The successful 
formation of a monolayer on the electrodes surface was then confirmed by 
voltammetry in 2mM FcMeOH in 100mM KCl. Figure. 4.9. shows the redox 
voltammetry of FcMeOH for an ITO electrode before and after monolayer 
formation. The depression of redox activity of the FcMeOH following the formation 
of a C16 monolayer can be directly attributed to electrode passivation and an effective 
decrease in the electrochemical surface area of the electrode by the alkane-
phosphono monolayer. Some of the redox activity of the electrode is preserved 
following the formation of this monolayer, indicating that defect sites are present in 
the monolayer. However, this is favourable as these sites will act as nucleation sites 
for nanoparticle growth[22]. 
Following monolayer formation, electrodes were wrapped with hydrophobic Teflon 
tape to give a working area on the electrode of 7x7mm. The working area of the  
electrode was then placed in an appropriate electrodeposition solution and a double 
potential step was applied to the working electrode to form nanoparticles on the 
surface. A large negative overpotential for a short time is used to form nucleation 
sites through the monolayer on the electrode surface and then a growth potential is 
applied immediately after this for an appropriate time in order to form nanoparticles 
of a desired size. Following the electrodeposition of metal nanoparticles on the 
electrode, an increase in the electrochemical surface area of the electrode is observed 
as expected. Due to the three dimensional nature of the nanoparticles formed on the 
surface of the electrode the effective surface area of the electrode then increases to 
approximately the same size as a bare electrode coincidentally. 
It was expected that  this approach would result in nanoparticles with a narrow size 
dispersion as nucleation only occurs during the overpotential step and thus all 
nanoparticles formed are electrodeposited for the same amount of growth time under 
the same growth potential. In this case for all types of nanoparticle the nucleation 
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potential was -1600mV and was applied for 20 milliseconds and the growth potential 
used was -100mV. The growth time was varied in order to obtain the desired size of 
nanoparticles. 
 
Figure 4.9 Cyclic voltammograms of ITO electrode throughout the fabrication of metal nanoparticles 
on the electrode surface. 2 mM FcMeOH in 100 mM PB was used to determine the electrochemical 
surface area of a bare ITO electrode (Blue), electrode following the formation of a C16 monolayer on 
the surface (Red) and following the electrodeposition of nanoparticles to the surface (green). 

























With this approach, nanoparticle deposition protocols were optimised to produce 
nanoparticles with a narrow size dispersion, regular shape and high abundance. The 
concentration of HAuCl4 and growth time were varied and the size, distribution and 
degree of homogeneity of nanoparticles for each growth time was determined by 
voltammetry and electron microscopy. Figure 4.10. shows voltammograms of ITO 
electrodes in 10mM H2SO4 vs Ag/AgCl following gold nanoparticle deposition for 
varying growth times. By integration of the oxide monolayer formation peak at 
approx. 800mV the total surface area of gold electrodeposited to the electrode can be 
determined. Following this, the electrodes were then imaged using FeSEM to 
determine the average diameter of nanoparticles on the surface of the electrode. 
These two area values were then used to determine the number of nanoparticles on 
the surface of the electrode. In Figure 4.10.(A) nanoparticles formed from a 3mM 
HAuCl4 deposition solution appear to have a poor size distribution, forming particles 
between approximately 50 and 300 nm with varying degrees of irregularity. By 
decreasing the growth time from 60 seconds to 10 seconds a greater degree of 
regularity could be achieved, however, size dispersion was poor and nanoparticles 
appeared to be formed closely packed and conjoined in parts.  Figure 4.10.(C) shows 






(A)  (B)  
(C)  
Figure 4.10. Cyclic voltammetry and FeSEM images of nanoparticles formed at varying 
concentrations of HAuCl4 with varying deposition times. Cyclic voltammetry of ITO AuNP substrates 
was carried out in 10 mM H2SO4 Vs. Ag/AgCl at a scan rate of 100 mV/s, and integration of the gold 
oxide formation peak at approximately 800 mV was used to determine the overall surface area of gold 
electrodeposited to the electrode surface. FeSEM SE imaging was carried out under an accelerating 
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Therefore  the formation of gold nanoparticles (AuNP), a 1mM aqueous solution of 
HAuCl4 with 100mM KCl as a supporting electrolyte was used. A three electrode 
electrochemical cell was set up, with a platinum wire as auxiliary electrode and a 
Ag/AgCl reference electrode. The working end of the ITO electrode was submerged 
in the deposition solution and the deposition program was carried out using the 
multi-potential steps function on the potentiostat.  
Electrodeposition of platinum nanoparticles (PtNP) and silver nanoparticles (AgNP) 
was carried out in a similar fashion, but from a solution of 1mM KPtCl6 in 10mM 
H2SO4 and 1mM AgNO3 in 10mM KNO3 with 15mM citric acid, respectively. The 
deposition curves for AuNP, AgNP and PtNP are shown in Figure 4.11. 
 
Figure 4.11. Amperometric i/t curves generated during electrodeposition of nanoparticles to the 
surface of ITO electrodes. Note, the initial 20 ms nucleation overpotential had been omitted in order 
to show detail. Values for charge passed during deposition of AgNP, AuNP and PtNP were 188, 331 

















A similar practice for the determination of size distribution and total particle number 
deposited was adopted for the formation of PtNP also and in Figure. 4.12. the 
voltammetry of PtNP formed on the surface of electrodes is shown. The typical Pt 
oxide formation peak may be observed at approximately 230 mV and and may be 
used to determine the overall surface area of Pt electrodeposited to the surface area 
of the electrode by integration of the peak area and using a value for the charge 
associated with oxide monolayer formation of 210µC [31]. Smaller peaks for Pt may 
also be observed at -110 mV and -220 mV and at approximately -300 mV the onset 
of hydrogen gas evolution due to water electrolysis may be observed. 
However, for silver nanoparticles (AgNP), the surface area of AgNP on the 
electrodes could not be reliably obtained due to the instability of silver at oxidising 
potentials. Figure 4.13. shows that successive cycles of voltammetry of AgNP on the 
surface of an ITO. At approximately 700 mV the oxidation of silver to AgO may be 
observed and at approximately 200 mV the reduction of AgO is observed[32]. It can 
be observed that successive cycles of voltammetry result in a loss of the oxidative 
and reductive processes associated with silver nanoparticles and thus a loss in total 




Figure. 4. 12. Cyclic voltammogram of PtNP electrodeposited to ITO electrode between 1500 and -
300 mV Vs. Ag/AgCl at a scan rate of 100 mV/s..  carried out in 10mM H2SO4 as supporting 
electrolyte. At approximately 200 mV the peak associated with Pt reduction is observed indicating the 
formation of PtNP on the surface of the electrode. Further evidence of PtNP formation is observed as 
the onset of current at approximately -350 mV  due to the evolution of hydrogen gas by water 
hydrolysis at the Pt surface. Through integration of the platinum reduction peak at approximately 
















Figure 4.13. Cyclic voltammogram of AgNP electrodeposited to ITO electrode between 1000 and 
-200 mV Vs. Ag/AgCl at a scan rate of 100 mV/s..  carried out in 10mM H2SO4 as supporting 
electrolyte. Oxidative and reductive peak maxima associated with AgNP occur at approx. 550 and 200 
















In Figure. 4.14. FeSEM images of each nanotextured electrode surface are shown. 
These images were used to determine the size and size distribution of nanoparticles 
deposited to the surface of the electrode and in Figure 4.15. these distributions are 
shown. Table 4.1. shows the results obtained from these distribution data sets as well 
as the total estimated nanoparticle abundance 
 
 Diameter of nanoparticles (nm)      




























































Table 4. 1. Values for nanoparticle size and distribution electrodeposited to the surface of ITO 
electrodes. Nanoparticle abundance for AuNP and PtNP was determined from the mean particle size 
and the total surface area of each respective metal through voltammetry. In the case of AgNP, the total 
number of nanoparticles was determined for a fixed area using FeSEM imaging and then extrapolated 
to the entire electrode surface. 
 
From this data as well as the data sets below it is clear that this method for the 
electrodeposition of noble metal nanoparticles yields an array of particles, directly 
adsorbed to the surface of an ITO electrode, with a relatively narrow size distribution 
in the case of AuNP and AgNP, yielding what may result in a nanotextured electrode 
surface capable of enhancing the luminescent properties of immobilised ECL 
luminophores. However, in the case of PtNP there is poor control over the 




(A)   
(B)   
(C)   
Figure. 4.14. FeSEM images of (A)AuNP, (B)AgNP and  (C)PtNP electrodeposited to ITO electrodes. 
Imaging shows that AuNP and AgNP samples exhibit good size and  spatial distribution on the 
electrode surface, while PtNP electrodeposited to the surface show markedly poorer spatial 




Figure. 4.15. Size distribution data for AuNP, AgNP and PtNP respectively. AuNP and AgNP 
deposition yields particles with an average size of 45nm and 71nm respectively, however the 
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The localised surface plasmon resonance of each nanotextured electrode surface was 
also measured in order to determine the suitability of the metal nanoparticles for 
providing a plasmonic enhancement to the emission of luminophores at the surface 
of the electrode. In Figure 4.16. the absorption spectrum of a ITO electrode with 
AuNP is overlaid with that of the absorption spectra of commercial nanoparticles in 
solution ranging in size from 20 to 80 nm. For the commercial AuNP the Ȝmax of the 
20, 40 and 80nm nanoparticles were 522 nm, 526 nm and 547 nm respectively. 
 
Figure. 4.16. Overlaid absorption spectra of AuNP electrodeposited to an ITO electrode with that of 
commercial nanoparticles in solution of varying sizes. Absorbencies of both solution and surface 
bound nanoparticles were determined in deionised water using a 5x7 mm windowed cuvette and a 



















Interestingly for the sample of AuNP electrodeposited to the ITO electrode surface, 
which had a mean particle diameter of 42 nm (determined by FeSEM imaging) the  
Ȝmax is significantly redshifted to 562 nm, compared with that of the 40 nm 
commercial nanoparticles in solution. This tendency for the LSPR of 
electrodeposited AuNP to be shifted towards longer wavelengths may be an 
advantage in terms of plasmonic enhancement of luminescence. As the Ȝmax of the 
ECL luminophore is approximately 610 nm, if gold nanoparticles of a particular size 
may be deposited that have a significantly overlapping absorption spectrum with that 
of the luminophores emission spectrum, this would potentially facilitate the radiative 
plasmon model of metal enhanced fluorescence discussed by Lakowicz et al.. In this 
scheme, a resonance energy transfer occurs from the excited state luminophore to 
that of the nanotextured surface, in this case the underlying metal nanoparticle, and 
this excited state created in the nanoparticle itself then decays radiatively[21, 33]. 
The nature of the enhancement occurs due to the much shorted lifetime of the excited 
state in the nanoparticle itself, typically in the order of femtoseconds. Thus 
luminophores coupled to the nanoparticle plasmon in this scheme may then undergo 
a greater number of excitation and emission cycles. 
In Figure. 4. 17. the absorption spectra for both 40 nm commercial AuNP and AuNP 
electrodeposited to an ITO electrode with an average size of 42 nm are normalised to 
the number of nanoparticles in solution/ surface bound from which the absorption 
spectra were measured. The surface bound nanoparticles appear to exhibit a much 
stronger absorption that that of their solution based commercial counterparts. This 
may be explained as a result of the distribution of size of particles produced. The size 
distribution observed is broader than that of commercially produced nanoparticles 
and it is seen size distribution data that a significant number of particles exist above 
the mean value of 42 nm. As larger nanoparticles generally exhibit larger extinction 
coefficients it is suggested that this greater absorbance may be due in part to the 
contribution of larger nanoparticles in the array. This explanation is also supported 




Figure. 4.17. Absorption plots of both commercial 40nm AuNP in solution and AuNP 























In Figure.4.18. the plasmon absorption bands of PtNP and AgNP are also shown 
alongside AuNP. It should be noted that for PtNP the absorption peak is very broad 
and poorly defined, as expected as the LSPR of Pt is quite weak and the overall 
surface coverage of PtNP formed on the electrode was low, as well as a broad size 
distribution, when compared to that of AuNP and AgNP depositions. In sharp 
contrast, the surface plasmon of AgNP is shown to be well defined and occurs at 
approximately 428 nm, which is in good agreement with literature reports of silver 
colloids, occurring close to the near UV region[18]. This may indicate that AgNP 
may be suitable for enhancing the emission of luminophores bound to their surface 
due to their considerable spectral overlap between the absorption of the nanoparticles 
and the absorption of the luminophore. However, as the method for luminophore 
excitation is electrochemically based, and therefore lacking in an incident source of 
light, in comparison to optical excitation, this scheme for enhancement of 
luminescence would not be valid in a ECL based assay. Coupled with the poor 
stability of AgNP under oxidative potentials required to generate ECL, the 
possibility of AgNP enhancing ECL was not considered further. 
 Figure 4. 18. Overlaid surface plasmon absorption spectra of AuNP AgNP and PtNP deposited to the 



















4.4.4. Surface Enhanced Raman Spectroscopy of Nanotextured Electrodes. 
 
Once the formation of nanoparticles on the surface was optimised and characterised, 
it was then determined whether or not these nanotextured surfaces had the potential 
to bring about any surface enhancement of the ECL luminophore. As the overall 
surface coverage of dye would be at a maximum of 10-10 mol cm-1 on a 2 
dimensional surface (monolayer surface coverage)[34], experimentally it was 
deemed that fluorescent spectroscopy was not sensitive enough to detect 
luminescence at such small scales. However, Raman spectroscopy is well suited to 
the detection of molecules at surface concentrations of 10-11 and lower. The effect of 
silver nanoparticles resulting in a strong enhancement of Raman signal is well 
documented in the literature[18, 35]. Reports of Gold being utilised in SERS are also 
abundant, albeit with a poorer performance being reported in most cases than that of 
silver[17].   
In order to measure the effect of surface enhancement by different nanotextured 
surfaces, nanoparticles were electrodeposited to ITO electrodes as previously 
described using 16-phosphonohexadecanoic acid as a template for nanoparticle 
formation. The resulting gold and platinum nanoparticles were then characterised 
spectroscopically and electrochemically. The electrodes were then placed in a 2mM 
ethanolic solution of 16-mercaptohexadecanoic acid for a minimum of 16 hours to 
form a monolayer of carboxylic acid termini on the surface of the nanoparticles, as 
well as a monolayer of carboxylic acid termini on the surface of the ITO as a result 
of the formation of a 16-phosphonohexadecanoic acid monolayer during nanoparticle 
formation. The ECL luminophore RuPICNH2 was then conjugated to the carboxylic 
acid termini surface through carbodiimide crosslinking chemistry. This was carried 
out in dimethylformamide (DMF) using dicyclohexylcarbodiimide (DCC) and N-
hydroxysuccinimide (NHS) as this nanoparticle/ monolayer/ dye system had no 
sensitivity to organic solvents and the yield for organic carbodiimide chemistry 
based on DCC being markedly higher than that of its aqueous based ethyl-
dimethylaminpropylcarbodiimide (EDC) counterpart. Following the conjugation 
reaction electrodes were washed with copious amounts of DMF to remove any 
unbound luminophore. The Raman spectra of the electrodes were then measured, 
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with a nanoparticle free ITO electrode used as a control. The resultant Raman spectra 
are shown in Figure. 4.19. where it can be seen that the PtNP electrode is almost 
identical to the control. The gold and silver nanoparticle samples show a broad peak 
at approximately 1600 cm-1 that may be the result of poor resolution of two peaks 
expected at approximately 1560 and 1605 cm-1 as a result of a C=C stretch mode. 




Figure. 4.19. Raman spectra of nanoparticle-ITO electrodes with C16 monolayers on the surface 
conjugated to RuPICNH2. Samples were excited with a 514 nm laser at 100% intensity using a 50x 
objective with a 300 µm for 10 accumulations and an acquisition time of 10.  For both AuNP and 
AgNP, a peak can be seen at ~1600 cm-1, believed to be a combination of peaks associated with C=C 
stretch modes of the bipyridyl groups, however this cannot be resolved. 








There are many reports of nanoparticles improving the spectroscopic characteristics 
of luminophores within close proximity, however it is well understood that there is a 
strong and somewhat counter intuitive relationship between distance and 
enhancement. There exists a maximum range at which the plasmon may extend to 
and ultimately where dye and plasmon may be in range for resonance energy transfer 
to occur and bring about enhancement[21]. This distance depends on a number of 
key factors including the quantum yield of the dye, spectral overlap of the plasmon 
absorption band and the luminophores emission wavelength, and the size and shape 
of the nanoparticles, but is usually limited approximately 10 nm. However, there also 
exists a minimum distance that molecules must be before an appreciable 
enhancement is achieved and quenching by acceptor states in the nanoparticle 
avoided. Therefore, it was decided to compare the Raman results of the monolayer- 
RuPICNH2 conjugation (16 carbons chain, approx. 2 nm) with that of RuPICNH2-
DNA hybridised to the surface (22bp, approx. 5.5-7.5 nm). In these experiments, 
nanoparticles were electrodeposited on an electrode and a thiolated DNA capture 
strand monolayer was formed on the surface. The electrode was then incubated in 10 
µM miR-132 and then in the RuPICNH2-probe conjugate. Thus, the surface was 
decorated with RuPICNH2. A lower surface coverage was expected due to a number 
of factors, chiefly that there would only be hybridisation at the surface of the 
nanoparticles and not in the spaces between. Also due to steric hindrance of the 
monolayer itself. In fact it has been reported that a closely packed, surface confined 
monolayer of nucleic acids can hybridise to target in solution at an efficiency of 
approximately 10%. 
However, as seen in Figure. 4.20., both gold and silver nanoparticle decorated 
surfaces had an enhancement effect of the Raman signal for RuPICNH2 immobilised 
to the surface via nucleic acids. In contrast, the blank and platinum nanoparticle 
samples remained featureless, which was expected due to both the poor morphology 
of PtNP on the surface and its weak ability to facilitate SERS. In both gold and silver 
samples there were strong bipyridyl vibrational modes visible at ~1570 and ~1610 
cm-1 associated with C=C stretching and at ~1330 and ~1495 cm-1 associated with 
C=N stretching. The AgNP sample also exhibited well defined peaks for C-C, CCH, 
and Ring breathing modes at ~1280, ~1190, and ~1030 cm-1 respectively. These 
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modes, while present in the AuNP sample, were only marginally observable over the 
background. 
Figure. 4.20. Raman spectra of nanoparticle-ITO electrodes with RuPICNH2 immobilised to the 
surface through hybridised miRNA. Samples were excited with a 514 nm laser at 100% intensity 
using a 50x objective with a 300 µm for 10 accumulations and an acquisition time of 10.  Both AuNP 
and AgNP electrodes exhibit strong raman signals associated with the bipyridyl groups of RuPICNH2. 







Finally, in order to get conclusive proof that both monolayer RuPICNH2 and DNA- 
RuPICNH2 samples did indeed have RuPICNH2 bound to the surface, and thus 
suggesting that the observed increase in raman signal was due to SERS, rather than a 
lack of bound luminophore, all samples were imaged using confocal microscopy. In 
Figure 4.21. images of all samples used in the previously mentioned raman studies 
are shown. It should be noted that the resolving power of light microscopy is limited 
by wavelength and numerical aperture[36] and therefore in these images samples 
appear to have nanoparticles much larger than those seen in FeSEM images. All 
examples where RuPICNH2 was conjugated to a monolayer on the surface of the 
electrode rather than through a nucleic acid chain have much higher apparent 
background luminescence (between nanoparticles), whereas samples in which the 
RuPICNH2 was immobilised to the surface through a nucleic acid strand 
hybridisation appear to have better differentiation between nanoparticles and the 
space between them. Regardless, it was observed that each sample showed the 
presence of RuPICNH2 bound to the surface in some form, and thus it was concluded 
that the differences in Raman spectra observed were due to the enhancement of 








Figure. 4.21. Confocal microscopy images of ITO-NP electrodes used in raman study. Images on the 
left are PT, Au and Ag monolayer-luminophore conjugated surfaces respectively, exhibiting a high 
degree of background luminescence due to conjugation of luminophore to the entire electrode surface. 
Images on the right are of miRNA bound luminophore exhibiting better nanoparticle definition. 
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4.4.5. ECL detection of miR-132 on gold nanoparticle ITO electrodes. 
 
Following on from this, the nanotextured electrode surface’s ability to improve the 
sensitivity of miRNA detection was investigated. As AuNP-ITO electrodes were 
seen to have both favourable electrochemical stability, compared to that of AgNP, as 
well as favourable optical properties, compared to that of PtNP, they were chosen as 
the nanotextured surface that would best suit the enhancement of the electrochemical 
detection of miR-132 through ECL. 
To begin with, AuNP ITO electrodes were compared alongside planar ITO 
electrodes in ECL using a 500 nM solution of RuPICNH2 and 50mM TPA in 
100mM phosphate buffer. The resulting ECL intensities are shown in Figure. 4.22. 
Here it can be seen that the maximum ECL intensity of the AuNP ITO electrode, 
approximately 2.21 A.U., is over 3 times greater than that of the bare planar ITO 
electrode, which was 0.69. As the surface area of the nanoparticles is determined to 
be 0.47cm2 from voltammetry, and if the area between nanoparticles is assumed to 
be rendered electrochemically inert by the phosphonohexadecanoic acid monolayer 
formation prior to nanoparticle deposition, then the surface area of both bare ITO (7 
x 7mm, or 0.49cm2) and the surface area of the ITO-AuNP electrodes can be 
considered to be similar. Thus it is suggested that the difference in ECL intensity 
observed between these electrodes is not due to changes in surface area. This 
indicated that the surface was a good candidate for the enhancement of ECL intensity 





Figure. 4.22. Overlaid ECL outputs of planar ITO (Blue) and AuNP ITO (Red) in the absence of 
RuPICNH2, and planar ITO (Green) and AuNP-ITO (Purple) in the presence of 500 nM RuPICNH2. 
All ECL was carried out in 100mM phosphate buffer with 50mM TPA as co-reactant vs. Ag/AgCl at 
a scan rate of 100 mV/s. 
With these results in mind an assay was carried for the detection of miR-132 was 
carried out using AuNP ITO electrodes. The formation of a nanotextured surface was 
carried out as previously mentioned in this chapter and surface plasmon absorption 
of each ITO-NP electrode was determined in order to ensure homogeneity between 
samples. The surface area of AuNP formed on each electrode was also determined so 
that assay results could be normalised with respect to the electrochemically active 
area. The electrodeposited AuNP were then placed in a solution of 1µM thiolated 
capture oligonucleotide for a minimum of 16 hours to form a monolayer of capture 
oligo nucleotide on the surface of the nanoparticles. The individual, independent, 
electrodes were then incubated with varying concentrations of miR-132 for a fixed 
time, after which they were washed and incubated in a solution of probe 
oligonucleotide/luminophore conjugate. Following the final incubation, electrodes 
were then washed with copious amounts of DPBS and then placed in a custom ECL 
















Figure. 4.23. ECL intensities of Planar and AuNP ITO electrodes plotted as a function of [miR-132] 
incubated with the electrode surface. All ECL measurements were carried out in 100mM phosphate 
buffer vs. Ag/AgCl with 50mM TPA as co-reactant.  
 
In Figure 4.23 the data resulting from this assay is presented alongside the data 
obtained for the assay using planar gold electrodes in Figure 4.8, Controls where 
electrodes were incubated in clean buffer ie. no miRNA target, are also shown for 
each respective assay. It is important to note that for the purpose of comparison,  
the data from the AuNP-ITO assay has been normalised to the surface area of the 
smaller planar gold electrodes that it is being compared to here. This was carried out 
in a bid to relate the ECL output of the relatively large AuNP-ITO electrodes to that 
of the smaller planar gold electrodes. 
If the value for ECL intensity of controls is subtracted from each assay respectively 
this data suggests that an enhancement of the ECL output is observed, as the signal 
output for each data point in the assay carried out on AuNP-ITO electrodes is 
approximately 2.5 times greater than that of the results of the assay carried out on 
planar gold electrodes. However the overall magnitude of the ECL intensity seen 
from control samples is still quite appreciable, most likely to non-specific binding of 
luminophore to the surface of the electrode. The ratio between the output of ECL in 
y = 0.0415ln(x) + 1.6929 
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the control versus assay samples is similar for both planar and nanoparticle modified 
electrode substrates and therefore it can be concluded that the amount of non-specific 
binding remained almost constant for both planar gold electrodes and AuNP-ITO 
electrodes. Therefore, using the data above and subtracting the value for controls 
from the overall ECL output for each electrode the equation of this calibration curve 
is then given as; 
y = 0.0415 ln(x) + 1.2509 
Which can then be used to calculate the theoretical limit of detection of this assay, 
which is given as 8.29 e-14 moles or 83fM. When compared to the theoretical limit 
of detection of the assay carried out on planar gold electrodes, of 252 fM, this does 
not appear to be statistically appreciable and thus the limit of detection of both 
assays is considered to be statistically the same. 
The overall increase in ECL for this assay is encouraging, and does suggest that 
some enhancement to the ECL is occurring, however, the nature of this enhancement 
is not immediately clear. There are three distinct possible factors that may be 
contributing to the enhancement observed, increased surface area of the electrode, 
plasmonic enhancement of the dye by the underlying nanoparticle and improved 
mass transport diffusion of coreactant. Initially the surface area argument may be 
easily dissuaded, as the results observed in Figure. 4.23. have been  normalised in 
order to relate them the surface area of the planar conventional gold electrodes used 
to generate the data for Figure 4.8. It may be argued that the area between 
nanoparticles, ie. the ITO surface, may also contribute to the electrode surface area, 
however, this area has been observed to be passivated by a monolayer during 
nanoparticle electrodeposition and would not be expected to facilitate charge transfer 
in an appreciable way compared with that of the gold nanoparticle surface. Also, 
controls for both of the above mentioned assays are close to equal in proportion to 
the assay results, suggesting that a larger electrode does not result in a larger signal. 
The observed signal enhancement must then be attributed to either plasmonic 
enhancement or improved mass transport diffusion. The case for plasmonic 
enhancement however lacks additional evidence such as shortening of luminescent 
lifetime and also the magnitude of ECL enhancement is much smaller than that 
reported previously in the literature[16]. 
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This approximate 2.5 fold increase in ECL intensity observed for the AuNP ITO 
based assay, compared to that of the planar gold electrode assay is  
far more likely to be due to the 3 dimensional nature of the AuNP ITO electrodes, 
and their ability to facilitate the fast mass transport diffusion of co-reactant to and 
from their surface, due to radial diffusion around the surface of the individual 
nanoparticles, as opposed to the linear diffusion that would be observed for a planar 








An assay for the detection and quantitative analysis of miR-132 by 
electrochemiluminescent detection of RuPICNH2 has been described. A method for 
the conjugation of the luminescence reporter luminophore, RuPICNH2 was 
optimised and shown to be effective both through confocal microscopy and ECL. 
Initial assays carried out on planar gold electrodes have shown that a theoretical limit 
of detection of sub picomolar miR-132 concentrations was achievable on a planar 
electrode substrate. Attempts were made to address this issue by the formation of a 
nanoparticle decorated substrate that would facilitate the plasmonic enhancement of 
RuPICNH2 luminescence. The optimisation and characterisation of such nanoparticle 
electrode surfaces is also reported , showing good control over size and distribution 
for metal nanoparticles electrodeposited to the electrode surface. Furthermore, the 
particles deposited to the surface display distinct plasmonic properties that are 
resonant with either the metal complex absorbance (AgNP) or emission (AuNP) 
making them attractive for both ECL and optical emission based assays. 
Attempts were then made to exploit the plasmonic properties of these nanotextured 
surfaces. Initially, surface enhanced raman spectroscopy gave good evidence that 
enhancement of luminescence could be possibly facilitated by gold nanoparticles on 
the surface of the electrode. However, this did not appear to be the case when 
examined by ECL analysis, and any improvement in signal was likely due to 
enhanced diffusional mass transport of co-reactant to the surface of the electrode. 
i.e., a contribution from radial diffusion when nanoparticles are present. 
Future work would likely be focused in two directions. Firstly on carrying out 
lifetime studies on the ECL emission of RuPICNH2 to determine whether the 
observed luminescent enhancement observed on nanoparticles may be attributed to a 
decreased lifetime. If this is the case it would make a strong case for the observed 
enhancement to be plasmonic in nature as it is well understood that in the scheme of 
radiative plasmon enhancement the emission from resonant energy transfer from 
luminophore to nanoparticle results in markedly reduced luminescent lifetimes. The 
other direction of future work would be focused on identifying novel luminophores 
206 
 
that may be exploited in the same way RuPICNH2 was in this ECL detection 
approach.  However, with a spectral overlap between the emission of the 
luminophore and the plasmon absorption of the nanoparticle surface, such as Iridium 
(III) luminophores, that have been shown to be compatible with ECL and also 
display strong emission at approximately 540 nm, markedly closer to the spectral 
region for the plasmon absorption band of the AuNP electrodeposited to the 
electrode surface in this chapter. In this scenario, the resonance energy transfer 
would occur from the excited state luminophore, to the nanoparticle, which may then 
radiate a photon under certain conditions. This radiative plasmon model of 
luminescence enhancement, first described by Lakowicz et al. is thought to be the 
most likely mechanism for the examples of SEECL reported in the literature[21, 33] 
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5. Conclusion and Future Work. 
 
This thesis reports on electrochemical approaches for the detection of cellular and 
genetic biomarkers of Neuroblastoma. Here the focus was on developing assays for 
the sensitive and selective detection of minimal disease biomarkers.  
The initial chapter was focused on reviewing the current literature surrounding 
neuroblastoma and miRNA, as well as the current and emerging approaches in 
detection of cellular and genetic biomarkers and their underlying mechanics. 
Following on from this, Chapter 2 was focused on the immobilisation of 
neuroblastoma cells to an electrode surface and their subsequent detection by 
electrochemical impedance spectroscopy and amperometry. The outcome of this was 
that while both approaches were capable of carrying out qualitative detection of cells 
immobilised to the surface of an electrode at low counts (<10 cells), signal output 
was not linear and quantitative data could not be reliably extracted from this assay 
for cell counts lower than approximately 100 cells. 
Chapter 3 was focused on the development of microcavity arrays for the 
immobilisation and lysis of neuroblastoma cells and the subsequent detection of 
miRNA targets within. This chapter was primarily concerned with the formation of a 
bifunctional microcavity array where the outer and inner surfaces of the microcavity 
array could be independently modified. The outer surface of the microcavity arrays 
was developed as a cell capture platform, while the inner surfaces of the 
microcavities were modified with an self-assembled monolayer of oligonucleotides 
complementary to miR-132, a miRNA whose expression is upregulated in 
neuroblastoma. Following cell lysis and immobilisation of miR-132 to the inner 
surface of the microcavity, an electrocatalytic PtNP modified with probe 
oligonucleotide could then be hybridised to the immobilised miRNA target. This 
PtNP, under an applied potential, could then carry out the electrocatalytic reduction 
of H2O2 producing a current proportional to the number of PtNP immobilised to the 
microcavity and thus, proportional to the number miRNA targets immobilised to the 
microcavity surface. The outcome of this work was that while cell immobilisation 
and lysis was carried out successfully, the subsequent detection of miRNA by 
amperometry proved to be inadequate, due to the excessive background reduction of 
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H2O2 by the microcavity surface itself. It was determined that this excessive current 
generation by the microcavity surface was a result of the formation of the 
microcavities themselves. Measures were taken to attempt to reduce the influence of 
the microcavity array on current generation, however these proved unsuccessful.  
Chapter 4 was then focused on carrying out the detection of miR-132 by 
electrochemiluminescence. Here the miRNA target would once again be detected 
through immobilisation to a surface by an oligonucleotide and then hybridisation of a 
probe, however in this case the probe was now a luminophore that could be excited 
electrochemically to produce a measurable light output. Initial assay results carried 
out on planar gold electrodes showed that ECL output could be correlated with the 
concentration of miR-132 applied to the electrode surface, however the assay had 
poor sensitivity. Therefore the latter half of this chapter was reported the attempts 
made to enhance signal output through development of electrodes with nanotextured 
surfaces. Throughout this work, the formation and characterisation of 
electrodeposited nanoparticles was reported. Gold and Silver nanoparticle surfaces 
were shown to give surface enhanced raman spectroscopy of luminophores when 
they were bound to the surface by miRNA hybridisation, or at a distance of 
approximately 7 nm. This signal enhancement was then shown to be distance 
dependant as surfaces with luminophores bound closely to the surface of 
nanoparticles by a self-assembled monolayer, approximately 2 nm in length. This 
approach of nanoparticle mediated surfaced enhanced electrochemiluminescence was 
applied to the detection of miRNA as previously described. While signal 
enhancement was observed, the sensitivity of the assay did not increase and it was 
unclear whether or not the perceived signal enhancement was due to plasmonic 
enhancement of luminophore emission, or due to the enhanced kinetics of the 
nanotextured surface. 
To elucidate the exact mechanism of enhancement observed here, future work would 
initially be concerned with the study of the change in luminescent lifetime of 
luminophores during ECL signal generation. If a change in the lifetime of 
luminophores bound to the surface of nanoparticles was observed to be shortened, 
this would suggest that the enhancement of luminescent emission observed at 
nanotextured surfaces was due to plasmonic enhancement rather than improved mass 
transport diffusion of coreactant. 
